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1 General introduction 
1.1 From genomics to functional genomics 
Genomics is the large-scale study of the genomes of organisms by 
biochemical tools, which was established by Nobel laureate Fred Sanger with the 
complete sequencing of genomes of 5S ribosomal RNA from Escherichia coli in 
1967 (Brownlee et al., 1967) and bacteriophage phi X174 DNA in 1977 (Sanger et 
al., 1977). However, the term “genomics” itself was coined by Tomas Roderick in 
1986. Genomics studies based on DNA sequencing were the central issue in the 
Pre-Genomic era, many significant milestones were reached during that time, such 
as the first sequencing of a gene of bacteriophage MS2 coat protein in 1972 (Min 
Jou et al., 1972), the first sequencing of a DNA-based genome of bacteriophage phi 
X174 in 1977 (Sanger et al., 1977), the first sequencing of a free-living organism of 
Haemophilus influenzae in 1995 (Reischmann et al., 1995) and a rough draft of the 
human genome by the Human Genome Project in early 2001 (International Human 
Genome Sequencing Consortium et al., 2001; Venter et al., 2001).  
This draft of the human genome as a symbol marked the coming of the Post-
Genomic era. However, at that time the intensive accumulation of complete gene 
codes in databases was still not sufficient to clarify their gene products. Several 
reasons result such difficulty: First, the existence of an open reading frame (ORF) 
in genomic data does not necessarily indicate the existence of the corresponding 
gene product, as was found in the case of alpha herpesviruses (Boldogkoei et al., 
1994); second, there is no strict linear relationship between genes and their 
corresponding gene products. This has been pointed out in by Pandey et al. in 2000 
(Pandey et al., 2000) and was indirectly supported with the study on the 
relationship between protein-fusion and gene co-expression by Gunter and 
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Gaasterland (Gunter et al., 2001); third, until now and even in the near future, it is 
still difficult to predict genes accurately from genomic data, as pointed out from the 
sequencing of human chromosome 22 (Dunham et al., 1999); fourth, as mentioned 
by Pandey et al., “the sequencing of related organisms will ease the problem of 
gene prediction through comparative genomics, the success rate for correct 
prediction of the primary structure is still low” (Claverie 1997, Pandey et al., 1999). 
The error rate was at least 8% in the annotations for 340 genes from the 
Mycoplasma genitalium genome (Brenner 1999) and even in the recent reports, the 
problem still exists in spite of the reduced error rate (Shampson et al., 2009).  
Furthermore, despite the difficult of identifying the gene products directly 
from their genome, the simple demonstrating the existence of the gene products is 
also not sufficient for understanding their function in a biological system. In order 
to understand the function of the genes, the genomes analyses have been improved. 
“Functional genomics” was initiated in the late eighties, which was conceived to be 
able to narrow the gap between traditional genome sequencing-based analysis and 
the required genome function analysis. The birth of functional genomics also 
marked the division of conventional genomics into two subtopics. Beside 
“functional genomics”, “structural genomics” was also invented (Burley et al., 
1999). During the early nineties, there were many different interpretations on 
functional genomics. In 1997, Philip Hieter and Mark Boguski pointed at a clearer 
task for functional genomics and enumerated several emerging methods (Hieter et 
al., 1997). Functional genomics nowadays is interpreted as a field, which utilizes 
the genomic data to describe gene functions and interactions. Especially studies on 
gene transcription, translation, and protein-protein interactions are in the focus of 
functional genomics. To this end, many associated techniques were developed in a 
rapid way: DNA microarrays (Schena et al., 1995, Shalon et al., 1996) and serial 
analysis of gene expression (SAGE) (Velculescu et al., 1995, Saha et al., 2002, 
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Matsumura et al., 2005) for mRNA, siRNA and cDNA transfection to study 
individual or libraries of genomic reagents in cell-based experiments (Mousses et 
al., 2003, Pullmann et al., 2007). A concept termed as “expressed sequence tag” 
(EST) (Adams et al., 1991) emerged during that time. As an important resource, 
ESTs have been intensively studied, benefited from above advanced methods 
(Nagaraj et al., 2006). Because most studies on ESTs are at the RNA level, the term 
“tanscriptomics” was proposed. In analogy to genomics, transcriptomics is the 
study of the transcriptomes. A recent review summerized the achievements of 
transcriptomics studies until now (Wang et al., 2009). The further that researchers 
go in addressing questions on functional genomics, the more they realize that 
studies only on gene function-related mutations and polymorphism, such as single-
nucleotide polymorphism (SNP) (Vignal et al., 2002) is insufficient, and that 
studies should also involve the measurement of final gene products (such as 
proteins and metabolites), which are opposite to transcripts, the prior gene product. 
Following the birth of transcriptomics, proteomics, the study of the proteomes and 
metabolomics, the study of the metabolomes (Oliver et al., 1998) emerged from 
functional genomics. 
1.2 Short historical background to proteins 
Proteins as distinct biological polymers have a long history in chemistry. In 
the eighteenth century, they were recognized as chemical compounds coagulating 
or flocculating under treatments with heat or acid by the French chemist and 
clinician Antoine Fourcroy (1755-1809) and others. The first elemental analysis of 
common proteins was performed by the Dutch chemist Gerhardus Johannes Mulder 
(1802-1880), to reveal the astonishing fact that nearly all proteins have a same 
empirical formula C400H620N100O120P1S1 (Mulder 1838). Mulder believed the 
proteins consists of a fundamental material, named as Grundstoff and hydrolysis of 
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proteins delivered a substance, with both amino and carboxylic functionalities. 
Hence, the substance was called an amino acid. The first two amino acids leucine 
(in 1819) and glycine (in 1820) were isolated by the French chemist and pharmacist 
Henri Braconnet (1780–1855). Mulder continued to identify the molecular mass of 
leucine and chemically synthesized it as the first synthetic amino acid in 1855 
(Perrett 2007). The term “protein”, derived from the greek word “prota” (of 
primary importance), however, was coined by Mulder’s associate in 1838, the 
Swedish chemist and clinician Joens Jakob Berzelius (1779-1848). Although later 
several other proteins such as albumins, fibrin and haemoglobin were isolated, the 
function of proteins in biological systems was not understood until the enzyme 
urease was demonstrated to be a protein (Sumner 1926). Before the phenylalanyl 
chain of insulin I/II in 1951 and the glycyl chain of insulin I/II in 1953 were 
sequenced by Frederick Sanger (Sanger et al., 1951, Sanger et al., 1953), proteins 
were presumed to be somewhat amorphous. The structures of myoglobin and 
haemoglobin were resolved by Sir John Cowdery Kendrew and Max Perutz, 
respectively (Kendrew et al., 1958, Perutz et al., 1960). Those were the first 3D 
structures determined by x-ray diffraction analysis.  
While the properties and structures of proteins such as catalytic activities of 
enzymes were studied by chemists, the biological functions of proteins in living 
organisms were also increasingly studied by biologists. Initially, proteins were 
studied individually. However, when the time of studying protein cellular functions 
came - studies into actin or tubulin (Weisenberg 1981), enzyme cascades such as 
the coagulation cascade (Zimmermann et al., 1978) or cell signalling such as 
Hedgehog signalling pathway (Nüsslein-Volhard et al., 1981) - a systematic study 
of proteins was appreciated in biology. 
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1.3 From functional genomics to proteomics 
Functional genomics made many achievements with mRNA studies. 
However when N. Leigh Anderson and Jeff Seilhamer presented the first multi-
gene comparison plot of mRNA vs protein abundance for cellular gene products in 
1997, they calculated a correlation coefficient between mRNA and protein of 0.48 
(Anderson et al., 1997). This correlation coefficient shows that the relationship 
between mRNA and proteins is not that strict. Studies of angiotensin (Pfeffer, 
1993), 7-transmembrane G-protein coupled receptors (Wess, 1997) and Alzheimer 
amyloid precursor protein (Hooper et al., 1997) showed that cellular control system 
can operate purely at the protein level. Transcriptomics cannot resolve the 
questions of cellular control systems. Furthermore, as proteins are more stable, they 
are much better samples than mRNA. Proteins are involved in nearly all biological 
activities, so they are the direct material to study functions of biological systems. 
“Functions: proteins 100 000 – mRNA 1” and “the current term functional 
genomics, which implies that function can be explored at the genomic level, is a 
bizarre…” were described in the review by Anderson (Anderson et al., 1998). No 
matter whether that comment extreme is or not, the proteomics indeed completely 
succeeded the principle and mission of functional genomics in studying functions 
of biological systems.  
Although the term “protein” originated in the field of chemistry as early as 
the nineteenth century, indeed much earlier than the term “gene”, “proteome” and 
“proteomics” were proposed later than “genome” and “genomics” in the field of 
molecular biology. The term proteome was coined by Marc Wilkins in 1994 in the 
symposium of "2D Electrophoresis: from protein maps to genomes" and later in his 
paper “from proteins to proteomes” to describe the proteome as “the PROTEin 
complement expressed by a genOME” (Wilkins et al., 1996). Nowadays, a 
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proteome usually refers to the entire of proteins expressed by a genome, cell, tissue 
or organism. Hence, proteome is not as genome strictly defined. To describe a 
proteome in an accurate way, the time and defined conditions to express the 
referred proteome have to be noted. In reality, the term proteome sometimes refers 
more widely to a group of cellular proteins, or a collection of proteins in certain 
sub-cellular biological systems. (In certain cases, a mixture of proteins from 
different organisms is also called a mixed proteome.) Due to alternative splicing of 
genes and post-translational modifications (PTMs) of proteins, there are more 
proteins than genes. To study a proteome is therefore more complex than a genome. 
The proteomics cannot be limited to the accumulation of the protein sequences like 
the genomics is a list of DNA sequences, but also including information on protein 
structures and the functional interaction between proteins. 
Although proteomics was first coined by James in 1997 (James, 1997), the 
origin of proteomics dates back to the late seventies when different high-resolution 
2D-electrophoresis methods were developed by Klose (Klose, 1975), O’Farrell 
(O’Farrell, 1975) and Scheele (Scheele, 1975) to assemble proteins databases. 
Hence, proteomics stood originally for analysis of a large number of proteins from 
a given cell line or organism on 2D polyacrylamide gels. With further developed 
techniques, proteomics is nowadays more widely defined as large-scale studies of 
proteins in living organisms, particularly their structures and physiological 
functions. 
Proteomics is complementary to genomics because it directly focuses on the 
proteins, which implements all biological processes. Verification of gene products 
by proteomics is a reliable way to interpret the genome. As a short summary, 
comparing to genomics or transcriptomics, the advantages of proteomics for 
studying the functions in biological systems are obvious: first, the existence of gene 
products can be confirmed by proteomics; second, the protein expression level can 
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be more accurately determined (Gygi et al., 1999); third, the subcellular 
localization of gene products can be monitored experimentally; fourth, the 
interaction between protein and the cellular chemical structures such can be 
analysed only in the protein level; fifth, modifications of the proteins are not 
encoded directly in the genome, such as isoforms, PTM, and regulation of protein 
function by proteolysis, recycling and sequestration in cell compartments can be 
investigated only by proteomics.  
1.4 From proteomics to functional proteomics 
In the genomic era, proteomics is mainly dependent on annotation from 2D 
protein gel of cell lysates (Berndt et al., 1999, Caron et al., 2002) and visualization 
of protein expression levels on 2D protein gels (Greenspan et al., 1995, Gygi et al., 
2000). The 2D gel approach dates back to the time when Frederick Sanger analysed 
the two polypeptide chains of Insulin (Sanger et al., 1951, Sanger et al., 1953). The 
resolution of the gel was always the bottleneck restricting the gel-based 
visualization of the proteome. The best 2D gel can resolve no more than 1000 
proteins, usually only for the most abundant proteins. However when the technique 
of mass spectrometric identification of gel-separated proteins was combined with 
proteomics, protein annotation on gel was widely extended. Comparing to classical 
Edman degradation technique, mass spectrometry is more sensitive for complex 
proteomes and able to be combined with high-throughput screening (HTS) 
techniques (Marvin et al., 2003). 
Proteins can be identified by gel-based mass spectrometric methods, however 
the information of the corresponding protein such as 3D structure, skeleton 
dynamicity, surface conditions (e. i. charges, lipo- or hydrophilic properties), 
interaction partners, or cellular localization are all lost with this method. These lost 
information indeed are more important than the sequence information of a protein 
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for studying its biological functions. In the Post-genomic era, many other 
techniques besides mass spectrometry joined in the proteomics for the complete 
study of functions of the biological systems. 
Mass spectrometric instrumentation for proteomics was quickly developed. 
Two soft ionization techniques, electrospray ionization (ESI) and matrix-assisted 
laser ionization (MALDI), enabled to ionize peptides or proteins (Fenn, et al., 1989, 
Karas et al., 1988). In order to analyse the complex proteome, four mass analyzers 
are routinely applied: quadrupole (Q), quadrupole/linear ion trap (QIT/LIT or LTQ), 
time-of-flight (TOF) and Fourier-transform ion cyclotron resonance (FTICR) mass 
analyzers. Nowadays, expensive hybrid analyzers are becoming popular for high 
sensitivity, such as Q-q-Q, Q-q-LIT, Q-TOF, TOF-TOF and LTQ-FTICR (Han et 
al., 2008). LTQ-Orbitrap is a new analyzer type, invented in 1999 (Makarov 2000), 
which was applied for proteome analysis and led to a fourfold improvement of 
sensitivity (Hu et al., 2005, Venable et al., 2007). The fragmentation techniques for 
tandem mass spectrometry (MS/MS) were also developed besides conventional 
collision-induced dissociation (CID), such as electron-capture dissociation (ECD) 
(Zubarev et al., 1998) or electron-transfer dissociation (Syka et al., 2004). With 
these new fragmentation methods, PTM of proteins can be better analysed (Shi et 
al., 2001, Chi et al., 2007). Benefited from the advanced technologies, the 
strategies for proteome annotation and PTM characterization were also improved. 
Bottom-up and Top-down are two usual strategies to analyse proteins. The bottom-
up approach refers to proteome separation before digestion followed by peptide 
mass fingerprinting-based acquisition or further peptide separation on-line coupled 
to tandem mass spectrometry to identify each protein. On the contrary, the top-
down approach means that the proteome is fractionated and separated into pure 
single protein or less complex protein mixtures, followed by off-line static infusion 
of samples into the mass spectrometer for intact protein mass measurement and 
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intact protein fragmentation to identify each protein. The shotgun method is a 
complementary method for the bottom-up approach (McDonald et al., 2003). 
However incorrect identification can lead to the loss of information from intact 
proteins and the limited dynamic range of mass spectrometric analysis only allows 
measurements of the most abundant peptides. The newer top-down approach 
provides direct analysis of modifications, but limits the ability to fragment intact 
proteins and the combination with throughout screening (Han et al., 2006, Parks et 
al., 2007).  
Protein-protein interactions (PPIs) study is another major field in functional 
proteomics. Protein microarrays are the first major application of PPIs. Similar to 
DNA microarrays, protein microarrays are applied to identify the substrates of 
proteins such as kinases (Schutkowski et al., 2004), transcription factors for gene-
regulation (Sala et al., 2009), or the targets of biologically active small molecules 
(Uttamchandani et al., 2006). Antibody microarray are a well-established protein 
microarray, and it is well known as the enzyme-linked immuno-sorbent assay 
(ELISA), used as a diagnostic tool in medicine and co-purification tool in plant 
pathology. Purification of protein complexes is a second part of PPIs. To purify 
entire multi-protein complexes by affinity-based methods, fusion proteins, 
antibodies, peptides, oligonucleotides or small molecules, targeting to a cellular 
target can be chosen to immunoprecipitate the complex by an antibody or 
immobilize the complex on a solid support via an associated ‘bait’ (Strausberg et 
al., 1999, Neubauer et al., 1998). Yeast-two-hybrid system (Y2H) and phage 
display are two other methods to study PPIs. Y2H was originally devised by 
Stanley Fields to monitor PPIs in Saccharomyces cerevisiae system (Fields et al., 
1989). A bait protein is fused to the DNA binding domain (DBD) and a prey 
protein is fused to the activation domain (AD) of a transcriptional activator. The 
interaction between bait and prey reconstitutes the functional transcription factor 
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and results in the expression of the reporter gene for positive selection. The bait 
protein can be screened against genomic or cDNA prey libraries expressing all 
encoded or expressed proteins in the organism or tissue of interest. Nowadays, 
improved Y2H systems have been reported, such as YTH for bacterial PPIs, 
MYTH for membrane associated PPIs and MAPPIT for mammalian PPIs (Suter et 
al., 2008). Like the Y2H, phage display is used for the HTS of PPIs, protein-
peptide or protein-DNA interactions. It uses bacteriophages to express proteins on 
their coat protein (Smith 1985). Highly diverse libraries (> 1010) can be represented 
as phage pools, and due to the link between genotype and phenotype, an antigen-
specific clone can be selected in vitro. Commonly used bacteriophages are M13 
and filamentous phage T7 (Kehoe et al., 2005, Sidhu et al., 2007). 
There are also several other methods in functional proteomics, such as 
fluorescence protein fusion to study protein localization (Van Roessel et al., 2002), 
proteomics analysis on large-scale mouse knockouts (Zambrowicz et al., 1998), 
RNA interference, as exemplified by small virus-induced gene silencing (VIGS) 
(Colbère-Garapin et al., 2005) or phenotypic analysis using deletion strains 
(Winzeler et al., 1999). 
1.5 From functional proteomics to chemical proteomics 
Although proteomics like genomics belongs to the study field of molecular 
biology, it returned to the chemistry study field recently, due to the inherent 
relationship. As shown in the above section, protein studies started in chemistry 
and chemical modification of proteins has a long-standing history in this field 
(Lundbald, 2004). The chemical tags used in proteomics today were established 
during the sixties to seventies. Chemical proteomics sometimes is considered as 
“methods to measure the interaction between small molecule compounds and 
protein targets” (Kruse et al., 2008). This view about chemical proteomics is 
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obviously too narrow; chemical proteomics is basically not different from 
conventional functional proteomics, but combines chemical tagging concepts 
(Leitner et al., 2006) systematically with proteomics, and enables this new hybrid 
methodology to much better resolve the difficulties in functional proteomics. 
Modifying functional groups in peptides to improve the sensitivity for mass 
spectrometry is one part of chemical proteomics. For example, the  “tandem mass 
tag” (Thompson et al., 2003) allows quantitation at the MS/MS level. Coumarin-
based tags were used to enhance detection sensitivity and fragmentation efficiency 
in MALDI-MS and -MS/MS (Pashkova et al., 2004). 
Introduction of labels for relative or absolute quantification is the second part 
of chemical proteomics. In stable isotope labelling (SIL), heavy isotopes such as 2H, 
13C, 15N and 18O are frequently used to determine protein levels. iTRAQ, an 
acronym for isobaric tag for relative and absolute quantification was introduced in 
2004 (Ross et al., 2004) and reductive dimethylation of amino groups (Hsu et al., 
2003) is a second method to label the proteome with heavy isotopes. These 
labelling methods enable mass spectrometry not only for determining the presence 
of a protein or PTM, but also for quantitative analysis of interiorly labelled 
proteomes. Stable isotope labelling of amino acids in cell culture (SILAC) (Ong et 
al., 2002), selective reaction monitoring (SRM) (Mayya et al., 2006) or multiple 
reaction monitoring (MRM) (Anderson et al., 2004) are further emerging mass 
spectrometric strategies.  
The introduction of affinity tags to enrich certain samples is the third 
important application in chemical proteomics. The cleavable isotope-code affinity 
tag (cICAT) originated from the isotope-code affinity tag (ICAT) techique, which 
is a method to quantify the proteome (Gygi et al., 1999). Unlike ICAT, the tags in 
cICAT incorporate a cleavage site in the linker region to its solid support (Zhou et 
al., 2002, Hansen et al., 2003). For cleavage, photoreactions or acids are used and 
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cysteine containing peptides are employed for attachment to the solid support. 
Similar to cICAT, visible isotope-coded affinity tag (VICAT) reagents tag thiols 
from proteins, by introducing a biotin affinity handle and a photocleavable linker 
for removing a portion of the tag, and an isotope tag for distinguishing sample and 
internal standard peptides (Bottari et al., 2004). Disulfide-exchange 
chromatography is used to enrich cysteine-containing peptides (Wang et al., 2001). 
The guanidine group of arginine can be reacted with 2,3-butanedione and a solid 
based boronate reagent to form bicyclo ring, which is labile for acid. This method 
enables to selective capture arginine containing proteins (Foettinger et al., 2005). 
PTM enrichment and characterization is the fourth major and significant part 
in chemical proteomics. In this study field, chemical proteomic approaches show 
almost unique properties. Phosphorylation and glycosylation are currently two 
intense study areas for PTM. Terms like phosphoproteomics or glycoproteomics 
were coined to show their special status as sub-proteomics study fields. 
Quantitation of natural phosphorylation is a major issue for analyzing 
phosphorylated proteins, and selective enrichment of phosphorylated peptides after 
digestion is required. Immobilized metal affinity chromatography (IMAC) with 
different metal ions or oxides such as Fe3+, Ga3+, TiO2, ZrO2, Al2O3 were developed 
(Sun et al., 2005, Schlosser et al., 2005, Kweon et al., 2006, Wolschin et al., 2005). 
Alternatively, -elimination of phosphate groups in pSer and pThr residues under 
alkaline conditions, followed by a Michael type addition of a thiol associated 
stable-isotope tags can also enrich or quantify the phosphorylated proteins 
(Adamczyk et al., 2002, Goshe et al., 2002, Amoresano et al., 2004). The study of 
PTM for glycosylation also focuses for the enrichment of glycosylated proteins. 
Besides traditional bioaffinity methods such as lectins (Kaji et al., 2003), chemical 
approaches were introduced, such as oxidation of the cis-diol to aldehyde, followed 
by a reaction with solid support hydrazine to form a hydrazone bond to immobilize 
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the glycosylated proteins (Zhang et al., 2003). Similar to phosphorylation, the N-
acetyl-glucosamine on serine or threonine residues can also be -eliminated under 
basic conditions (Vosseller, et al., 2006). Other PTMs, such as acetylation, 
methylation, S-nitrosylation and others were also studied by chemical proteomic 
approaches (Jaffrey et al. 2001, Hess et al. 2005). 
Some other techniques were and still are appearing in chemical proteomics. 
Instead of fluorescent fusion proteins, small organic molecules imaging techniques 
show potential advantage (Fernández-Suárez et al., 2008). PPIs can be influenced 
by small molecules, such as 14-3-3 proteins with fusicoccin (Malerba et al., 2004). 
Chemical microarrays are used for drug screening and discovery (Ma et al., 2006). 
Simliar to Y2H, Y3H is also a method to expand the Y2H principle (Schneider et 
al., 2008) and is another milestone showing that chemical proteomics enlarges 
conventional functional proteomics. 
Chemical proteomics is still a young family member in the field of life 
science, however due to its noble lineage from chemistry, it is destined to become 
one of the most prominent parts of proteomics. The publications achieved during 
only a short time period and earned high attentions, which is the best verification 
for its great potential. 
1.6 Chemical biology in chemical proteomics 
When scientists started to address biological questions based at the molecular 
level, the new interdiscipline chemical biology was born. Chemical biology was 
already reported in the early twentieth century (Dale, 1934, Beard, 1952), and the 
first publication could date back to 1916 (Henderson, 1916). The term chemical 
biology however first appeared in publications from the sixties (Stirewalt, 1963).  
One part of chemical biology is categorized as chemical genetics, which is 
defined as using chemical tools to study genetics (Mitchison, 1994, Schreiber, 
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1998). Forward chemical genetics (FCG) follows the way from effect to cause 
(“from phenotype to genotype” in forward genetics), first to screen the effect, that 
an inhibited or stimulated protein induces phenotype changes, and then to identify 
the small molecules causing the effects by regulation of the functions of certain 
proteins (Lokey 2003, Burdine et al., 2004). In contrast, reverse chemical genetics 
(RCG) follows the way from cause to effect, (“from genotype to phenotype” in 
reverse genetics), first to search the cause, i. e. a ligand stimulating or inhibiting the 
important protein by screening compound libraries, and then to study the effect, 
that introduction of that specific ligand to a cell or organism to prove the resulting 
changes in phenotype (Blackwell et al., 2003, Mayer, 2003). Chemical compounds 
libraries enable either forward or reverse chemical genetics. The required chemical 
compounds libraries consists for example of natural products (NPs), natural product 
derivatives (NDs), or collections derived from diversity oriented synthesis (DOS), 
tagged libraries, target guided ligand assembly (TGLA), dynamic combinatorial 
libraries (DCL) or annotated chemical libraries (ALC) (Walsh et al., 2006). These 
established chemical tools were also applied for many other chemical biology 
investigations and not only in chemical genetics screening.  
Another part of chemical biology focuses on medicine. The term “medicine” 
is derived from the Latin ars medicina (the art of healing). Considering this, 
medicine could be defined as the art and science of healing. It encompasses 
maintaining and restoring health and treating illnesses. To this end, chemical 
biology for medicine is also applied mainly for two sub-areas, pharmacology and 
physiology. For its application in pharmacology, clinicians initially argued that 
those “entering medicine should not waste their time on chemistry” (Rosenfeld, 
2003), but after the “magic bullet” was introduced by Paul Ehrlich in the early 
twentieth century (Ehrlich, 1911), such opinions lost markets swiftly. Those magic 
bullets are small molecules, which target specific tissues or microbes. This is the 
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starting point for modern pharmacology. Nowadays the pharmacologic functions of 
small molecules are more carefully studied, implemented via interactions between 
small molecules with DNA, RNA and proteins (Schreiber, 2005). Unlike 
pharmacology, physiology focuses on basic questions in life science. The way in 
which chemical biology is studied in the context of physiology is also different 
from that for pharmacology. Since physiological study values more about the 
activity and function of enzymes, activity-based protein profiling (ABPP) and 
affinity-based profiling (AFP) as two chemical biology methods were specially 
developed (Fonovi et al., 2008, Beroza et al., 2005). AFP is designed to target the 
non-catalytic residues of proteins or enzymes, whereas ABPP is designed to target 
the catalytic residue of enzymes and enzymes need to be active to facilitate the 
labelling. Although there are already many chemical biology techniques in 
chemical proteomics, they are mainly used for determining the PTM of proteins, 
measuring the changes of proteins abundance, studying the interacting partners and 
regulation mechanism of proteins, but not be able to study the activity of proteins. 
The changes in the phenotype may either be due to changes in the overall amount 
of proteins, or be caused by the changes in the activity of proteins. ABPP can 
directly measure the changes in the activity of proteins and is frequently used for 
studying the activity of proteases (Evans et al., 2006). 
The functions of a biological system consist of the function of all interior 
proteins. Thus, to study the function of a biological system need first to study the 
function of the individual protein. However to study the function of an individual 
protein individually is less sufficient and efficient than to study the protein in its 
natural proteome. That is why the in vivo results are more appreciated than the in 
vitro results. Since the studying object in life science already from protein becomes 
proteome, the principles in system biology are naturally involved in the modern 
chemical biology.  
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1.7 Protease for life science 
Proteases, which hydrolyse the peptide bonds, form a subclass of the 
hydrolase enzyme family and are classified as EC 3.4 in the EC number 
classification of enzymes. Proteases can be classified into subgroups from different 
aspects. From the substrate aspect, proteases can be classified in two classes, which 
hydrolyse proteins or hydrolyse peptides. From the hydrolytic position aspect, 
proteases can be classified as endopeptidases (internal), aminopeptidases (N-
terminal exopeptidase) or carboxypeptidases (C-terminal exopeptidase). From the 
catalytic mechanism aspect, proteases can be classified as serine, cysteine, aspartate, 
threonine, metallo or glutamate proteases. On the basis of evolutionary 
relationships, proteases are grouped into clans that share structural similarities 
(homology) and are then further subgrouped into families with similar sequences. 
In this thesis work, the proteases are mainly classified by their catalytic 
mechanisms.  
From the protein structural aspect, all proteases can be roughly separated into 
a catalytic part and a structure maintaining part. The catalytic part sometimes is 
also called the active site pocket, which is the place for hydrolysis of the substrates. 
The oxyanion hole is a place inside the active site pocket, to polarize the carbonyl 
group of the amide bond, which will be hydrolyzed. The oxyanion hole contains 
Lewis acids such as an amide proton, acid proton or metal ion, which could interact 
with the oxygen atom of the carbonyl group. The activation energy of the 
hydrolysis of this amide bond will be reduced by the polarization of the carbonyl 
group in the oxyanion hole, so that the stable amide bond can be hydrolyzed under 
physiological conditions. The polarized carbonyl group will be attacked by a 
nucleophile. In case of serine, threonine or cysteine proteases, the nucleophile is the 
deprotonated hydroxyl or thiol group of the corresponding serine, threonine or 
cysteine amino acid. Whereas in case of aspartate, glutamate or metallo proteases, 
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the nucleophile is an activated water molecule. The substrate binding pocket 
stabilizes the peptide of the substrates and is responsible for selecting substrates. 
The selection of substrate pocket is achieved by the interaction between the amino 
acid of the peptide with each single substrate binding pocket, named as S1, S2, 
S3… or S1’, S2’, S3’…. “S” refers to subsite, “S or S’” refers to the direction (to 
N-terminal or C-terminal), and “1, 2, 3…” refers to the position (Van der Hoorn, 
2008). The substrate position associated with the substrate binding pocket is noted 
as “P1, P2, P3… or P1’, P2’, P3’”, relative to the substrate binding pocket (Nazif et 
al., 2001).  
Serine proteases are the most abundant proteases and their catalytic triad was 
the first well studied protease catalytic mechanism system (Damaschun et al., 1968, 
Steitz et al., 1969). The catalytic triad is a coordinated structure consisting of 
histidine, serine and aspartate as three essential amino acids. The hydroxyl group of 
the active site serine attacks the carbonyl group in the oxyanion hole, to cleave the 
peptide bond, release the amine-containing product fragment, and generate a 
peptidyl-O-protease covalent enzyme intermediate (acylation), which will be 
hydrolyzed in a second half-reaction (deacylation). Serine proteases are often 
divided into four major clans: chymotrypsin-like, subtilisin-like, alpha/beta 
hydrolase, and signal peptidase clans (Barrett et al., 1995).  
Cysteine proteases are another large group of proteases, which share a 
similar catalytic mechanism as serine proteases, sometimes lacking the aspartate 
residue of the catalytic triad. The thiol group of the active site cysteine attacks the 
carbonyl group to cleave the peptide bond and to generate a peptidyl-S-protease 
intermediate, which will be hydrolyzed in a second half-reaction. Cysteine 
proteases are often grouped into 7 major clans: CA, CD, CE, CF, CH, PA and PB 
(Barrett et al., 2001).  
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Aspartate proteases utilize two aspartate residues to hydrolse peptide 
substrates. The acid-base mechanism-based process includes the coordination of a 
water molecule between these two highly conserved aspartate residues, and one 
activates the water by abstracting a proton, enabling the water to attack the 
carbonyl group of the substrate (Brik et al., 2003). Aspartate proteases are normally 
active at acidic pH values.  
Metalloproteases hydrolysis of substrates via a metal ion in the active site 
pocket, which is coordinated by the imidazole groups of three conserved histidines. 
The fourth coordination position is left for a water molecule, which is activated by 
the chelated metal ion and deprotonated by the carboxylate group of one adjacent 
glutamate or aspartate residue to attack the carbonyl group of the substrate (Holz et 
al., 2003). Most metalloproteases are zinc-dependent, but also cobalt.  
The threonine proteases were described for the first time in 1995 in the 
proteasome (Orlowski et al., 2000). The threonine hydroxyl group and its free 
amino group are coordinating a water molecule. Following a cyclic deprotonation 
process, the amino group abstracts a proton from the water molecule and the water 
molecule abstracts the proton of the hydroxyl group. The deprotonated hydroxyl 
group as a nucleophilie attacks the carbonyl group of the substrate (Bochtler et al., 
1999).  
Glutamate proteases are similar to aspartate protease and were reported 
recently (Meijers et al., 2004). Most of these proteases have their zymogens and 
endogenous inhibitors. 
Proteases exist in all organisms and act in a multitude of physiological 
reactions from simple degradation of proteins to highly regulated cascades. Hence, 
they are one of the most important enzyme classes in life science. They can either 
cleave a specific peptide residue via limited proteolysis, depending on the amino 
acid sequence of a protein or degrade a complete peptide into amino acids via 
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unlimited proteolysis. Through these proteolytic processes, proteases can abolish 
functions of a protein by destroying its essential domain or they can create an 
active protein from inactive precursors. Thereby proteases can work as biological 
switches and the regulatory mechanisms are achieved by controlling the lifetime of 
proteins, which play important physiological role like hormones, antibodies, or 
other enzymes. Through subsequent cooperative cascade reactions, proteases can 
effect a rapid and efficient amplification of a physiological response to a biological 
signal. For example, some acid aspartate proteases, such as pepsin, are secreted into 
the stomach (Johnson, 1985) and serine proteases, such as trypsin and 
chymotrypsin, are present in the duodenum (Goldberg, 2000) enable humans to 
digest the proteins in food; the blood-clotting cascades, the lyses of the clots as well 
as the correct action of the immune system are highly regulated by blood serum 
proteases such as thrombin, plasmin or the Hageman factor (Bouma et al., 2006, 
Amara et al., 2008, Borensztajn et al., 2008, Krupiczojc et al., 2008). Some 
proteases, such as elastase and cathepsin G present in leukocytes, play several roles 
in metabolic control (Korkmaz et al., 2008). The cysteine proteases cathepsin K 
and caspases have vital roles in mammalian cells such as bone resorption, apoptosis, 
necrosis and inflammation (Le Gall et al., 2008, Franchi et al., 2009, Strasser et al., 
2009).  
1.8 Background to activity-based protein profiling (ABPP) 
Biological regulation consists of functions of numerous proteins, however 
the function of a protein is dependent on its activity. As discussed in the above 
sections, for a more detailed study on enzyme functions, we need to consider their 
activity. The variation of the active states enable enzymes to act as the biological 
switch for regulation of physiological processes. The activity of enzymes, for 
example a protease, is regulated by pH, co-enzymes, co-factors, temperature, ion 
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strength, etc. The ABPP approach is one of the best methods until now to directly 
study the activities of these enzymes. 
The term ABPP was first coined by Benjamin Cravatt in 1999, appearing in 
the paper “Activity-based protein profiling: the serine hydrolases” (Liu et al., 1999).
The principle of ABPP is to utilize the catalytic feature of enzymes and label them 
with small organic molecules. Those small organic molecules are termed activity-
based probes (ABPs), which mediate chemical reactions with active site residue of 
enzymes. The reactions are taking place only when the enzymes are active. For 
enzymes utilizing the catalytic amino acid as a nucleophile for the catalytic process, 
such as serine, cysteine, threonine proteases, glycosidases or phosphatases, ABPs 
usually react with the catalytic amino acid in the active site and form a covalent 
bond. For the enzymes utilizing an active water as a nucleophile for the catalytic 
process, such as aspartate, glutamate or metallo proteases, ABPs coordinate with 
the amino acids or metal ion, which activate the catalytic water, and, with the help 
of a photoreactive moiety, crosslink to the amino acid residue in the active pocket. 
For the non-hydrolytic enzymes such as lipid or protein kinases, ABPs 
(wortmannin-based probes) react with the amino acid (lysine) in the nucleotide 
binding site and form a covalent bond. All target enzymes, while covalently bound 
with ABPs, are permanently inactivated. Biotin or fluorophore tags in ABPs are 
used to visualize the labelled enzymes. Therefore ABPP is a multi-principles 
method, which is not only limited for screening or comparing the enzymes 
activities from different proteomes (Jessani et al., 2002, Jessani et al., 2004), but 
also can be applied for determining novel enzymes from an unknown proteome 
combined with different protein identification strategies  (Borodovsky et al., 2002, 
Jessani et al., 2005), for inhibitor discovery (Greenbaum et al., 2002, Leung et al., 
2003), for tissue based-imaging (Blum et al., 2005) or the elucidation of novel 
enzymatic mechanisms (Wang et al., 2008). 
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Different ABPs are needed to realize the plentiful ABPP strategies. Although 
the term ABPP was proposed till 1999 with the fluorophosphonate (FP) probe, the 
history of ABPs dates back to 1997, when Matthew Boygo and his colleagues 
developed vinyl sulfone (VS) probes for the proteasome (Bogyo et al., 1997). To 
enable ABPP, ABPs need three moieties, a warhead, a linker and a reporter tag. 
The warhead is the active moiety, as an electrophile, reacts with the enzyme to 
form a covalent bond. Therefore warhead is the most important moiety of ABPs, 
and usually responsible for selecting enzyme and determining its activity. The 
reporter tag is responsible for visualization of the labelled enzymes. Depending on 
the purposes of assays, the reporter tag could be an affinity or fluororescent tag. 
The linker is a spacer between warhead and reporter tag. A good linker can enhance 
the selectivity and labelling affinity of ABPs (Jeffery et al., 2003).  
According to the warhead design strategy, ABPs can be classified into four 
major subgroups: natural product-based, mechanism-based, direct and non-directed 
probes. Natural product-based probes are probes derived directly from a natural 
product, utilizing the probe to find out its related biological targets. The natural 
product has a reactive moiety and can form a covalent bond with its target. 
Successful examples are like E-64-based probes for the papain family of cysteine 
proteases, derivated from E-64 a metabolite of Aspergillus japonicus (Hanada et al., 
1978, Bogyo et al., 2000); wortmannin-based probes for lipid and protein kinases, 
derived from a furanosteroid metabolite of Penicillium funiculosum Talaromyces 
(Penicillium) wortmannii, a covalent inhibitor of phosphoinositide 3-kinases 
(PI3Ks) (Stoyanova et al., 1997, Yee et al., 2005); microcystin-based probes for 
serine or threonine phosphatases, derived from the cyclic nonribosomal peptide and 
cyanotoxin produced by cyanobacteria (Gupta et al., 1997, Shreder et al., 2004). 
Mechanism-based probes mimick the catalytic transition state of the substrate 
within an enzyme. Because the probe mimics the transition state, it can interact 
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with the enzyme and bind the enzyme via a covalent bond. Examples are like FP 
probes for serine hydrolases (Liu et al., 1999); acyloxymethyl ketone (AOMK) 
probes for cysteine proteases (Kato et al., 2005); VS probes for the proteasome and 
ubiquitin-specific cysteine proteases (Bogyo et al., 1997, Borodovsky et al., 2002); 
2-Deoxy-2-fluoro glycoside probes for retaining exo and endo-glycosidases 
(Hekmat et al., 2005) and -Bromobenzylphosphonate for tyrosine phosphatases 
(Kumar et al., 2004). Photoreactive probes are special mechanism-based probes for 
non-covalent substrate binding enzymes, such as metallo or aspartate protease. The 
photoreactive group, such as benzophenone, can crosslink enzymes covalently 
under UV irradiation. The reported examples are photoreactive hydroxamate 
probes for metalloproteases (Chan et al., 2004) and photoreactive hydroxyl 
ethylene probes for aspartate proteases (Li et al., 2000). A direct probe is a probe 
derived from a known inhibitor, which has usually defined targets. Whereas the 
non-directed probe is a probe based on a chemical reactive moiety and the targets 
of these probes are usually difficult to predicted before the experiment. The non-
directed probes were first introduced by Benjamin Cravatt and a well known 
example is sulfonate ester (SE) based probes (Adam et al., 2002), however many 
other probes have been developed in the meantime. 
According to the reporter tag, ABPs can also be classified into three versions: 
affinity tagged, fluorophore or radioactive tagged and click chemistry support 
probes. Affinity tagged probes are widely used for purification or identification of 
labelled proteins. The most common affinity tag is biotin, which tightly binds 
avidin. The disadvantage of biotin is poor solubility and membrane permeability. 
Fluorophore tagged probes are very useful for profiling and imaging, comparable to 
conventional GFP or YFP. The fluorophore can be chosen depending on the assay 
conditions. Modified quencher fluorophore ABPs were introduced by Matthew 
Bogyo, revealed the unique advantage of activity-based imaging (Blum et al., 
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2005). Click chemistry support probes combine the bio-orthogonal chemical 
labelling technique with ABPP methodology, enabling ABPs to behave more 
similarly to inhibitors in vivo, minimizing the influence of the tag on the  warhead. 
It was introduced by Benjamin Cravatt (Speers et al., 2003). The trifunctional click 
patner enables click chemistry support probes to be more powerful (Speers et al., 
2004). 
The last part of this section will shortly discuss the relationship between 
ABPs and inhibitors. ABPs and inhibitors are in principle very similar. However, 
ABPs must irreversibly bind the enzymes whereas inhibitors can either bind 
reversibly or irreversibly. Irreversible inhibitors can be directly converted into 
ABPs as directed probes, whereas reversible inhibitors, e. g. based on an aldehyde, 
boron acid, -keto carbonyl, -keto amide or -keto aldehyde as active moieties 
(Bogyo et al., 2002) can only be transformed into ABPs by adding a photoreactive 
group. ABPs need a reporter tag and linker whereas inhibitors do not require them. 
Therefore all APBs are synthetic products whereas inhibitors can also be natural 
products. ABPs are usually designed to label the enzymes in an one-to-one 
stoichiometry whereas inhibitors can be synthesized to label the enzymes in one-to-
more stoichiometry (Loidl et al., 1999a,b). 
1.9 ABPP for plant biology 
Organisms are divided into two domains: prokaryotes and eukaryotes. 
Eukaryotes can be further classified into the kingdoms of animal, plant, fungi and 
protist. Perhaps for the reason of cognate relationship, the animal kingdom is most 
well-studied. A search of the reports of chemical biology study in PubMed 
(www.pubmed.org) till 14.07.2009, the reports for animal science are 15294 pieces, 
almost five times as much as the reports for plant science (3219 pieces). This 
demonstrates that the research intensity in plant biology is much less strong than in 
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animal biology. Generally, animals are considered as a higher life form than plants, 
and therefore most advantage methodologies are applied priorly in animal biology. 
However, botanic system shares many similarities with animal system, so the study 
of plant biology could be of benefit for animal biology and vice versa. Plant 
biology even has the advantage for certain studies for juristic or ethic reasons. 
Hence, we are applying chemical biology tools to study plant biology. 
Immunity is a common and essential physiological phenomenon, occurring 
in all organisms. Surprisingly, the plant immune system is similar to the animal 
innate immune system but features its own characters (Jones et al., 2006). The 
plant immune system uses two large branches of disease resistance (R) proteins to 
defend microbes or pathogens. The first type, recognising microbial- or pathogen-
associated molecular patterns (MAMPs or PAMPs), uses transmembrane pattern 
recognition receptors (PRRs). The second type, targeting pathogen effectors 
(proteins secreted by pathogen with virulent or avirulent effects) from diverse 
kingdoms uses polymorphic nucleotide binding leucine rich repeat domain (NB-
LRR) motif proteins. The defense machinery works in a “zigzag” way, which 
consists of four phases. In phase one, PRRs result in a PAMP-triggered immunity 
(PTI) with recognising PAMPs (or MAMPs). In phase two, the PTI is interfered by 
pathogen virulent effectors, which leads to an effector-triggered susceptibility 
(ETS). In phase three, certain pathogen avirulent effectors (Avr) can be recognised 
by NB-LRR proteins by forming cognate Avr-R pairs according to the “gene-for-
gene” theory (Flor, 1971). This causes an effector-triggered immunity (ETI). ETI 
accelerates and amplifies PTI, leading to disease resistance and usually a 
hypersensitive cell death response (HR). In phase four, due to natural selection of 
pathogens, ETI is suppressed by shedded or diversified pathogen effectors. Nitric 
oxide, reactive oxygen species (ROS), salicylic acid (SA) and jasmonates are such 
small molecules in plants, joining defense processes. 
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It is known that proteases play very important roles in the plant-pathogen 
interaction. Indeed, two recent reviews have discussed the function of plant 
proteases (Van der Hoorn et al., 2008a,b). Plant cysteine proteases such as papain-
like proteases Rcr3 and NbCathB are associated with HR (Rooney et al., 2005, 
Gilroy et al., 2007); caspase-like proteases mcII-Pa and VPEs are essential for 
program cell death (PCD) (Suarez et al., 2004, Hatsugai et al., 2006). Plant serine 
proteases such as carboxypeptidase-like proteases SNG1/2 are associated with UV-
B protection (Lehfeldt et al., 2000, Lorenzen et al., 1996). Plant aspartate proteases 
such as pepsin-like proteases CDR1 and PCS1 induce high levels of reactive 
oxygen intermediates (ROIs) and SA or prevent cell death during gametogenesis 
(Xia et al., 2004, Ge et al., 2005). The other plant hydrolases like soybean endo--
1,3-glucanase-A (EGaseA) are also defense-related enzymes (Rose et al., 2002). 
The pathogen hydrolases such as endo--1,4-xylanases (GH10/11) and 
polygalacturonases (PGs) are important for pathogens to degrade the plant cell wall 
(Juge, 2006). 
The application of ABPP for plant enzymes (e. g. hydrolases) studies can 
reveal novel aspects of the plant-pathogen interactions. ABPP of the plant 
proteome with known or novel ABPs can reveal novel enzymes, which might be 
responsible for the regulation of important defense processes in plants. Comparison 
of the ABPP results between diseased and normal plant proteomes can directly and 
quickly display variation of the activity for certain enzymes in vitro or in vivo. 
ABPs can also be used for inhibition of selected enzymes, or to observe phenotype 
changes. Fluorescent ABPs can visualize enzymes in vivo to study their localization, 
cyclization and lifetime. 
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2 Aim of the PhD mission 
In chemical biology, chemical tools are used to elucidate complex biological 
systems. Chemical biology research usually consists of three different stages. First, 
an interesting biological question is formulated. To answer this question, suitable 
chemical probes are designed and synthesized in a second stage. These probes are 
then applied to the biological system to investigate the biological question. 
Until now, the only technology to directly demonstrate the role of switching 
between the active/inactive states of enzymes during plant defence is ABPP. Since 
the discovery of ABPP ten years ago, several ABPs have been developed and used 
in pharmacological and physiological studies. However, a broader use of ABPP is 
still limited by the availability of suitable probes. 
In an attempt to expand this limited applicability of ABPP, in this thesis, new 
types of ABPs were designed, synthesized and evaluated as potential probes for the 
study of plant-pathogen interactions.  
To develop effective ABPs in an efficient way, different design strategies 
have been tested and discussed accompanying with five questions, to generate 
different types of novel ABPs: 
Lipstatin is a natural product that can covalently bind to the active site of 
lipases. Its derivate, tetrahydrolipstatin (THL), is a well-known drug used for 
obesity. The THL-based probes with an anti--lactone moiety were generated with 
natural product-based design strategy. In order to target as many lipases as possible, 
only the reactive scaffold of THL was employed for probe design. This structural 
simplification, however, implies the danger of losing THL’s biological function. 
How tolerant are the THL-based probes to chemical modification in respect to 
retaining intrinsic targeting selectivity? This is the first question to discuss ABPs 
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design strategy and the biological profiling with anti--lactones was studied 
consequently (chapter 3.1).  
A mechanism-based probe design strategy was applied for two types of 
probes. Syn--lactone-based probes were chosen, as a syn--lactone moiety exists 
in cysteine protease inhibitors of picornavirus. Additionally, AOMK-based probes 
were chosen, as the AOMK moiety is a well-known warhead. The advantage of 
mechanism-based probes is the high possibility to label a certain class of enzymes, 
whilst the disadvantage is the low labelling selectivity. To overcome this 
disadvantage, mechanism-based probes with epoxide or AOMK warheads were 
studied to enhance the labelling selectivity. The second question addressed is that: 
is it possible to enhance the selectivity of syn--lactone-based probes with a similar 
strategy (chapter 3.2)?  
In an attempt to develop structurally novel, non-directed probes, azirine and 
aziridine derivatives were also investigated. These derivatives were chosen as they 
are natural products with diverse biological activities featuring reactive moieties 
isolated from various species. With this project, the possibility of transforming 
azirines and aziridines into ABPs is discussed (chapter 3.3). 
Moreover, the development of a direct probe based on the known serine 
protease inhibitor AEBSF was used to answer the fourth question: is it possible, as 
often proposed in literature, to directly transform AEBSF into a direct probe 
(chapter 3.4)? 
The last question, being the most essential and challenging task in the thesis 
is: can we design specific probes for targets of interest in plant biology? The probes 
with the well-studied AOMK warhead were designed to investigate two interesting 
biological targets; the role of an avirulent protein AvrPphB in plant-pathogen 
interactions (chapter 3.5) and the functions of a plant caspase like-cysteine protease 
VPE (chapter 3.6). 
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Finally, the development of reactive natural products into ABPs was also 
investigated. The reactive natural product Gibbestatin B (GNB) featuring a reactive 
epoxide moiety was chosen for this purpose. As GNB is not commercially available, 
prior to probe design, a total synthesis of GNB is required. Consequently, synthetic 
approaches towards this interesting natural product were pursued in this thesis.  
After the successful development of novel probes, they should be evaluated 
in ABPP assays to characterize their labelling properties. However, the ultimate 
goal is to use these newly developed ABPs for the biological study of plant-
pathogen interactions. To this end, biological experiments employing host plants 
and plant pathogens were devised and performed. 
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3 Results and Discussions 
3.1 Natural product-based ABP design of anti--lactones 
3.1.1 Introduction 
The natural product lipstatin is an inhibitor of pancreatic lipase and was 
originally isolated from the gram-positive bacterium Streptomyces toxytricini 
(Weibel et al., 1987; Hochuli et al., 1987). Its tetrahydro derivate, known as 
terahydrolipostatin (THL) (trade name Orlistat®), has been developed by Roche for 
clinic therapy of severe obesity and hyperlipidemia (Figure 1). 
O
O
OO
NHCHO
THL
O
O
OO
NHCHO
Lipstatin  
Figure 1. Structure of lipstatin and THL 
 
Many biomedical studies on THL have been published during last two 
decades (Hauptman et al., 1992; Zhi et al., 1995; Ellrichmann et al., 2007) 
demonstrating that THL inhibits lipases with high potency by a covalent 
mechanism, which makes it an ideal template for APBs. Although the direct 
structure of lipase inhibited by lipstatin or THL is still not reported, the crystal 
structure of thioesterase with THL showed that the hydroxyl group of serine 
attacked the carboxyl group of the -lactone moiety, leading to ring opening and 
formation of a stable enzyme-acyl complex (Pemble et al., 2007; Figure 2). 
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Figure 2. Crystal structure of the thioestrase domain of human fatty acid synthase (FAS) 
inhibited by THL: the serine (S-113) in the active site attacks the -lactone moiety of THL to 
open the -lactone ring and to form a new ester. 
 
 Several targets of THL in mammalian organisms are already known but no 
targets in plants have been described yet. To investigate the targets of THL in 
plants, ABPs based on THL were developed. To synthesize THL-based probes, 
several approaches can be followed. The first total synthesis of THL has been 
accomplished in 1993 (Hanessian et al., 1993) and biosynthesis of lipstatin has also 
been investigated heavily (Eisenreich et al., 1997; Goese et al., 2000; Schuhr et al., 
2002). Key step of either total or biosynthesis is the formation of the 2-oxetanone 
moiety by an aldol reaction. Consequently, an aldol reaction also represents the key 
step of the synthesis of THL-based probes. As structure-activity relationship studies 
of THL-based lipase inhibition have revealed that the formylated leucine moiety in 
THL is not essential for inhibition, this moiety was not included in the probe design 
to simplify the required synthesis. 
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3.1.2 Syntheses 
To generate THL-based probes, an asymmetric synthesis of anti--lactone is 
highly advantageous as they could be directly transformed into corresponding 
lactones by simple esterification of the required anti-(3S)-hydroxy-(2S)-alkyl-
carboxylic acid derivates, which can be obtained via an asymmetric aldol reaction 
between a corresponding aldehyde and a carbonyl compound attached to a chiral 
auxiliary by the Masamune methodology (Masamune et al., 1996). Based on this 
strategy, the retro-synthetic analysis of THL-based probes requires two synthetic 
building blocks, i.e. a carboxyl auxiliary derivate an aldehyde derivate and an 
organoborane-based reagent (Schema 1). 
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Scheme 1. Retro synthetic analysis of THL-based probes 
 
In principle, the required anti-product could be obtained also with Evans-
type chiral auxiliaries (Evans et al., 1981; Evans et al., 1982; Brown et al., 1992), 
that deliver a syn-aldol product, which can then be converted to the anti-aldol 
product via Mitsunobu inversion of the 3-hydroxyl group (Mitsunobu et al., 1967).  
Masamune-type auxiliaries however lead directly to the desired anti-aldol product 
and are therefore for our requirements more suitable. Two kinds of Masamune-
types auxiliaries have been developed so far: The S-3-(3-ethyl)pentyl thioate-based 
auxiliaries deliver a very good anti/syn-selection (~ 30:1) and ee % (> 90%) 
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(Masamune et al., 1986). However these thioates are not stable under basic 
conditions and the preparation of the required chiral organoborane is not 
convenient (Masamune et al., 1985). The second type is based on chiral ester 
derivatives (Masamune et al., 1996), which we chose for convenience for the 
synthesis of probes. 
The auxiliary that we used is derived from the natural product norephedrine 
of which both enantiomers are commercially available. The synthesis was achieved 
following Masamune’s protocol (Atsushi et al., 1997), using (1S, 2R)-(+)-
norephedrine to obtain the correct enantiomer for the THL-probes (Scheme 2). The 
amino group of (1S, 2R)-(+)-norephedrine was sulfonated with triMsCl to form 1, 
using the organic base triethylamine. The sulfon amide group of 1 was 
subsequently benzylated with benzyl bromide and caesium carbonate to yield the 
final auxiliary 2. All steps of the syntheses were convenient and occurred with high 
yields. 
N
OHPh
S
O
O
NH2
OHPh
N
H
OHPh
S
O
O
(1S,2R)-norephedrine 1 2
a b
 
Scheme 2. Synthesis of the Masamune auxiliary: a. TEA, triMsCl, DCM, 0 °C – rt, 3 h, 99%; b. 
BzBr, Cs2CO3, MeCN, reflux, 0.5 h, 95%. 
 
The preparation of the dicyclohexylboron triflate reagent was performed 
similar to the protocol of Atsushi (Atsushi, 2004) (Scheme 3), starting from the 
addition of borane to cyclohexene to obtain dicyclohexylboron 3. 3 was then 
reacted with trifluoromethanesulfonic acid to generate the organoborane reagent 4. 
The handling of trifluoromethanesulfonic acid proved as critical for the reaction, as 
it reacts heavily with traces of water including air moisture. Although the 
synthesized boron triflate is known as very sensitive, it could be stored under argon 
at 4 °C for half a month in a hexane solution. 
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Scheme 3. Synthesis of dicyclohexylboron triflate: a. BH3-SMe2, diethyl ether, 0 °C, 3 h, 99%; b. 
CF3SO3H, hexane, rt, 3 h, 89%. 
 
All ABPs require an appropriate reporter tag. For THL-based probes, two 
possibilities to link the tag to the molecules are reasonable, being either an 
attachment on the ester or on the aldehyde moiety. To link this tag to the reactive -
lactone warhead, an amide linker was chosen. To incorporate the required amine 
moiety into the molecule, we therefore employed an appropriately protected 6-
amino hexanoic acid as a starting carboxyl building block for the aldol reaction. 
Consequently, derivate 8 was prepared (Scheme 4). Towards this purpose, 6-
amino-hexanoic acid was transferred into its methyl ester 5, and then its free amino 
group was di-Boc-protected in two steps to yield 6. Hydrolysis of the methyl ester 
of 6 with the strong base n-Bu4NOH led to 7, which was then coupled with the 
chiral Masamune auxiliary 2 to obtain the desired building block 8. 
H2N CO2H H2N COOMe (Boc)2N COOMe
a b, c
5 6
d
(Boc)2N CO2H(Boc)2N O
O
N
S
O
O
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e
 
Scheme 4. Synthesis of building block 8: a. SOCl2, MeOH, 0 °C, 8 h, 100%; b. (Boc)2O, Na2CO3, 
dioxane/H2O (1:1), 0 °C - rt, overnight, 100%; c. (Boc)2O, DMAP, THF, reflux, 21 h, 90%; d. n-
Bu4NOH, MeCN/H2O, rt, 30 min, 100%; e. 2, DCC, DMAP, DCM, rt, overnight, 95%. 
 
Unfortunately, 8 was instable under aldol reaction conditions. Most probably, 
the di-Boc protecting group was incompatible to the strongly electrophilic boron 
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reagent. The synthetic plan was therefore revised (Scheme 5) by employment of a 
benzyloxycarbonyl (Cbz) protecting group instead of the di-Boc protection. In 
addition, this amino group was introduced this time into the aldehyde building 
block 10, which was derived from 6-amino-hexanol was via N-Cbz protection and 
oxidation with IBX in two steps. As a carboxylic acid building block, two 
lipophilic carboxylic acids, i.e. heptanoic acid or 4-phenyl-butanoic acid were 
coupled with the chiral auxiliary 2 to form the corresponding esters 11 and 12. The 
Masamune anti aldol reaction of 10 and 11 or 12 formed the desired anti-(3S)-
hydroxy-(2S)-alkyl-carboxylic acid esters 13 and 14. The auxiliary of 13 and 14 
was removed by hydrolysis with the mild base lithium hydroxide. Cyclization 
between the resulting free carboxyl group and the -hydroxyl group with 
benzenesulfonyl chloride at 0 °C for two days and the subsequent Cbz deprotection 
by hydrogenation led to the molecules 19 and 20. 
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Scheme 5. Synthesis of -lactones molecules: a. DCC, DMAP, DCM, rt, overnight, 84%; b. 
CbzCl, NaHCO3, dioxane/H2O (1:1), rt, 4 h, 87%; c. IBX, THF, 0 °C - rt, overnight, 95%; d. 4, 
TEA, DCM, -78 – 0 °C, 4 h, H2O2, pH=7, MeOH, rt, overnight, 88%; e. LiOH, THF/H2O (1:1), rt, 
3 d, 75%; f. Py, PhSO2Cl, 0 °C, 2 d, 70%; g. Pd/C, H2, EtOH, rt, overnight, 100%. 
 
In the next step, an appropriate tag was added to these intermediates. For this 
type of probes, biotin as a suitable tag was chosen. To minimize the spatial 
influence of biotin on lipase inhibition, an additional spacer was introduced 
between the biotin and the -lactone moiety (Scheme 6). Towards this purpose, 
biotin was coupled with previously prepared 5 (Scheme 4) to yield 6, which was 
subsequently hydrolysed with n-Bu4OH to obtain the biotinyl linker 22. 
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Scheme 6. Synthesis of the biotinyl linker: a. 5, HBTU, TEA, MeCN, rt, 3 h, 78%; b. n-Bu4NOH, 
MeCN/H2O, rt, 30 min, 84%. 
 
22 was then coupled with 19 and 20 to generate the probes 23 and 24 
respectively (Scheme 7). Because of the low solubility of biotin in DCM, the 
coupling reaction was performed in a solution of DCM containing a minimal 
amount of DMSO to solubilize all reagents. 
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Scheme 7. Synthesis of anti--lactone probes: a.PyBOP, HOBt, TEA, DCM/DMSO, rt, 
overnight, 70%. 
 
For biological competition experiments, also the non-tagged, acetylated 
derivatives 25 and 26 were synthesized by acetylation of 19 and 20. In addition, for 
click-chemistry based profiling, also a probe 27 with an alkyne tag was generated 
by coupling of 4-pentynoic acid to 19 using DIC/HOBt as coupling reagents 
(Scheme 8). 
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Scheme 8. Synthesis of anti--lactone probes 25 – 27 from 19 and 20: a. Ac2O, DIPEA, DCM, rt, 
overnight, 57%; b. 4-pentynoic acid, DIC, DCM, rt, 4 h, 40%. 
3.1.3 Bioassays 
To test the reactivity of the designed probes, commercially available wheat 
germ lipase and Pseudomonas fluorescence lipase were tested in a labelling assay 
(Figure 3). Both probes 23 and 24 caused biotinylation of a 35 kDa and a 42 kDa 
proteins of wheat germ lipase, whereas no labelling was observed with the 
Pseudomonas fluorescence lipase. The reactivity of the probes to a plant lipase 
encouraged us to profile the probes in Arabidopsis proteomes. 
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Figure 3. Probe 23 and 24 in vitro evaluation with commercially available lipases: wheat germ 
lipase Type I (WGL); Pseudomonas fluorescence lipase (PL); the commercial enzyme was 
prepared as a 0.5 mg/ml aqueous solution, and that solution was incubated with 4 μM probe for 3 
h. The proteins on the protein blots were detected by streptavidin-HRP. 
 
Labelling with probes 23 and 24 was performed on leaf and cell culture 
extracts (Figure 4). In leaf extract, probe 23 caused two bands of 27 and 35 kDa, 
the lower band was stronger than the higher band. Probe 24 only gave one band of 
27 kDa. In cell culture extract, both probes caused 27 and 35 kDa signals and 
signals at 42 and 56 kDa. There was also one strong 30 kDa background band that 
is also present in the no-probe-control. The labelling intensity from cell culture 
extract was higher because of a higher protein concentration. These data suggest 
that probes 23 and 24 share the same labelling targets but with different affinities. 
At high protein concentration (like in cell culture), both probes would cause a 
similar labelling pattern. The different affinity of both probes is caused by a 
different side chain. The longer aliphatic chain of 23 is more similar to the side 
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chain of THL, so it could fit the pocket of enzyme better than the aromatic side 
chain of 24. Because probe 23 and 24 cause nearly identical labelling profiles, 23 
was chosen for subsequent labelling assays. 
 
Figure 4. Labelling of Arabidopsis leaf extracts (LE) and cell cultures (CC) with probes 23 and 
24: Protein extracts were 5 mg/ml (LE) and 50 mg/ml (CC) and incubated at pH 6 with 4 μM 
probes for 3 h. The proteins on the protein blots were detected by streptavidin-HRP. 
 
To investigate the properties of probe 23, different competitive labelling 
assays were performed (Figure 5). Since the probe 23 was analogues to THL from a 
chemical aspect, it was interesting to investigate if they showed the same labelling 
reactivity. The assay showed that in Arabidopsis leaf extracts, the labelling of the 
27 and 35 kDa signals could not be competed by THL (Figure 5a). Labelling with 
probe 23 could also not be competed by E64, ebelactone B and 18, but by 17 as 
well as 25 and 26 for the lower band (27 kDa) (Figure 5b). The results from THL, 
E64 and ebelactone B suggested that the targets of probe 23 were not lipases, 
cysteine proteases or membrane methyl esterases. 17 was better competing with 23-
labelling than 25 indicating that the benzyl oxy carbonyl residue (17) is closer to 
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biotinyl residue (23) than amino acetyl residue (25) from the aspect of labelling 
reactivity. 24 had lower labelling affinity than 23, so its derivates 18 and 25 could 
not compete 23 very well. The molecules with longer side chains (17, 23) had a 
better affinity to the target, implying that the labelling pocket of target is quite deep.
 
Figure 5. Competition assay of probe 23: a. Competition with lipase inhibitor THL; b. 
Competition with cysteine protease inhibitor E64, esterase inhibitor ebelactone B (Eb) and 
derivatives 17, 18, 25 and 26; Protein extracts (~5 mg/ml) were co-incubated at pH 6 with 40 μM 
inhibitors and 4 μM probe 23 for 3 h. The proteins on the protein blots were detected by 
streptavidin-HRP.  
 
The competition assays suggest that the targets of the probe 23 were not the 
expected lipases or esterases. The direct way to identify the targets is to purify the 
labelled proteins, however all attempts were not successful due to the low 
abundance of the targets. Nevertheless several assays were performed to study the 
properties of the labelling. Labelling at various pH values showed that the optimal 
labelling condition was pH 6 (Figure 6a). At lower pH such as 4, labelling did not 
occur whereas labelling intensity also decreased with increasing pH value. There 
was no influence to the labelling by the absence or presence of the reduction 
reagent L-cysteine and labelling was also independent from calcium ions (Figure 
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6b). Labelling occurred in a very short time and was finished between 30 to 60 
minutes (Figure 6c). The localization assay showed that the targets were mainly 
soluble proteins whereas the background bands were in the membrane (Figure 6d). 
 
Figure 6. Characterisation of labelling with probe 23: a. pH curve; b. Influence of cofactors: 
reduction reagent L-cysteine (Cys) and CaCl2 (Ca); c. Time course of labelling; d. protein 
localization analysis: total cell culture (T), soluble protein (S) and membrane protein (P); protein 
extracts (~5 mg/ml) (except for d, 20 mg/ml), were incubated at pH 6 (expect for pH curve) with 
4 μM probe for 3 h. The proteins on the protein blots were detected by streptavidin-HRP. 
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Target identifications in bacterial systems were performed by Thomas 
Boettcher, a PhD student from the group of Dr. Stephan Sieber (LMU). Click probe 
27 was used for in vivo labelling of five different bacterial proteomes (Figure 7). 18 
labelled proteins were identified from the cytosol and from the membrane fractions. 
The probe caused many labelling signals in bacterial proteome. 
 
Figure 7. Target identification of probe 27 in bacterial proteome: Five different bacteria [Bacillus 
licheniformis (BL), Bacillus subtilis (BS), Escherichia coli (EC), Pseudomonas putida (PP), 
Listeria welshimeri (LW)] were labelled with probe 27 in vivo; the bacterial proteins were 
separated as cytosol proteins (C) and membrane proteins (M) in advance; The proteins were 
separated by SDS-PAGE and detected by an azide linked fluorescence tag. 
 
 
 
Zhe Ming Wang Results and Discussions Doctoral Dissertation 2009 
 - 43 - Chemical Genomics Centre (CGC) 
3.1.4 Discussion 
The synthesis of the probes was completed in 9 steps in generally good 
yields. As expected, the auxiliary delivered a good enantiomer selection for the 
natural product analogues. Unfortunately, the synthesized -lactone probes proved 
as rather instable as hydrolysis of the probes in the DMSO stock solution even at -
20 °C occurred after already half a year, which limits applicability of these probes. 
The labelling reactivity was normal in the Arabidopsis proteome, and it could label 
proteins from a proteome of a concentration of 5 mg/ml.  
The idea of a natural product-based probe design did not work well in this 
project. The reason could be the strong modification of the molecule. The peptide 
moiety on the side chain of THL seems to have a more significant contribution as 
originally anticipated. Probes lacking this modified side chains seem to lose the 
original targeting ability of THL for lipases. However, this can still label other 
proteins, demonstrating the subtle conformational requisites for selective enzyme 
targeting with natural products. 
 
 
Zhe Ming Wang Results and Discussions Doctoral Dissertation 2009 
 - 44 - Chemical Genomics Centre (CGC) 
3.2 Mechanism-based ABP design of syn- -lactones 
3.2.1 Introduction 
The genome of the model plant Arabidopsis thaliana encodes for ~320 serine 
and ~140 cysteine proteases, which include large families of subtilase-like 
proteases (~60 SLPs), serine carboxypeptidase-like proteins (~60 SCPLs) and 
papain-like cysteine proteases (~30 PLCPs) (Beers et al., 2004) Studies on some of 
these presumed plant proteases revealed that they can catalyze nonproteolytic 
reactions. Phytochelatin synthase, for example, acts as a glutathione transpeptidase, 
leading to phytochelatin which is required for heavy metal tolerance (Clemens et 
al., 2006). Furthermore, a number of SCPLs act as acyltransferases in the 
production of sinapoyl secondary metabolites, which protect plants against UV 
radiation (Lehfeldt et al., 2000). Some of the other proteases play key regulatory 
roles in defense and development, but the role, substrate and activation mechanisms 
of most of these enzymes are unknown (Van der Hoorn et al., 2008). 
So far, ABPP of plant proteases was mainly done using DCG-04, a 
biotinylated version E-64, which inhibits PLCPs (Greenbaum et al., 2000). ABPP 
with DCG-04 on Arabidopsis leaf extracts revealed the activities of six different 
PLCPs, including RD21 (Responsive-to-dessication-21) and AALP (Arabidopsis 
Aleurain-like Protease) (Van der Hoorn et al., 2004). To expand the range of serine 
and cysteine proteases that can be monitored by ABPP, a series of activity-based 
probes containing a 2-oxetanone reactive group were designed. This reactive group 
is found in covalent inhibitors of hepatitis A virus 3C (HAV-3C) proteinase and the 
proteasome (Dick et al., 1997; Lall et al., 1999). The inhibition mechanism of 
HAV-3C proteinase with -lactones is very well understood, so the mechanism-
based syn--lactone ABPs were developed.  
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3.2.2 Syntheses 
The employed synthetic strategy was straightforward, using the chiral amino 
acid pool to develop an enantioselective sythesis. Towards this purpose, threonine-
based syn--lactones were generated via intramolecular threonine cyclization as 
established by Dr Rengarajan Balamurugan from Prof. Dr. H. Waldmann’s group. 
Consequently, a L-threonine derived -lactone was generated (Scheme 9). N-Boc-
protected L-threonine as a starting material was cyclized via the coupling reagent 
PyBOP to form 28. 28 was then deprotected with trifluoroacetic acid and p-
toluenesulfonic acid to yield the -lactone tosyl salt 29, which proved as a good 
starting material for further coupling reactions.  
2928
BocHN
O
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OH
O
BocHN O
a O
H3N OTos
b
 
Scheme 9. Synthesis of the threonine based -lactone tosyl salt: a, PyBOP, TEA, DCM, 0 °C – rt, 
6 h, 85%; b. TFA, PTSA, 0 °C. 15 min, 97%. 
 
According to a previously published X-ray structure (Yin et al., 2005), the -
lactone moiety should occupy the S1 pocket of the protease; therefore, an 
additional L-amino acid attached to its amino group should accommodate the S2 
pocket, leading to more specific labelling. Consequently, eight different natural or 
non-natural amino acids were coupled with 29 to form syn--lactone derivatives 30 
– 37, which were then deprotected with trifluoroacetic acid and coupled with 22 to 
obtain the final threonine-based syn--lactone probes 38 – 45 (Scheme 10). 
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Scheme 10. Synthesis of threonine-based syn--lactone probes: a, ClCO2Et, TEA, Py, DCM, -
5°C - rt, overnight; b. TFA, DCM, rt, 1 h; c. 22, PyBOP, TEA, DMSO, rt, overnight 
 
Six natural amino acids were chosen to probe binding specificity: L-
tryptophan (40) and L-phenylalanine (41) for evaluating the influence of aromatic 
residues on the P2 position; L-serine (43) and L-glutamine (39) as hydrophilic, non-
charged amino acid residues at P2 position; L-leucine (42) for testing the lipophilic 
character of the P2 position and L-proline (38) as a turn-inducing moiety. 
Furthermore, two modified amino acids were also included for comparison (Figure 
8), i.e. a tryptophan derivative in which the indole moiety was modified with a 
formaldehyde group (44) and a N-methyl leucine derivative (45). With such slight 
modifications, the sensitivity of recognition for the P2 position could be very well 
distinguished.  
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Figure 8. Structures of probes 44 and 45 
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In order to obtain also a probe suitable for in vivo labelling, derivative 46 
was also synthesized (Scheme 11). Thus, leucine -lactone derivative 35 was 
deprotected with trifluoroacetic acid and coupled with 2-azido acetic acid to yield 
the probe 46. 
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Scheme 11. Synthesis of click version probe  46: a. TFA, DCM, rt, 1 h; b. N3CH2CO2H, PyBOP, 
TEA, DCM, rt, overnight, 66%. 
3.2.3 Bioassays 
The probes were tested for labelling of Arabidopsis leaf proteomes of the 
first generation of probes (39, 44 and 45). Only 39 caused labelling (Figure 9a). P2 
positions of 44 and 45 have non-natural amino acids whereas 39 has a glutamine. 
This implied that modification of the natural amino acid prevents the probe for 
labelling. Probe 39 caused two weak signals of 50 and 60 kDa, indicating that 
glutamine is not the most suitable amino acid for the P2 position. The second-
generation probes (38, 40, 41, 42 and 43) carry proline, tryptophan, phenylanine, 
leucine and serine. Probes 40, 41 and 42 caused strong labelling whereas probes 38 
and 43 did not cause labelling (Figure 9b). In case for the P2 position of probes 
with tryptophan and leucine, when they were natural amino acid, the probes (40 
and 42) caused labelling while when they are chemical modified, the probes (44 
and 45) did not cause labelling. This indicates the importance of the P2 position of 
the probes for labelling. However probes 41-42 caused almost identical labelling 
patterns, implying that tryptophan, phenylanine and leucine do not influence the 
specificity of the probes. Probe 41 was chosen for further studies. 
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Figure 9. Labelling Arabidopsis leaf extracts with a series of threonine based -lactone probes: a. 
Profiling with a first generation probes containing chemical modified tryptophan (44) or leucine 
(45) and natural glutamine (39) at P2 position; b. Profiling with second generation probes 
containing tryptophan (40), leucine (42), phenylalanine (41), proline (38) or serine (43) at P2 
position; Protein extracts (~5 mg/ml (a) and 0.15 mg/ml (b)) were incubated at pH 8 with 2 μM 
probes and 1 mM DTT for 3 h. The proteins on the protein blots were detected by streptavidin-
HRP, 10 minutes long exposure (a) whereas 5 seconds short exposure (b). 
 
Since -lactone molecules can be inhibitors of cysteine proteases (Lall et al., 
1999), we compared labelling profiles of 41 with DCG-04, which labels papain-like 
cysteine protease (Figure 10). These assays were done in Caspase buffer at pH 7.4 
and TBS buffer pH 7.5, and these buffers do not cause different labelling patterns. 
Probe 41 and DCG-04 have significantly different labelling profiles, indicating that 
they do not label the same targets. Labelling by probe 41 was competed by its non-
biotinylated derivate 33 but not by 35, the non-biotinylated derivate of probe 43, 
which had no labelling reactivity. Surprisingly, labelling by probe 41 can also be 
competed by E-64, the non-biotinylated analogue of DCG-04. One hypothesis is 
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that E-64 has a broader target range than DCG-04, including the targets of probe 41. 
A direct way to prove this hypothesis was to identify the targets of probe 41.  
 
Figure 10. Comparison of labelling between DCG-04 and 41: DCG-04 and 41 were profiled for a 
labelling assay as well as a competition assay with their own inhibitors in Arabidopsis leaf 
extracts with two buffer systems (Caspase pH=7.5, TBS pH=7.4) respectively. Protein extracts 
(~50 μg/ml) were co-incubated at pH 7.5 with 2 μM probe (DCG-04 and 41) and 60 μM 
inhibitors (E-64, 33 and 35) and 1 mM DTT for 3 h. The proteins on the protein blots were 
detected by streptavidin-HRP. 
 
The purification of 41-labelled proteins was performed by Christian Gu 
(Figure 11a) and protein mass spectrometry analysis was done by Dr. Tom Colby.  
The strongest band of 24 kDa was identified as the 23 kDa PsbP protein, which is a 
non-proteolytic protein but involving in photosynthesis. The MS data showed that 
41 was bound to the N-terminus of PsbP (Figure 11d). 
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Figure 11. Identification of the major IS4 (41)-labelled protein: a. Purification of IS4 (41)-
labelled proteins from Arabidopsis leaf extracts. Arabidopsis leaf extracts were labelled with and 
without IS4 (41) and biotinylated proteins were captured and purified on magnetic streptavidin 
beads. Proteins eluted from these beads were analyzed on protein blot, probed with streptavidin-
HRP (left), and on coomassie-stained protein gel (middle). The differential protein band at 23 
kDa was isolated (brackets), analyzed by tandem mass spectrometry and confirmed as being PsbP 
using specific PsbP antisera on the purified proteins (right); b. Peptide mass fingerprint (PMF) of 
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the 23 kDa protein band. Proteins isolated from the 23 kDa region of the IS4 (41)-labelled 
proteins (blue) and no-probe control (NPC, red) were analyzed by MS. Only part of the PMF is 
shown. Peptides from bovine serum albumine (BSA, *), streptavidin and trypsin were present in 
both IS4 and the NPC sample. The remaining IS4 (41)-specific peptides covered most of the 23 
kDa mature PsbP protein (right). Peptides a-e are indicated in the PMF, the other matching 
peptides were outside the shown PMF. The section of the PMF with the IS4 (41)-modified N-
terminal peptide is shown in the inset and explained on the right. Both the IS4 (41)-labeled 
peptide and its oxidized form have predicted masses that match the masses in the PMF inset; c. 
Fragmentation data of the IS4-labeled N-terminal peptide. The predicted y-ions (right) are found 
in the spectrum at the expected masses (left). The b-ions are also found in the spectrum, with an 
additional mass of IS4. Also IS4 itself, and fragments of IS4 (41) are found in the spectrum (b1, 
b2 and b3 ions); d. Proposed structure of the N-terminus of IS4-labeled PsbP, based on the 
peptide fragmentation data. IS4 is linked via a normal threonine through a peptide bond to the N-
terminal Ala of PsbP.  
 
To further study 41-labelling, a series of assays were performed (Figure 12). 
Labelling occurred in mild basic conditions (Figure 12a), required reducing agent 
DTT (Figure 12b), completed rapidly within half an hour (Figure 12c) and 
increasing concentration of proteome resulted in enhanced labelling, indicating that 
the probe is over excess compared to its targets (Figure 12d).  
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Figure 12. Labelling properties of probe 41: a. pH curve; b. Cofactor DTT dependent labelling, 
DTT = 1 mM; c. Time course of 41 labelling; d. Protein concentration dependent labelling; 
Protein extracts (~50 μg/ml) (except for d) were incubated at pH 8 (except for a) with 2 μM 
probe 41 and 1 mM DTT (except for b) for 3 h (except for c). The proteins on the protein blots 
were detected by streptavidin-HRP. 
 
Labelling by probe 41 can be prevented by adding E-64 (Figure 10). We next 
determined if E-64 derivatives and other proteases can also prevent 41-labelling. 
Labelling by probe 41 could be competed by its non-biotinylated derivate 33 and 
all E-64 derivatives (E-64, E-64c and E-64d), whereas DCG-04 labelling could not 
be competed by 33. When DCG-04 was mixed with probe 41, DCG-04-signals 
were of the same labelling intensity but the intensity of 41-signals were reduced. 
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The mixed probe labelling could be competed by E-64 (Figure 13a). All the 
cysteine protease inhibitors could compete with 41-labelling whereas serine 
protease inhibitors such as PMSF, TLCK and TPCK could not compete (Figure 
13b). This indicated that the labelling of 41 requires cysteine proteases.  
 
Figure 13. Competition assay of 41: a. Investigation the labelling relationship between DCG-04 
and 41: DCG-04 vs 41’s competitor 33, 41 vs DCG-04’s competitors (E-64, E-64c and E-64d) 
and the mixture (DCG-04 + 41) vs E-64 in two doses (10 times- and 30 times-equivalent); b. 
Competition of 41 with other known serine or cysteine protease inhibitors: ZFAfmk (Zm), 
AcLvkCHO (Ac), leupeptin (Lp), Antipain (Ap), Chymostatin (Cm) as well as E64, PMSF, 
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TLCK and TPCK. Protein extracts (~50 μg/ml) were co-incubated at pH 8 with 2 μM probe 
(DCG-04 and 41) and 30 μM of inhibitors (except for two marked E64 competition assays in a) 
and 1 mM DTT for 3 h. The proteins on the protein blots were detected by streptavidin-HRP. 
 
If 41 had multiple targets, it probably would have different affinities to 
different targets. To monitor different affinities, several competitors were tested in 
a concentration series to compete with 41 labelling. The intensity of the strongest 
five signals were measured and plotted against the competitor concentration 
(Figure 14). These experiments showed that leupeptin was the strongest competitor 
(Figure 14c) and 33 was the weakest competitor (Figure 14d); E-64d was less 
potent than E-64 as a competitor (Figure 14a-b). However the intensities of all 
signals decreased similarly, indicating that 41 had almost the same affinity to all 
targets. 
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Figure 14. Monitoring the intensity variation of labelling bands of 41 with different competitors: 
E-64 (a), E-64d (b), leupeptin (c) and 33 (d) were diluted in a series of increased concentration to 
compete with 41; The labelling intensity of the five strongest signals of 41 was plotted against the 
concentration of competitor. 
 
Many evidences implied the labelling process of 41 is required for cysteine 
proteases, however the final labelled protein is a non-catalytic protein. 41-labelling 
can be interfered by DCG-04 (Figure 13a) implied that the target of 41 will be one 
of targets of DCG-04. The Arabidopsis genome encodes for 30 PLCPs, of which at 
least ten are expressed in leaves (www.genevestigator.ethz.ch), and six were 
identified by DCG-04 in leaf extracts (Van der Hoorn et al. 2004). We reasoned 
that one of these leaf PLCPs could be responsible for IS4 labelling. We therefore 
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generated knock-out lines by selecting lines carrying a T-DNA insertion in the 
genes encoding leaf-expressed PLCPs. IS4 labelling occurs in leaf extracts of all 
mutants, except of the rd21-1 line. However by adding recombinant RD21 to 
proteomes of rd21-1 mutant plants can complement IS4 labelling again. This 
demonstrates that only RD21 is required for IS4 labelling in leaf extracts (Wang et 
al., 2008). To understand the labelling mechanism, hypothesized that IS4 binds to 
RD21 and forms a thioester intermediate that can be transferred to the N-terminus 
of PsbP. Since a thioester bond is common to all intermediates of PLCPs with their 
substrates, we tested if thioesters formed from peptides could also be ligated to 
other proteins by RD21. To prove this hypothesis, we made a biotinylated peptide 
PepA (Bio-FTAYGE), which causes a labelling profile that is very similar to that 
of IS4. The unnormal labelling phenomenon finally revealed a new labelling 
mechanism of ABPP, proving mechanism of transligation (Figure 15). 
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Figure 15. Model for IS4 and pepA labelling of PsbP by RD21. IS4 (41) (a) and pepA (b) bind to 
RD21. The Phe of these acceptor molecules is at the P2 position, making contact with the S2 
substrate binding pocked of RD21. The active site Cys of RD21 acts as a nucleophile, resulting in 
a unstable thioester intermediate (c). At neutral to basic pH, the N-terminal amino group of PsbP 
acts as a nucleophile, resulting in IS4 (41) labelling of the N-terminus of PsbP through a peptide 
bond (d). 
3.2.4 Discussion 
Although we designed -lactone derivatives as activity-based probes, the fate 
of these small molecules in plant extracts appears more complex than we predicted. 
IS4 labelling does not depend on the activity of the targeted proteins but is the 
result of an indirect labelling through a presumed protease. This illustrates that 
further investigation of unexpected labelling sites can lead to intriguing molecular 
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mechanisms. The discovery of the mechanism of transligation makes a 
complementary contribution to the ABPP proposal. Usually when we use designed 
ABPs to perform ABPP, we expect to find the targets in the gel. However this story 
tells that what is visualized does not need to be indeed the targets of the probe. The 
idea of mechanism-based probe design is reliable, however the enzyme-mediate 
labelling should also be considered. In this case, from a chemical aspect, it is 
known that the instability of the newly formed cysteine protease-probe conjugate, 
that can be imagined from the known labelling mechanism of cysteine proteases 
will use the thiol group of cysteine to attack the -lactone ring and form a thioester 
bond. However we could not predict whether this instable thioester bond could be 
tolerant to the ABPP condition. The final result shows us that the instable thioester 
bond indeed was not tolerant to the labelling condition. However this instability of 
the thioester bond revealed an unusual protease labelling mechanism. Whether 
these reactions also occur in living cells will be as an exciting topic for further 
studies. 
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3.3 Non-directed ABPs design of aziridines and azirines 
3.3.1 Introduction 
The non-directed probe design strategy was introduced by Cravatt in 2002, 
employing a sulfonate ester moiety as a reactive warhead (Adam et al., 2002). The 
non-directed strategy is based on the incorporation of a reactive functional group 
that does not represent a classical irreversible enzyme inhibitor as a warhead and to 
accommodate it with a linker and a reporter tag. Clearly, the reactivity of the 
warhead is critical for this approach as a too low reactivity will result in a weak or 
even no labelling while a too high reactivity will lead to false positive results 
resulting from unspecific labelling. As noted by Evans et al. in a review on this 
strategy, the “application of these probes significantly expanded the scope of 
enzymes addressable by ABPP, further underscoring the utility of combinatorial 
strategies for probe discovery.” was mentioned in the review (Evans et al., 2006). 
To date, several reactive functional groups have already been used for probes 
design, such as epoxides, -lactones, or halogeno methyl ketones. Further examples 
are the -chloroacetamide (Barglow et al., 2004) or reactive spiroepoxide (Evans et 
al., 2005) based probes. We rationalized that aziridines and azirines, in which a 
nitrogen residue replaces the oxygen of epoxide, might represent good candidates 
for non-directed probes. Besides the structural similarity of aziridines and azirines 
with epoxides, these also feature a similar reactivity, being an electrophilic reactive 
group that can react in nuleophilic ring opening reactions. 
The aziridine moiety can be found in various natural products such as 
azinomycin or miraziridin A (Corre et al., 2004 and Schaschke et al., 2004). Also 
azirines are elements of several bioactive natural products such as Azirinomycin 
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isolated from Streptomyces Aureus (Miller et al., 1971) or dysidazirine isolated 
from the marine sponge Dysidea Fragilis (Molinski et al., 1988) (Figure 16).  
N
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n-C12H25
(R)-(-)-dysidazirine  
Figure 16. Structure of  azirinomycin and R-(-)-dysidazirine 
 
Their central feature is the chiral center on the C3 position of the cyclic ring, 
which is connected to a carboxylic acid moiety, either in a free acid form or as a 
methyl ester. Therefore, ABPs based on this natural product motif could employ 
the required tag moiety either on the C3 attached carboxyl group or to the C2 ring 
position. 
3.3.2 Syntheses 
The chiral 2H-azirines (Figure 16) are synthetically accessible from 
corresponding chiral aziridine precursors via elimination (Davis et al., 1995). This 
intermediate can be prepared via an aza-Darzens asymmetric synthesis from N-
sulfinyl imines. (Davis et al., 1999) This synthetic route offers the advantage that it 
proceeds via an activated N-(p-toluenesulfinyl) aziridine intermediate which could 
also represent an interesting non-directed probe. In order to evaluate the impact of 
the attachment of the tag on labelling efficiency, two kinds of probes were initially 
synthesized.  
The first probe 51 was prepared with the tag on the C-2 side chain (Scheme 
12). To obtain this compound, the hydroxyl group of 5-hexyn-1-ol was converted 
into 47 with tosyl chloride in pyridine at 0 °C, followed by a substitution with 4-
hydroxy-benzaldehyde in DMF at 100 °C to form 48. 48 was then converted into 
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sulfinyl imine 49 with an in situ prepared lithium tolylsulfinyl trimethylsilyl amide 
in tetrahydrofurane. The sulfinyl imine can be isolated at room temperature and 
reacted with 2-bromo methyl acetate via an aza-Darzens reaction to generate the 
chiral aziridine 50 in good yields. Addition of lithium diisopropyl amide then 
induced elimination to the final product 2H-azirine 51. 
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Scheme 12. Synthesis of 51: a. TsCl, Py, 0 °C, overnight, 54%; b. 4-hydroxybenzaldehyde, 
Cs2CO3, DMF, 100 °C, 16 h, 87%; c. (1R, 2S, 5R)-Menthyl-(S)-p-tolylsulfinate, THF, LiHMDS, 
-78 °C, 7 h, 37%; d. BrCH2CO2Me, THF, LiHMDS, -78 °C, 20 min, 70.6%; e. LDA, TMSCl, 
THF, -78 °C, 15 min, 48%. 
 
With this strategy, 2H-azirine 51 could be conveniently prepared in a short 
reaction sequence with modest yields. Originally, we aimed at the synthesis of an 
acetylene derivative of 51 (Scheme 12). However, due to a side reaction during the 
last reaction step, the TMS-acetylene derivative 51 was obtained because an excess 
of TMSCl was used. As removal of the TMS group risked the degradation of the 
probe and as a TMS-acetylene residue in principle should be compatible with a 
“click chemistry” protocol, we decided to employ 51 as a first test probe. 
As this side reaction is an inherent problem of our synthesis strategy, we 
stopped our in parallel-performed synthesis (Scheme 13). 54 was obtained by 
following essentially the synthetic protocol as described for 50. In brief, the 
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commercially available trans-2-tridecenal was converted into its sulfinyl imine 53 
and the second building block 2-bromo 5-hexyne acetate 52 was prepared by 
esterification of 2-bromo acetic acid. Aza-Darzens reaction of 52 with 53 then led 
to the chiral aziridine intermediate 54. 
a
b c
52
53
C10H21 O
NH H
S
C10H21
Br
OH
O
Br
O
O
C10H21 N S O
O
O
O
54
 
Scheme 13. Synthesis of 54: a. HO(CH2)4CCH, DCC, DMAP, DCM, rt, overnight, 56%; b. (1R, 
2S, 5R)-menthyl-(S)-p-tolylsulfinate, THF, LiHMDS, -78 °C, 7 h, 85%; c. 52, THF, LiHMDS, -
78 °C, 20 min, 87%. 
 
With these two probes in hand, some first labelling assays were performed. 
Unfortunately, no labelling with 51 could be detected. 54 however showed 
promising labelling characteristics (Figure 17). The efficiency of labelling with 54 
demonstrated that the attachment of a tag to an ester group is compatible with 
labelling condition; secondly, the N-(p-toluenesulfinyl) aziridine is a suitable 
reactive warhead for labelling. These findings forced us to investigate these probe 
types more deeply. To prevent however any future problems with the acetylene 
moiety, the azide functionality was introduced as a tag for click chemistry. 
As both (1R, 2S, 5R)-(-)-menthyl-(S)-p-toluenesulfinate and its enantiomer 
(1S, 2R, 5S)-(+)-menthyl-(R)-p-toluenesulfinate are commercially available, the 
syntheses of the next generation of probes was established in the following manner. 
First, the 2-bromo 6-azido-hexyl acetate 55 and 2-bromo hexyl acetate 56 were 
prepared once in a large amount (Scheme 14). Starting from 2-bromo acetic acid, 
esterifications with two different alcohols were performed in good yields. 
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Scheme 14. Synthesis of 55 and 56: a. alcohol, DCC, DMAP, DCM, rt, overnight, 53%. 
 
To introduce diversity into the probes, the C2 N-sulfinyl imine reaction 
intermediates were prepared from different aldehydes with both chiral menthyl-p-
toluenesulfinates (Scheme 15). The employed aldehydes were chemically different: 
The derivates 57 and 58 were synthesized to incorporate the side chain of 54, which 
led to successful labelling in the first generation probes. A shorter aliphatic version 
of 57 and 58 was also prepared (59 and 60). In addition, derivates with aromatic 
side chains were synthesized (61, 62, 67 and 68). To investigate the role of the 
double bond on the side chain, compounds 63 and 64 were made. 
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Scheme 15.  Synthesis of the collection of N-sulfinyl imines: a. (1R, 2S, 5R)-(-)-menthyl-(S)/(1S, 
2R, 5S)-(+)-menthyl-(R)-p-tolylsulfinate, THF, LiHMDS, -78 °C, 7 h. 
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The subsequent aza-Darzens reaction between these N-sulfinyl imines 57-68 
and 2-bromo acetic acid esters 55 and 56, then allowed the generation of a 
collection of N-(p-toluenesulfinyl) aziridines were obtained (Scheme 16). 
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Scheme 16. Synthesis of the collection of N-(p-toluenesulfinyl) aziridine probes: a. 55, THF, 
LiHMDS, -78 °C, 20 min. 
 
Additionally, to follow up the initial hit with the azirine derivative 54, the 
2H-azirine 81 this time carrying an azide instead of alkyne click tag was prepared 
from 69 with the same protocol as for 51 (Scheme 17).  
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Scheme 17. Synthesis of 81: a. LDA, TMSCl, THF, -78 °C, 15 min, 20%. 
3.3.3 Bioassays 
Probes 51 and 54 were tested immediately after preparation. The labelling 
procedure was performed as decribed in Chapter 3.1 and 3.2, complemented by an 
additional “click chemistry” step (Kaschani et al., 2009, see experimental part for 
the reaction condition). A representative example is shown in Figure 17. 
 
Figure 17. Labelling assays of probes 51 and 54: Protein extracts (~50 μg/ml) were incubated 
with probe of 5 and 10 μM, in pH 6 and 8 buffer solution for 3 h and one step more of a “click 
chemistry” to add a biotin tag on the probe. The proteins on the protein blots were detected by 
streptavidin-HRP. 
 
Unfortunately, the 2H-azirine probes 51 and 81 did not cause any labelling 
pattern neither at low pH or high pH. However, the N-(p-toluenesulfinyl) aziridine 
probe 54 caused a strong labelling band around 40 kDa at pH 8. Nevertheless, the 
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required probe labelling concentration of 10 μM was quite high and the experiment 
was hampered by a difficult reproducibility of labelling. 
Profiling experiments with the collection of N-(p-toluenesulfinyl) aziridines 
69-80 however resulted in a strong labelling pattern as depicted in Figure 18. 
 
Figure 18. Labelling assays of N-(p-toluenesulfinyl) aziridine probes series: Protein extracts (~50 
μg/ml) were incubated at pH 8 with 5 μM probe for 2 h and one step more of a “click chemistry” 
to add a biotin tag on the probe. The proteins on the protein blots were detected by streptavidin-
HRP. 
 
The different side chains of the probes had a distinct influence on labelling: 
69 and 70 with long unsaturated aliphatic chains, 75 and 76 with long saturated 
aliphatic side chains, 79 and 80 with long aromatic side chains generally caused 
stronger labelling than the probes with short side chain such as unsaturated 
aliphatic, aromatic and cyclic 71 – 74 and 77 – 78. Surprisingly, the different 
enantiomers did not cause different labelling patterns and although the probes 
featured different side chains and thus were chemically diverse, all labelling 
patterns seemed after visual inspection identical. Finally, the resolution of the gels 
was in all cases rather low, resulting in smeared bands. Unfortunately, also 
different labeling conditions did not improve the profiling quality. Despite these 
disadvantages, a pull down assay for identification of the targets was performed 
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analogously to the one described in chapter 3.2, but failed to deliver any positive 
results. After these negative results, a further follow up of this project was stopped. 
3.3.4 Discussion 
The non-directed 2H-azirine and N-(p-toluenesulfinyl) aziridines probes were 
synthesized by a straightforward synthesis route. A probe collection was generated 
by variation of the substitution pattern and the chiral centre on the three-membered 
ring. However, the adjacent biological assays were unsuccessful. 
Despite that 2H-azirine is a very reactive organic molecule, it exists as a 
stable compound in nature. It was therefore reasonable to assume that it could be 
used for labelling. However, no reproducible 2H-azirine based labelling could be 
detected. This unpleasant finding might result from the instability of the reactive 
ring system in the employed labelling conditions.  
The synthetic intermediate N-(p-toluenesulfinyl) aziridine is a less reactive 
organic molecule and showed some promising labelling patterns. This indicates a 
mild chemical reactivity of the warhead which is a prerequisite for the design of 
proper non-directed probes. The variation of the backbones from N-(p-
toluenesulfinyl) aziridine did not result in distinct labelling patterns. Thus, it seems 
that also this reactive group is much less reactive than 2H-azirines, it still reacts 
unspecific with the proteome, leading to the conclusion that also these type of 
aziridines are unsuitable for ABPP applications. 
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3.4 Direct ABP design of AEBSF-based probes 
3.4.1 Introduction 
4-(2-aminoethyl) benzenesulfonyl fluoride hydrochloride (AEBSF) is a water 
soluble, irreversible serine protease inhibitor. Its specificity is similar to another 
serine protease inhibitor PMSF, nevertheless with higher stability at low pH values. 
It was discovered and applied as a pharmacological agent to inhibit chymotrypsin, 
kallikrein, plasmin, thrombin, and trypsin proteases, and many studies about the 
physiological functions of AEBSF from neurology, immunology and medicine 
were reported (Rideout et al., 2001; Nakabo et al., 1996; Okada et al., 2003).  
Sulfonate ester (SE) probes as nondirected probes were introduced by 
Cravatt, Sorensen and co-workers several years ago (Adam et al., 2001; Adam et 
al., 2002 and Adam et al., 2004). The mild chemically reactive group of SE could 
endow the carbon electrophile with an ability to target a broad spectrum of 
labelling sites in enzymes. SE probes proved to be a versatile chemotype for the 
creation of ABPs that target a broad range of enzyme classes. 
Compared to sulfonate esters, benzenesulfonyl fluorides have a much higher 
reactivity, and this high reactivity could disturb its labelling selectivity, similar to 
that of the azirine probes (Chapter 3.3). However AEBSF has been used for 
pharmacological studies, so directed probes i.e. AEBSF-based probes are still 
worth to generate and to test for monitoring serine proteases activities in plant 
proteomes. In addition to several known serine protease probes, such as 
Fluorophosphonate (FP) probes (Kidd et al., 2001), AEBSF-based probes may 
target new classes of serine proteases. 
 
 
Zhe Ming Wang Results and Discussions Doctoral Dissertation 2009 
 - 69 - Chemical Genomics Centre (CGC) 
3.4.2 Syntheses 
AEBSF is commercially available and was used as a starting material. The 
design of the probes introduced the diversity on the amine function of AEBSF. To 
this end, peptide couplings that were performed in a parallel manner were used 
(Scheme 18). In brief, AEBSF was coupled with diverse N-Boc protected amino 
acids using PyBOP as the coupling reagent and TEA as a base. Subsequent 
deprotection with trifluoro acetic acid and coupling with the biotinyl linker building 
block 22 led after HPLC purification to the final products (82 – 86).  
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Scheme 18. Synthesis of a collection of sulfonyl fluoride probes: a. PyBOP, TEA, DCM, rt, 2 h; 
b. TFA, DCM, rt, 1 h; c. 22, PyBOP, TEA, DMSO, rt, overnight. 
 
The probes 82 to 86 were synthesized in a parallel reaction synthesizer 
without isolation of the reaction intermediates in a moderate yield of 30%. This 
might have resulted from the known instability of sulfonyl fluoride moiety, which 
could be improved by shortening the reaction time.  
Subsequent biological evaluation of the synthesized probes (see next section) 
revealed 84 (later on named as DS06) as a representative example compound of all 
other probes. Therefore, a fluorescence derivative of DS06 (84) was synthesized, 
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resulting in the generation of probe 87 (later on named as DS06R, scheme 19). The 
synthetic route for DS06R (87) was similar to the biotinylated probes, but in the 
last step rhodamine N-succinimidyl ester was coupled instead of the biotinyl linker.  
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Scheme 19. Synthesis of the fluorescence probe 87: a. PyBOP, TEA, DCM, rt, 2 h; b. TFA, 
DCM, rt, 1 h; c. 5(6)-Carboxytetramethylrhodamine N-succinimidyl ester, PyBOP, TEA, DMSO, 
rt, overnight, total 8.2%. 
3.4.3 Bioassays 
Arabidopsis leaf extracts were labelled with AEBSF-based-probes 82 to 87. 
All probes caused strong labelling of multiple proteins (Figure 19). There was no 
difference in the labelling pattern between the different probes, which indicates that 
variation of the amino acid in the main chain of the probes did not affect labelling 
selectivity.  
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Figure 19. Labelling of Arabidopsis leaf extracts with sulfonyl fluoride probes: Biotinylated 
AEBSF (BA) and its amino acid conjugates (82 – 86) were incubated with Arabidopsis leaf 
extracts in two buffer systems (NaOAc pH 6 and Tris pH 8). The protein extracts (~0.2 mg/ml) 
were incubated at pH 6 (NaOAc) or pH 8 (Tris) with 20 μM probe for 2 h. The proteins on the 
protein blots were detected by streptavidin-HRP. 
 
A similar labelling profile was generated by labelling with the fluorescent 
probe 87 (Figure 20). Since this fluorescent probe represented the labelling profiles 
of all the other probes and since it is easy to handle, probe 87 was chosen for 
further studies. 
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Figure 20. Co-labelling of 87 and 84: equal concentration of fluorescent probe 87 and 
biotinylated probe 84 were mixed and incubated with an Arabidopsis leaf extract: The labelled 
proteins were detected by streptavidin-HRP (a) and by a fluorescence photometer (b). The protein 
extracts (~30 μg/ml) were incubated at pH 8 with 2 μM probe for 2 h.  
 
To further characterise labelling, probe concentration and pH value were 
varied (Figure 21). Low probe concentration (~60 nM) already caused labelling 
(Figure 21a) illustrated the labelling sensitivity of probe 87. The signal intensities 
increased with increasing probe concentrations in the same ratio, which suggested 
that the probe 87 had almost the same affinity to all the targets. Furthermore, there 
was no saturation of the intensity of the signals, indicating that labelling cannot be 
saturated. Labelling at various pH revealed that the intensities of the signals 
increase with the rising pH value. This increased labelling is in contrast to the 
presumed probe stability since sulfonyl fluoride is less stable at higher pH. 
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Figure 21. Labelling at various probe concentrations and various pH values: a. the probe 
concentration of 87 ranges from 4 nM to 4 μM; b. the pH value ranges from 4 to 9; Protein 
extracts (~20 μg/ml) were incubated at pH 8 (a) with 2 μM probe (b) for 2 h. The labelled 
proteins on protein blot were detected by fluorescence photometer. 
 
Whether 87 is an activity-based probe was still not clear based on the above 
results. To understand the labelling mechanism, identification of the targets was 
required. Christian Gu performed a pull down assay with 84-labelled proteins and 
Dr. Colby did the protein mass spectroscopy analysis. More than hundred proteins 
were identified but there were no serine proteases or other proteases. The identified 
proteins represent different classes providing no clue on the labelling mechanism of 
the probes (84 and 87). However one 84 labelled peptide from a glutathione S-
transferase (AtGSTU20, class 20) was identified (Figure 22). The labelling 
position of probe 84 was not on the active centre residue but on a tyrosine, distant 
from the active site. 
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Figure 22. Mass spectrometry of 84-labelled peptide: the sulfonyl group was bound with a 
phenol group from tyrosine side chain; the probe 84 (blue); the peptide from AtGSTU20 (black) 
with the labelled tyrosine was (red) colour. 
 
To illustrate the unusual labelling position, a structure-based model was 
required. There is no crystal structure of Arabidopsis AtGSTU20 available, 
however the structure of its rice homologue OsGSTU1 (Dixon et al., 2003) with 
substrate – glutathione (GSH) was reported (Figure 23). GSH locates in the 
substrate-binding pocket of GST, the sulphur atom of GSH points to the adjacent 
tyrosine (Y-116), distant from the active site similar to the 84-labelled tyrosine in 
AtGSTU20. If that GSH could be replaced by probe 84, the tyrosine can attack the 
sulfonyl fluoride moiety of probe 84. This illustration helps us to understand the 
possible mechanism of probe 84 labelling the peptide from AtGSTU20 at the 
tyrosine residue. 
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Figure 23. Crystal structure of rice GST1 (OsGSTU1) in complex with glutathione: In the C-
domain GSH (space filling model) interacts with Y-116; the phenol group of Y-116 points to the 
cysteine side chain of GSH.  
 
In the meanwhile, the group of Prof. Dr. Cravatt (Scripps Institute, La Jolla) 
also made the same observation. With the alkyne-labelled AEBSF probe (BC) 
(Figure 24), they identified also many unrelated proteins including GST from 
labelled mouse liver extracts. 
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Figure 24. Structures of probes from the Cravatt lab: Click probe BC and fluorescence probe 
BCR 
 
They identified 43 labelled peptides, 72% of those peptides were labelled on 
tyrosines and 28% were labelled on serines. Furthermore, it is found that probe BC 
labelled tyrosines at multiple positions of the same peptide indicating that the 
targets could be multi-labelled. Labelled proteins included three classes of GST 
(class μ1, 1 and 1) as well as other proteins. Labelling with the different probes 
on plant and animal proteomes are mostly in agreement, except for competition 
assays. The signals of BCR could not be competed by adding an excess of AEBSF 
(in mouse liver extract) whereas the signals of 87 were successfully competed by 
AEBSF (in Arabidopsis leaf extract) (Figure 25). 
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Figure 25. Competition assay between 87 and AEBSF: Arabidopsis protein extracts (~20 μg/ml) 
were at pH 8 pre-incubated with 600 μM AEBSF for 30 min and then labelled with 2 μM probe 
87 for 2 h. The labelled proteins on the protein blot were detected by a fluorescence photometer. 
 
The opposite observations from two competitions can only be caused by two 
different factors. One is based on the biological difference between the two 
proteomes; the other is based on the chemical difference between BCR and 87. As 
it unreasonable to assume that the proteome changes the labelling activity of probe, 
the only cause seems to be the difference between those two probes, and an assay 
for comparing 87 and BCR was hence designed (Figure 26).  
The labelling pattern of 87 and BCR are different both in Arabidopsis leaf 
extract and mouse liver extract. The chemical structure difference between 87 and 
BCR is only one additional amino acid, however the side chain of that amino acid 
is not important, since probes 82 – 86 caused similar labelling patterns. Therefore 
the difference between 87 and BCR can only be explained by a spatial distance 
between warhead and reporter tag. The rhodamine moiety in 87 is further away 
from the warhead than in BCR. If the labelling pocket of the protein is too narrow, 
87 would have better labelling affinity than BCR.  
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Consistent with distinct probe targets, 87 and BCR had also their own 
competitors. 87-labelling can be competed by AEBSF but not by acetylated 
AEBSF (Ac-AEBSF). In contrast, BCR can be competed by Ac-AEBSF but not by 
AEBSF.  
 
Figure 26. Comparison of the labelling profile between 87 and BCR: 87 and BCR have a same 
AEBSF warhead (red), a same fluorescence tag (black), the slight difference is that 87 has a 
glycine more (yellow). Arabidopsis leaf extracts or mouse liver extracts (~20 μg/ml) were pre-
incubated at pH 8 with 600 μM AEBSF or Ac-AEBSF for 30 min and then labelled with 2 μM 
probe 87 or BCR at pH 8 for 2 h. The labelled proteins on protein blot were detected by 
fluorescence photometer. 
3.4.4 Discussion 
AEBSF-based probes did not label any serine proteases but many other 
enzymes such as GST, both in mammalian and plant proteomes. There are four 
possible explanations: One reason could be that AEBSF indeed does not target 
serine proteases, so the probe could not target serine proteases. Due to many clinic 
results showing that AEBSF cause phenol type, it could be that AEBSF does only 
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target serine proteases in vivo but not in vitro; an alternative explanation is that it 
targets serine proteases in situ but that label could be transferred to other enzymes 
under in vitro condition; the last possibility is that 87 is not equal to AEBSF itself, 
although it can be competed by AEBSF. Our studies could give previous 
pharmacological study of AEBSF a new idea. AEBSF can inhibit serine proteases 
in vitro however it does not mean that AEBSF must target serine proteases in vivo 
and it could have many other targets. 
Except for the targets, a significant variation of labelling selectivity caused 
by different linker is another prominent finding in this study. The different amino 
acids in probes 82 – 86 do not lead to a variation of labelling selectivity. But 
removing this amino acid significantly changes the labelling properties of the probe. 
Variation of the amino acid (82 – 86) does not change the spacer distance between 
warhead and tag, and does not change the labelling selectivity, but removing this 
amino acid shortens the spacer, changing the labelling properties of the probe. A 
long spacer may reduce the mobility of the probe whereas a short spacer may cause 
spatial problems in the presence of a bulky reporter tag.  
The reason of AEBSF-based probes preferably labelling at tyrosine could be 
explain that the benzene ring in AEBSF has an additional interaction with the 
phenol ring in tyrosine, and this interaction enhances the labelling affinity of 
AEBSF-based probes to tyrosine. 
The difference between AEBSF and its acetylated form Ac-AEBSF is the 
free amino group in AEBSF, causing a positive charge at pH < 9 on AEBSF. But 
whether this additional dipole really induces the different competition ability of 
AEBSF and Ac-AEBSF to probe 87 is still unknown. 
Based on our observations, AEBSF-based probes can be considered as multi- 
targets-reactivity probes, especially sensitive to GST, but they are not ABPs. Since 
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they do label many targets in one time, they could be used as an inhibitor instead of 
inhibitors cocktail in proteomics studies. 
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3.5 Mechanism-based ABPs design of AOMK for AvrPphB 
3.5.1 Introduction 
Plant–pathogen interactions are governed by specific interactions between a 
pathogen avr (avirulence) gene and the corresponding plant disease R (resistance) 
gene. When corresponding R and avr genes are present in both host and pathogen, 
disease will be resisted. However, if either of the two genes is inactive or absent, 
disease takes place (Flor et al., 1971). This “gene-for-gene” hypothesis was 
proposed 40 years ago but the gene-for-gene interaction had been interpreted on the 
protein level in the nineties for the first time (Keen et al., 1990). A model for the 
interaction between Avr and R proteins has been refined into “guard” and “decoy” 
models that involves an additional host protein (Van der Biezen et al., 1998; Dangl 
et al., 2001; Van der Hoorn et al., 2008). To complete the model, more Avr and R 
protein pairs need to be studied. 
The avirulence gene avrPphB was original discovered from Pseudomonas 
syringae pv. phaseolicola, which infects bean. Bean cultivars carrying the R3 
resistance gene introduce a hypersensitive reaction (HR) (Anastasia et al., 2002). 
AvrPphB was later found to induce a HR in Arabidopsis plants carrying the NB-
LRR resistance gene RPS5 (Warren et al., 1998 and Shao et al., 2002). AvrPphB is 
secreted into host cells by the Type Three Secretion System (TTSS) (Tampakaki et 
al., 2002), and belongs to a novel family of cysteine proteases. Its natural substrate 
is the Arabidopsis PBS1 protein kinase, which is specifically required for 
AvrPphB/RPS5-mediated resistance (Swiderski et al., 2001). The crystal structure 
showed that AvrPphB has a papain-like fold with a distinct substrate-binding site 
(Zhu et al., 2004). The information from the AvrPphB’s structure and amino acid 
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sequence of its natural substrate enable the design of its specific mechanism-based 
ABPs.  
Acyloxymethyl ketones (AOMKs) were introduced first in the last century 
(Bromme et al., 1989 and Pliura et al., 1992) and were reported as inhibitors of 
asparaginyl endopeptidase (Loak et al., 2004). ABPs with an AOMK warhead were 
generated by Boygo and his co-workers (Kato et al., 2005) and showed exceptional 
class-wide reactivity with cysteine proteases in proteomes. AOMK has a high 
selectivity for two major clans of cysteine proteases, the CA clan (cathepsin B and 
L) and the CD clan (caspase-3, legumain, Arg- and Lys-gingipains) (Evans et al., 
2006). Since AvrPphB belongs to the CA clan, AOMK was chosen as warhead for 
the AvrPphB probes. 
3.5.2 Synthesis 
For the synthesis of these probes (Figure 27), a solid phase peptide synthesis 
strategy (SPPS) was chosen, following essentially the protocols developed by the 
Bogyo laboratory.  
The AOMK moiety is introduced into the P1 position of the probe via a 
substitution reaction. To this end, the corresponding amino acid is transformed into 
a chloro or bromo methyl ketone (CMK or BMK) intermediate and then reacted 
with 2,6-dimethylbenzoic acid to obtain the AOMK-based amino acid (AS-
AOMK). In order to prevent side reaction during the reaction of the CMK or BMK 
intermediate and 2,6-dimethylbenzoic acid, two different protocols have been used 
which take into consideration the different chemical properties of P1 inhibitor 
residue. 
The designed probes for AvrPphB were based on the XXA-AOMK motif 
(thus alanine as a P1 residue), requiring the synthesis of an alanine AOMK (A-
AOMK) building block. Its synthesis could be separated into two parts, i.e. the 
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generation of Fmoc-Ala-CMK in solution (Scheme 20) and preparation of a 
semicarbazide linker on aminomethylpolystyrene resin (Scheme 21). For the 
synthesis of Fmoc-Ala-CMK, Fmoc-protected alanine was first converted in situ 
into a mixed anhydride with isobutylchloroformate and N-methyl morpholine in 
tetrahydrofurane, followed by a reaction with freshly generated diazomethane. The 
newly formed organo diazomethane compounds were immediately reacted with a 
one to one mixture of HCl and acetic acid to obtain the final chloro methyl ketone 
88. The resin 89 with a semicarbazide linker was obtained from commercial 
aminomethyl polystyrene resin, to which first carbonyl diimidazole and then 
hydrazine were added. 
FmocHN
O
OH
a, b, c
FmocHN
O
Cl
88  
Scheme 20. Synthesis of 88: a. isobutyl chloroformate, NMM, THF, -10°C, 25 min; b. 
diazomethane, 0 °C – rt, 3h; c. HCl/AcOH, 0 °C, 5 min, total 100%. 
 
Aminomethyl polystyrene
H2N
H
N
H
N
O
H2N
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Scheme 21. Preparation of the semicarbazide linker 89: a. carbonyldiimidazole, DMF, rt, 3h; b. 
hydrazine, DMF, rt, 1h. 
 
After preparation of the semicarbazide linker, 88 was loaded on the resin and 
converted to resin-bound Fmoc-A-AOMK by reaction with dimethylbenzoic acid 
and KF in DMF to obtain the acyoxymethyl hydrazone 90 (Scheme 22). 
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Scheme 22. Synthesis of building block 90 for SPPS: a. 88, DMF, 50°C, 3h; b. dimethylbenzoic 
acid, KF, DMF, rt, overnight.  
 
After complete syntheses of intermediate 90, standard SPPS was applied for 
the further synthesis of the probes (Figure 27), coupling first either aspartate, 
glutamate, phenylalanine, serine or arginine, then as a next amino acid glycine and 
finally 4-pentynoic acid or 2-azido acetic acid as the reporter tag of the probes. 
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Figure 27. A collection of AOMK based probes for AvrPphB 
 
As mentioned above, the natural sequence of the peptide is XXGDK, and the 
G241A, D242A, and K243A mutations reduce the peptide cleavage by about 90, 75, 
and 15%, respectively (Shao et al., 2003). Consequently, variation of the P2 
position of the probes was pursued to investigate the role of the unique acidic 
property in P2 position, which is highly unusual for ‘standard’ cysteine proteases of 
the papain-like super family. The former experience with probes such as IS4 or E64 
suggested that papain-like cysteine proteases usually prefer hydrophobic groups 
such as a benzyl or iso-butyl group on the P2 position. Hence, the probes 95 and 96 
were prepared. In order to check the impact of the negative charge on binding, 
probes 99 and 100 featuring a positive charged P2 position were also synthesized. 
Finally, to probe the general influence of side chain residues on binding, probes 91-
94 and 97-98 were synthesized, which should allow a first glimpse on the spatial 
arrangement of the critical P2 position. 
Later, after a first profiling assay revealed that 91 and 92 are most promising, 
a rhodamine labelled version 101 (later on named as FH11) was synthesized for 
more thorough screening (Figure 28). 
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Figure 28. Structure of the fluorescently labelled probe 101 
3.5.3 Bioassays 
AvrPphB is an avirulence protein from Pseudomonas syringae pv. 
phaseolicola. To obtain AvrPphB for labelling assays, we need first to clone the 
avrPphB gene and overexpress the protein. AvrPphB is injected into the host 
cytoplasma via the TTSS. When during the infection it is activated is unknown, and 
one hypothesis is that AvrPphB is only activated upon interacting with the plant 
proteome. Based on this hypothesis, we wanted to make sure to overexpress the 
active enzyme for labelling, so AvrpPhB was overexpressed in Nicotiana 
benthamiana by infiltration of Argobacterium tumefaciens. The avrPphB gene 
sequence was amplified from Pseudomonas syringae pv. tomato carrying an 
avrPphB encoding plasmid and cloned into a binary vector, behind a plant-specific 
constitutive 35S promoter (Figure 29a). The haemagglutin (HA) epitope was fused 
to the C-terminus of AvrPphB to detect the protein with an anti-HA antibody. This 
binary vector (pZM05) was transformed into Argobacterium tumefaciens via 
electroporation. The transformed Argobacterium tumefaciens were infiltrated into 
leaves of Nicotiana benthamiana. Proteins were extracted after 2-5 days and 
analyzed by anti-HA western blot. However, AvrpPhB was not detected with an 
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antibody on western blot. Instead, pZM05 triggered cell death within 2.5 days after 
agroinfiltration, which might explain the absence of AvrPphB-HA protein 
accumulation (Figure 29b).  
 
Figure 29. AvrPphB expression in planta: Agrobacteria carrying binary plasmid pZM05 were 
infiltrated into N. benthamiana leaves in the presence of silencing inhibitor p19; a. map of 
transfer DNA of pZM05 (35S, constitutive promoter; HA, haemagglutin epitope; NptII, 
kanamycin resistance gene); b. AvrPphB expression triggers cell death. Pictures were taken at 2.5 
days after agroinfiltration. 
 
A second strategy for protein expression was to express AvrPphB in 
Pseudomonas syringae pv. tomato DC3000, which does not contain the avrPphB 
gene. Although AvrPphB would be expressed without interacting with plant 
proteome, it was still worth to test if AvrPphB is active. To perform this strategy, a 
new vector for bacterial over expression was constructed by Dr. Kaschani, using 
pZM05 as a template (Figure 30a). 
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Bacteria containing the vectors pFK141 (AvrPphB-HA) and pFK142 
(AvrPphB-his) as well as the non-transformed bacteria were grown overnight at 28 
°C in normal growth medium (NYG). To determine if Pseudomonas syringae 
secretes AvrPphB, the medium and bacterial pellet were separated and proteins 
from the medium were precipitated with acetone. Analysis of the proteins on 
western blot using anti-HA antibodies, revealed a 28 kDa signal in the bacterial 
pellet sample of bacteria expressing AvrPphB-HA, which matched the calculated 
molecular weight of AvrPphB-HA (Figure 30b). The protein expression level was 
low, and 10 minutes exposure not only caused a strong signal but also increased 
background signals of 34 kDa above the AvrPphB-HA signal. 
 
 
Figure 30. a, Structure of AvrPphB vectors: pFK141 contains a terminal HA epitope whereas 
pFK142 contains a terminal His tag; PNM, a strong constitutive promoter; b, AvrPphB 
expression in Pseudomonas: non-transformed Pseudomonas (-), Pseudomonas expressing HA-
tagged (pFK141) or His-tagged (pFK142) AvrPphB were grown in rich medium; Secreted 
proteins (medium) and protein in bacterial pellet (bacteria) were analyzed on western blot, using 
anti-HA antibody. 
 
These results demonstrated that AvrPphB was not secreted by Pseudomonas 
into the medium but it accumulated inside bacteria at low level. To increase protein 
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levels, Pseudomonas was grown in minimal medium (min-A), which mimics the 
natural habitat of Pseudomonas during infection. Western blot analysis with anti-
HA antibody on proteins from bacteria revealed a strong 28 kDa signal for bacteria 
expressing AvrPphB-HA but only when the bacteria were grown in min-A (Figure 
31a). 
Protein extracts of Pseudomonas grown in min-A medium were used for a 
labelling experiment with probe 101. Fluorescence scanning revealed clear 28 kDa 
signals from Pseudomonas carrying pFK141 and pFK142 suggesting that AvrPphB 
is covalently labelled with probe 101 (Figure 31b). The fluorescence bands 
correspond with the band on the anti-HA western blot and the coomassie gel. 
 
Figure 31. a. AvrPphB expression in two media: Different Pseudomonas strains were grown 
overnight in NYG or mim-A medium; The bacterial pellet was used for anti-HA antibody 
western blot analysis; b. Labelling of AvrPphB with probe 101: Bacteria pellet proteins were 
incubated at pH 8 with 5 μM 101 for 2 h. Fluorescent Proteins were detected by an in-gel 
fluorescence scanner, anti-HA antibody and coomassie staining in sequence. 
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To confirm that the labelled protein indeed represents AvrPphB, a pull-down 
assay was performed using Nickel beads, which bind the His tag of AvrPphB-his. 
The 28 kDa fluorescence signal only appeared in the enriched sample from 
Pseudomonas carrying vector pFK142 (Figure 32). This indicates that AvrPphB-
His was captured on the Nickel beads in a high yield and the fluorescence band 
showed labelling of AvrPphB with 101. 
 
Figure 32. Pull down assay of 101-labelled AvrPphB-His: Extracts from pFK142-containing 
bacteria were labelled with 101 for 2 hours and incubated Nickel beads for 2 h to immobilize His-
tagged proteins; Proteins on Beads (B) or Supernatant (S) were detected in gel by fluorescence 
scanning and coomassie staining. 
 
These results not only showed the activity of the probe but also the activity of 
AvrPphB. Based on these results, two properties of AvrPphB were revealed. First, 
AvrPphB is already active in the extract from Pseudomonas. Second, AvrPphB is 
not secreted by Pseudomonas unless there is a stimuli, which could happen during 
infection.  
To further investigate the properties of AvrPphB, labelling was performed at 
various pH values. This revealed that AvrPphB is active at neutral pH value, 
coinciding with the pH value of the plant cytoplasm (Figure 33). In fact, pH 8 was 
not the good labelling pH for probe 101 but the neutral pH values.  
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Figure 33. pH curve of labelling of AvrPphB with 101: AvrPphB-containing extracts were 
incubated at various pH with 5 μM 101 for 2 h, Fluorescent proteins were detected by in-gel 
fluorescence scanner. 
 
PLCPs are usually active at acidic pH value, but AvrPphB is active at neutral 
pH value. Since the cytoplasm of Pseudomonas syringae is mildly acidic (Dawson 
et al., 2009), AvrPphB is inactive inside bacteria. When the bacteria inject 
AvrPphB into the cytoplasm of host cell, having a neutral pH value, AvrPphB is 
activated. Thus in our pH-dependent ABPP assay, the AvrPphB shows the most 
labelling activity at pH 7, which matches the physiological reason in nature. 
The last assay was the competition assay to test the specificity of probe 101 
(Figure 34). Labelling by 101 (P2 = D) could be competed by pre-incubation with 
92 (P2 = D), but not by the other inhibitors (P = E, F, S, R). This shows that 101 
and 92 have a high labelling specificity. Especially in the case of 92 where the P2 
position is aspartic acid whereas the P2 position of 94 was glutamic acid. The fact 
that inhibitors containing P2 = D are effective, but P2 = E not, is intriguing since 
the two inhibitors differ only in one methylene group, indicating that the S2 pocket 
of AvrPphB is too shallow to accommodate P2 = E.  
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Figure 34. Competition assay of 101: The AvrPphB containing extracts were pre-incubated with 
alkyne-tagged probes 92, 94, 96, 98, 100 at 100 μM for 30 minutes, and remaining non-inhibited 
AvrPphB was labelled with fluorescence probe 101 of 5 μM for another 1.5 hours. Fluorescent 
proteins were detected by in-gel fluorescence scanner. 
3.5.4 Discussion 
The design of probe 101 as well as its click version 91 and 92 were 
successful according to the biological results. Due to the highly selective AOMK 
moiety and using aspartate and glycine at P2 and P3 position, the probes are 
specific to AvrPphB. Variation of amino acid at the P2 position confirms that the 
AvrPphB active pocket is selective towards the P2 position of the substrate. This is 
a unique character among PLCPs, since most PLCPs prefer substrates with 
aliphatic or aromatic residues at the P2 position. However, the natural substrate of 
AvrPphB carries aspartate at P2 position. The competition experiment showed that 
only inhibitors with aspartic acid at P2 position prevent 101 labelling but even with 
glutamic acid did not. This implies that the S2 substrate-binding pocket in 
AvrPphB is too shallow to accommodate the extra chemical residue. This 
experimental observation is supported by the crystal structure, in which an arginine 
residue is located in the S2 pocket that could be responsible for the narrow space. 
The absent labelling activity of AvrPphB at low pH value could result the 
denaturation of AvrPphB. Recently another avr protein, AvrPto was reported that it 
is denaturated at low pH in order to be transportable via TTSS (Dawson et al., 
Zhe Ming Wang Results and Discussions Doctoral Dissertation 2009 
 - 93 - Chemical Genomics Centre (CGC) 
2009). The pH-sensitivity and that strict selectivity for P2 = D by AvrPphB could 
be related to the physiological function of this protease.  
After generation of ABPs for AvrPphB, future biological work on AvrPphB 
could be benefited and carried on utilizing the ABPP. We could still investigate the 
time course of expression and secretion of AvrPphB by Pseudomonas into different 
hosts in vivo; the localisation of secreted AvrPphB in plant intra- or extracellular; 
or to monitor the proteolytic in- or active state of AvrPphB. To explore the role of 
AvrPphB in the plant-pathogen interactions, the AvrPphB probes could be utilized 
as a powerful tool. 
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3.6 Mechanism-based ABPs design of AOMK for VPE 
3.6.1 Introduction 
Vacuolar processing enzymes (VPEs) are cysteine proteases responsible for 
the maturation of various vacuolar proteins in higher plants (Hara-Nishimura et al., 
1991). VPE can be subdivided into two subfamilies, one is specific for protein 
storage vacuoles in seeds and another is specific for lytic vacuoles in vegetative 
organs (Kinoshita et al., 1995). The VPE-mediated processing is similar in both 
situations and VPE cleaves at Asn-Gln bonds of natural substrates with a unique 
mechanism (Yamada et al., 1999). Activation of VPE occurs through self-catalytic 
removal of an auto-inhibitory C-terminal propeptide (Kuroyanagi et al., 2002). This 
self-activation process is similar to that of AvrPphB. Like caspases, VPE is 
involved in a mediate virus-induced hypersensitive cell death (Hatsugai et al., 
2004). There are four VPEs in Arabidopsis, namely , ,  and -VPE. The 
reversible Caspase-1 inhibitor Ac-YVAD-CHO and VPE inhibitor Ac-ESEN-CHO 
were introduced already. To monitor the change of activities for VPE in vivo and in 
vitro, specific ABPs need to be generated. 
Based on the success of AvrPphB probes, a similar probe design strategy was 
applied. AOMK was chosen as the warhead, since it can carry a P1 amino acid 
residue that determines selectivity to clan CD proteases like caspase and VPE. 
3.6.2 Syntheses 
The AOMK-based probes for VPE were synthesized by the same strategy as 
the probes for AvrPphB. The VPE probes were based on a XXN-AOMK motif. 
Contrary to Fmoc-Ala-AOMK, which was linked to the resin via a semicarbazide 
linker, the corresponding Asn-AOMK derivative can be obtained via side chain 
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linking of a corresponding Asp-AOMK building block to a 2-chlorotrityl chloride 
resin (Scheme 23). Consequently, Fmoc-Asp-AOMK was required as a building 
block for solid phase synthesis.  
To this end, Fmoc-Asp(OtBu)-OH was used as a starting material and 
converted into Fmoc-Asp(OtBu)-BMK, followed by solution transformation into 
the corresponding Fmoc-Asp(OtBu)-AOMK 103 (Scheme 23). Deprotection of the 
side chain t-Bu-ester with TFA generated building block 104, which was then 
coupled to 2-chlorotrityl chloride resin to deliver resin bound 105. 
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Scheme 23. Synthesis of building block 105 for SPPS: a. isobutylchloroformate, NMM, THF, -
10 °C, 25 min; b.  diazomethane, 0 °C - rt, 3h; c. HBr/AcOH, 0 °C, total 100%; d. 
dimethylbenzoic acid, KF, DMF, rt, overnight, 60%; e. TFA, DCM, rt, 1h, 100%; f. 2-Cl-trityl 
resin, DIPEA,  DCM, rt, 2h. 
 
The BMK reaction condition was much harsher than for CMK and hydrogen 
bromide was applied very carefully. After the synthesis of 105, standard SPPS was 
used to synthesize the biotinylated and fluorophore attached probes 106 and 107 
(Figure 35). 
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Figure 35. Structures of the biotinylated probe 106 and fluorescently labelled probe 107  
3.6.3 Bioassays 
The probe 107 was directly labelled with Arabidopsis leaf extract of different 
lines: Columbia (Col) wildtype contains an endogenous amount of VPE; -VPE 
overexpressed (O) line has high level of -VPE protein; -VPE knockout (K) line 
and VPE quadruple knockout (K) lines lack -VPE or all VPEs respectively. The 
result showed that probe 107 caused two 43 kDa signals in Col and O lines. The 
size of the labelling coincides with the theoretical VPE protein size. The signal was 
absent in single and quadruple knockout lines but more intensive in the -VPE 
overexpressed line, confirming that the signal represents VPE (Figure 36a). To 
prove that the labelling was specific, a competition assay of probe 107 was carried 
out with its cognate biotin tagged probe 106. The assay showed that the labelling of 
107 can be competed by 106 (Figure 36b). 
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Figure 36. Evaluation of probe 107 as an ABP for VPE: a, Labelling of probe 107 with 
Arabidopsis leaf extract of different lines: Columbia wildtype (Col), -VPE overexpressed (O), 
-VPE knockout (K), , , , -VPEs quadruple knockout (K); b, biotin tagged probe 106 
prevents the labelling of probe 107 in Arabidopsis leaf extract of -VPE overexpressed line; 
Arabidopsis leaf extracts of different lines (~100 μg/ml) was labelled with 5 μM probe 107 (a) or 
pre-incubated with 100 μM 106 for 30 min and then labelled with 5 μM probe 107 (b) at pH 5.5 
for 2 h. The labelled proteins on protein blot were detected by fluorescence photometer and 
coomassie stain. 
3.6.4 Discussion 
The simple biological assays prove that 107 is an ABP for VPE of 
Arabidopsis. The probe is very specific and highly selective for VPE, so this 
project gave another good example of the selectivity of the AOMK warhead to 
cysteine proteases. Unlike AOMK-based probe 101 for AvrPphB (chapter 3.5), 
which is a CA clan cysteine protease, this AOMK-based probe 107 is for VPE, a 
CD clan cysteine protease. The difference between probes 101 and 107 is only two 
different amino acids in the P1 and P2 positions, illustrating that the subtle 
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selectivity of targeting cysteine protease is dependent on the properties of the 
substrate pocket of the enzyme. 
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3.7 Natural product syntheses of Gibbestatin 
3.7.1 Introduction 
To date, Gibbestatins A-C have been described (Hayashi et al., 1999) of 
which Gibbestatin B (GNB) is the most important derivative. It was originally 
isolated in 1984 as the antibiotic 2-11-B from Streptomyces sp. 2-11 (Kinashi et al., 
1984), however without stereochemical assignments. In 1999, together with two 
other gibbestatins, the structure of GNB (Figure 37) was more thoroughly 
elucidated by spectroscopic analyses (Hayashi et al., 1999). Despite these advances, 
two chiral centres at C16 and C17 could only be assigned in relative 
stereochemistry (trans). Later, the same group reported an inhibitory effect of GNB 
on both gibberellin A3 (GA)-induced -amylase production in the cereal aleurone 
layers and the expression of various genes induced by GA, abscisic acid (ABA) and 
auxin on tobacco and Arabidopsis plants (Hayashi et al., 2000). This report 
concluded with the notion that GNB acts in a similar manner as typical plant 
hormones.  
To investigate the exact biological functional of GNB, an identification of its 
biological target is required. To this end, two strategies are in principle applicable: 
first, GNB can be transformed into an ABP for target pull-down experiments or 
second, a Y3H can be performed, necessitating a transformation of GNB into 
suitable hybrid ligands (Schneider et al., 2008). As access to the natural product is 
limited, both strategies require a previous natural product synthesis.  
The structure of GNB features one epoxide moiety and several double bonds. 
Its mode of action is still unknown, however several possibilities for a potential 
reaction of GNB with cellular proteins can be imagined from its functional groups. 
Thus, the epoxide group could be attacked by a nucleophile in an analogues manner 
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as in the natural product E-64, leading to ring opening either at C-16 as well as C-
17; in addition, GNB could be attacked by a nucleophile in a Michael-type reaction. 
Importantly, both reactions would lead to stabe, covalent protein-GNB conjugates, 
allowing efficient pull-down experiments with GNB in complex proteomes. 
As GNB represents an interesting natural product due to its inherent 
biological activity, a total synthesis was pursued, aiming at the synthesis of 
sufficient amounts of GNB for further biological screening and target identification. 
To date, no synthesis of GNB or a structurally related natural product has yet been 
reported.  
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Figure 37. Structure of GNB 
 
Although GNB is only a middle size natural product, the high density of 
functional groups still turns it into an interesting synthetic challenge. GNB features 
three double bonds, one benzene ring, one epoxide moiety and one carbonyl group 
in a only 22-carbon atoms molecule. Retro-synthetically, several strategies for 
synthesis of GNB can be differentiated.  
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3.7.2 Previous synthesis approachs for GNB 
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Scheme 24. Comparison of two retro-synthetic strategies towards GBN synthesis developed by 
Dr. Rama Narayana: a linear synthesis route (orange) and a more convergent synthesis route 
(blue) as an improved second route. However, both routes failed to deliver the desired product at 
a late stage of synthesis. 
 
The previous synthetic trial was performed by Dr. Rama Narayana (A 
postdoctoral fellow in the Kaiser group), and he first used a linear synthetic 
strategy to synthesize GNB. Because only the chiral centres on C12 and C20 were 
assigned during previous spectroscopic studies, an enantioselective aldol reaction 
was adapted for the generation of the 12S and 20S chiral centres. A Sharpless 
asymmetric epoxidation was utilized to generate both derivatives (16S, 17S & 16R, 
17R) on the epoxide moiety, because chiral information on C16 and C17 are still 
unknown (Scheme 24). Thus, first a deconjugated salicylic acid derivate 111 was 
synthesized (Scheme 24), which was then subsequently transformed into the final 
product by an anti-aldol and a HWE reaction as key steps. Starting from 2-
methoxyl benzoic acid, 11 steps are required to synthesize 111 (unpublished data). 
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It however turned out that the last step of this reaction sequence, consisting of a 
hydrolysis of methyl ester and adjacent coupling with the chiral auxiliary for the 
following aldol reaction could be achieved only in disappointing bad yields. 
Consequently, an improved synthetic route was sought. 
To this end, a convergent synthetic strategy was devised, basing again on an 
auxiliary-mediated enantioselective aldol reaction and a Sharpless epoxidation. Due 
to the instability of the TBS and t-butyl protecting groups on the salicylic acid 
moiety during the first synthetic trial, an alternative protecting group, i.e. an 
acetone acetal was used during the convergent synthetic route. As a key idea, GBN 
was divided into three building blocks via a formal separation of C8-C9 and C14-
C15 (Scheme 24). The synthesis of each building block can be achieved by 
straightforward chemistry. Indeed, the syntheses of the C8 benzyl phosphonate 
building block 112 (Scheme 24) and C15 epoxide building block 114 (Scheme 24) 
were optimized during the synthetic studies and could be achieved in good to high 
yields. The synthesis of the required building block 113 (Scheme 24) however 
could still not be achieved satisfyingly as the aldol reaction proved unexpectedly 
difficult (unpublished data). Although an assembly of 113 with the 114 could be 
achieved, the subsequent HWE reaction with 112 to complete the synthesis could 
not be performed under the investigated reaction conditions. 
3.7.3 First synthesis approach for GNB 
Retro-synthetic analysis of the first synthesis approach 
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Scheme 25. Second convergent retro-synthetic strategy 
 
At this point in time, an improved synthetic route including the gained 
knowledge of the previous trials of Dr. Narayana was developed during this thesis 
(Scheme 25): As the last step, i.e. the HWE reaction between 112 and 113/114 
building block failed in the previous synthetic route, the order of reactions was 
changed in the second convergent retro-synthesis. Thus, first 113 and 112 building 
blocks were connected by a HWE reaction and then as a last step, a HWE reaction 
between 114 and the other C14 phosphonate derivative 118 to form the C14-C15 
double bond was envisaged. The synthesis of 114 was already established 
previously. Consequently, only the generation of 118 had to be investigated. To this 
end, the C14 phosphonate moiety 118 was envisioned to be accessible by an 
elongation of the C13 aldehyde moiety 120 by a nucleophilic addition with diethyl 
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ethylphosphonate to form the C13-C14 bond. 120 could be obtained from 121, 
which in turn could be prepared by a HWE reaction between 112, whose synthesis 
was previously established, and the C9 aldol product based moiety 122. 122 could 
be generated with an auxiliary-based enantioselective aldol reaction as a key step 
within total 12 steps in total. 
However, a critical view on this synthetic strategy reveals that the generation 
of the two chiral centers on C12 and C20 is rather elaborate. As a consequence, the 
total yield of the reaction sequence was rather low, turning the final assembly of the 
synthesized building block into a tedious task. Thus, an alternative strategy would 
be advantageous for a more efficient synthesis of GNB. 
 
Synthesis of the first synthesis approach 
 
Benefited from the former experience of the GNB synthesis by Dr. Rama 
Narayana and the already obtained intermediates from his former synthesis, the 
synthesis of building block 112 was started with 126. 126 was refluxed in 10% 
sodium hydroxide ethanol solution for 2 hours to hydrolyze the ethyl ester. The 
obtained 6-methyl salicylic acid was isolated without further purification and 
reacted with acetone, thionyl chloride and a catalytic amount of DMAP in 
dimethoxyethane to protect the hydroxyl and carboxyl groups of salicylic acid as 
acetonide 127. Benzylic bromination with NBS and AIBN yielded 128, which then 
was refluxed in anhydrous toluene with triethylphosphite to generate the desired 
benzyl phosphonate building block 112 (Scheme 26). 
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Scheme 26. Synthesis of building block 112: a. NaOH, EtOH, reflux, 2 h; b. DMAP, CH3COCH3, 
SOCl2, Dimethoxyethane, < 30 °C, 3 h, 89%; c. NBS, AIBN, CCl4, reflux, overnight, 99%; d. 
P(OEt)3/Toluene, reflux, 3 h, 96%. 
 
To simplify the synthetic work, the (16S, 17S) isomer on the epoxide moiety 
was first chosen as the target molecule. After successful establishment of the 
synthetic route, the corresponding (16R, 17R) isomer could be synthesized easily. 
The synthesis of the required building block 114 started with a Sharpless 
asymmetric epoxidation of (E)-2-buten-1-ol to obtain [(2S, 3S)-3-methyloxiran-2-yl] 
methanol (129), which was then oxidized with DMP to generate the volatile 
building block 114 (Scheme 27). 
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Scheme 27. Synthesis of building block 114: a. DIPT, tBuOOH, Ti(OiPr)4, DCM, - 20 °C, 2 h, 
54%; b. DMP, DCM, 0 °C, 1 h, 90%. 
 
To perform the second convergent retro-synthetic strategy, preparation of the 
aldol-derived building block 122 is essential. The direct Masamune anti-aldol 
reaction was not compatible with the later reaction conditions, so a combination of 
a syn-aldol reaction and Mitsunobu inversion was adapted (unpublished data). To 
perform this strategy, two small fragments 124 and 125 were required. 124 was 
synthesized by mono-protection of 1,3-propanediol with TBDPSCl to generate 130 
followed by oxidation to the aldehyde 124 with a Swern oxidation. 125 was 
prepared from a coupling reaction of bromoacetyl bromide with of (2R)-4-(phenyl 
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methyl)-2-oxazolidinone (Evans auxiliary) to form 131 followed by bromide 
displacement by refluxing with triethylphosphite (Scheme 28). 
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Scheme 28. Syntheses of building blocks 124 and 125: a.TBDPSCl, DIPEA, DCM, rt, overnight, 
90%; b. DMSO, (COCl)2,  DCM, TEA, -78 °C, 2 h, 70%; c. bromoacetyl bromide, n-BuLi, THF, 
-78°C, 1 h, 94%; d. P(OEt)3, reflux, overnight, 80%. 
 
After accomplishing the preparation of 124 and 125, a HWE reaction 
between both led to 132, which then was subjected to a syn-aldol reaction with 
acetaldehyde to generate the syn-aldol product 133. In order to achieve the required 
inversion of the hydroxyl group, 133 was first transformed into an anti-para-
nitrobenzoic ester 134 by a Mitsunobu-type reaction, which was then hydrolyzed to 
generate the desired anti-aldol product 135. Surprisingly, the subsequent 
methylation of 135 failed with all employed methylation reagents such as 
iodomethane, methyl triflate and diazomethane in combination with different bases 
such as 2,6-di-tert-butyl-4-methyl pyridine, pyridine or TEA. The reason for the 
unsuccessful methylation could be the unfavorable spatial conformation of the 
substrate. The auxiliary seemed to strongly shield the reaction center of 135 by 
other reagents. As a consequence, the required building block 123 could not be 
synthesized (Scheme 29).  
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Scheme 29. Synthesis of building block 123: a. NaHMDS, THF, 0 °C – rt, 1 h, 85%; b. Bu2BOTf, 
TEA, CH3CHO, DCM, -78 °C – rt, 4 h, 91%; c. DIAD, TPP, PNBA, THF, 0 °C, 30 min, 91%; d. 
K2CO3, MeOH, rt, 1.5 h, 79%. 
 
Although 135 could not be methylated directly, this problem could be 
circumvented by removing the shielding auxiliary, which only results in some 
additional steps. However, in order to test if the designed synthetic strategy is 
feasible at all, the methylated syn-aldol product 136 was used to perform the test 
reactions. 136 was reduced with LiBH4 to remove the auxiliary and then protected 
with DHP to generate 137. The TBDPS protecting group was released with TBAF 
to obtain 138, which was then in situ oxidized to an aldehyde with DMP and 
transformed into 139 via a HWE reaction with building block 112. Deprotection of 
THP by PPTS in methanol yielded 140, which was then oxidized with DMP to 141. 
The aldehyde 141 was reacted with deprotonated diethylethylphosphonate to 
generate 142, which was then transformed into 143 by Dess-Martin oxidation 
(Scheme 30). The subsequent synthesis had to be stopped at this step because the 
Zhe Ming Wang Results and Discussions Doctoral Dissertation 2009 
 - 108 - Chemical Genomics Centre (CGC) 
synthetic intermediate 143 could be obtained only in too low amounts for the 
further reactions overall steps. From 136 to 143, 9 steps were required for synthesis. 
As a consequence, although a transformation of 135 into the corresponding isomer 
of 136 by an alternative strategy in principle would be possible, the overall reaction 
sequence seems very uneconomic and an alternative strategy for the synthesis of 
GNB was sought. 
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Scheme 30. Test reactions for final part of the synthesis: a. LiBH4, Ether/Methanol, 0 °C – rt, 3 h, 
93%; b. DHP, PPTS, DCM, rt. 5 h, 80%; c. TBAF, THF, rt, 3 h, 85%; d. DMP, DCM, 0 °C, 1 h, 
90%; e. t-BuOK, 112, THF, 0 °C – rt, 1 h, 57%; f. PPTS, MeOH, rt, 2 d, 66%; g. DMP, DCM, 0 
°C, 1 h, 86%; h. EtPO(OEt)2, n-BuLi, THF, -78 °C, 1 h, 23%; i. DMP, DCM, 0 °C, 1 h, 50%. 
3.7.4 Second synthesis approach for GNB 
Retro-synthetic analysis of second synthesis approach 
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Scheme 31. Third convergent retro-synthetic route 
 
The third convergent retro-synthesis developed within this thesis is based on 
a division of GNB into two parts via the C12-C13 bond (Scheme 31). Although the 
generation of a carbanion at C12 of 144 as a prerequisite for a nucleophilic 
substitution and a subsequent stereoselective substitution at an activated carbon 
acid moiety surely is a difficult task, the suggested synthesis route is much more 
straightforward than previous ones. Thus, this reaction requires careful 
optimization of reaction conditions. As the complementary reaction partner of the 
carbanion, a suitable leaving group at the C13 moiety 145 was carefully discussed. 
Several potential groups could react with the generated carbanion in the desired 
manner, e.g. an acyl halide or active anhydride, which all are available from a 
carboxylic acid derivative. Thus, a HWE reaction on the former 114 building block 
could generate such a carboxylic acid. As for 144, it could also be obtained from 
the former 112 building block and a new C9 conjugated aldehyde building block 
146 by a HWE reaction. 146 could then be prepared within 2 steps from 
acetaldehyde by a proline-catalyzed one pot asymmetric synthesis of 5-hydroxy-
(2E)-hexenal (Cordova et al., 2002). It is obviously that the third version of  the 
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convergent retro-synthesis immensely simplifies the total synthesis of GNB despite 
the risky last step. 
 
Synthesis of second synthesis approach 
 
According to the third convergent retro-synthetic strategy, the building block 
147 was required. To this end, the ylide 149 was generated from methyl 
bromopropionate and triphenylphosphine. In a one-pot reaction, 129 was oxidized 
with manganese oxide and subsequently reacted with 149 to yield 150. Subsqeuent 
hydrolysis under mild basic conditions generated building block 147 (Scheme 32). 
The hydrolysis step still requires further optimization in future because hydrolysis 
of the epoxide moiety also occurred under the employed reaction conditions. 
OMe
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Br
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O
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149 150 147  
Scheme 32. Synthesis of building block 147: a. TPP, NaOH, H2O, 70°C, 24 h, 95%; b. 129, 
MnO2, DCM, rt, 2 d, 97%; c. 0.1 M NaOH, H2O/THF, rt, 3 h, 51%. 
 
The other building block 144 was obtained by an efficient reaction sequence. 
Acetaldehyde in THF solution in presence of L-proline undergoes a self-triple 
condensation to form 148 featuring the correct conformation, which was then 
methylated under a mild reaction to obtain 146. 146 was subjected to a HWE 
reaction with 112 to generate the building block 144 (Scheme 33). The synthetic 
route is compact with a very good overall yield (51%). 
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Scheme 33. Synthesis of building block 144: a. L-Proline, THF, 4 °C, 14 h; b. TfOMe, 2,6-di-(t-
butyl)-4-methylpyridine, DCM, rt, overnight, 90%; c. t-BuOK, 112, THF, 0 °C – rt, 1 h, 80%. 
 
After obtaining the building blocks of 144 and 147, the completion of the 
synthesis of GNB is very close. Deprotonation studies on 144 revealed n-BuLi as 
most efficient. The further synthesis is anticipated as following: 147 will be 
transformed into an active anhydride, which is added to the carbanion of 144 to 
generate a protected GNB derivative. Complete deprotection then delivers GNB 
(Scheme 34). Although the critical coupling reaction might not occur with high ee 
ratio, this route is still more efficient due to the in comparison to previous trials 
highly shortend reaction sequence.  
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Scheme 34. Future synthetic plan for the synthesis of GNB 
3.7.5 Discussion 
We hope that with this fourth strategy, the total synthesis of GNB is very 
close to the end. This strategy for the first time does not rely on an auxiliary-based 
aldol reaction that strongly shortens the overall synthetic steps as no introduction 
and cleavage of the auxiliary is necessary. Instead, this method relies on an 
efficient organocatalytic transformation that introduces enantioselectively a 
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required first stereocenter that will be used to direct the outcome of subsequent 
reactions. 
We did not accomplish the synthesis yet. However, what we have learned via 
performing the synthesis is almost more meaningful than the synthesis itself. To 
study the synthesis is equally important as to complete the synthesis. The total 
synthesis of GNB will finish in soon future within few steps.  
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4 Summary (English) 
The present thesis includes the study and development of suitable small 
molecules for ABPP. Within this thesis, 4 different types of ABP design strategies 
were studied and 6 types of ABPs collections were generated. To this end, around 
150 organic compounds were characterised as reaction intermediates or products; 4 
proteomes from botanic, bacterial and mammalian species were profiled in vitro or 
in vivo respectively; around 200 1D-SDS-PAGE and manifold MS proteomics 
analyses were performed; several targets of the designed probes have been 
identified and the associated genetic work of cloning and in planta protein 
expression has also been completed. 
 
The summary of the whole PhD work is separated in three parts – the first 
chemical, the second chemical biological, and the third biological – in order to 
facilitate a more detailed discussion. 
4.1 Chemical part 
3 probes and 2 inhibitors with an anti--lactone warhead (chapter 3.1), 9 
probes and 8 inhibitors with a syn--lactone warhead (chapter 3.2), 2 probes with 
an azirine warhead (chapter 3.3), 13 probes and 1 inhibitor with an aziridine 
warhead (chapter 3.3), 6 probes and 1 inhibitor with an AEBSF warhead (chapter 
3.4) and finally 18 probes with an AOMK warhead (chapter 3.5 and 3.6) were 
generated. Of these probes, 3 were rhodamine tagged fluorescent probes, 16 were 
biotin tagged affinity probes and 27 were azide or acetylene tagged chemical 
orthogonal probes.  
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For generation of the anti--lactone compounds, a Masamune auxiliary 
based synthetic strategy was used and delivered the desired -lactones with a high 
enantioselection and yield (chapter 3.1). With this methodology, probes with 
variant chemical moieties were generated. However, in later synthetic approaches 
(chapter 3.7), this methodology proved incompatible for variant aldol reactions 
such as a 1,3 or 1,5-shifted aldol reaction, probably due to lower reactivity and 
stability of the ester-based Masamune aldol reaction partner than the amide-based 
Evans aldol reaction partner.  
The cyclization of serine or threonine to form syn--lactone compounds 
followed by peptide couplings proved as a direct and convenient method to 
generate a syn--lactone-based probe collection in a short time (chapter 3.2). 
The Aza-Darzens asymmetric synthesis was demonstrated to be a versatile 
method to generate aziridine or azirine compounds. The reaction proved as 
compatible with many chemical moieties and application of the commercially 
available chiral menthyl-p-tolylsulfinate auxiliary led to a good enantioselection of 
the sulfinyl imine intermediate. Consequently, this methodology enabled the 
generation of a complete probe library (chapter 3.3) with yields ranging from 30% 
to 90%.  
Also AEBSF-derived probes featuring a sulfonyl fluoride moiety were 
synthetically straightforward available, although reaction yields were only modest 
due to hydrolysis under peptide coupling or purification conditions (chapter 3.4).  
The AOMK derivatives were rapidly and conveniently accessible by SPPS, 
enabling the generation of several AOMK-based peptide probes (chapter 3.5 and 
3.6). 
Finally, the total synthesis of GNB was studied intensively. To date, four 
different synthetic strategies were evaluated, two of them within this thesis (chapter 
3.7). To this end, around 40 reaction intermediates were prepared. Each re-
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evaluation of the synthesis strategy improved the former one, resulting in a more 
efficient synthesis regarding protecting group strategy or the number of 
intermediates. The latest retro-synthesis involved an allyl anion nucleophilic 
substitution based strategy, replacing the previously used aldol reaction-based 
strategy, thereby shortening the required synthetic steps significantly. The proline-
catalyzed one pot asymmetric synthesis of 5-hydroxy-(2E)-hexenal represents a 
short and efficient way to prepare the required building block. Although the total 
synthesis is not yet completed, the required building blocks were fully 
characterised, requiring now the final assembly. However, the employed strategy 
seems very promising and therefore finalisation of the synthesis should be possible 
in the near future. 
4.2 Chemical biological part 
Four ABP design strategies being direct, non-directed, natural product based 
and mechanism based probe design were studied within this thesis. The natural 
product based probe design strategy was used to obtain two THL-based ABPs. 
However, the targets of these two ABPs proved different from the expected lipase 
targets. One reason for this might be the modification of the peptide moiety on the 
side chain of THL, indicating that even subtle chemical modifications can change 
the target of a natural product. For future probe designs, it seems preferably to keep 
the synthesized probe as similar as possible to the natural product, although this 
burdens the required chemical synthesis.  
With the mechanism-based probe design strategy, 9 syn--lactone-based 
probes and 18 AOMK-based probes were obtained. Interestingly, the 9 syn--
lactone-based probes finally did not prove as “classical” ABPs. Instead, a 
transpeptidase activity of a previously known cysteine protease RD21 was 
discovered (chapter 3.2). The 18 AOMK-based probes for AvrPphB and VPE were 
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demonstrated to act as ABPs, labelling their target enzymes very specifically 
(chapter 3.5 and 3.6). These “opposite” results from the two types of probes 
evaluated during this thesis indicate that “classical” mechanism-based probes can 
be obtained only if the reacting warhead irreversibly binds the target enzyme while 
a “transiently” formed covalent bond can lead to unexpected results. 
Following the direct probe design strategy, 6 AEBSF-based probes were 
generated. Unexpectedly, these probes proved not as ABPs (chapter 3.4). One 
reason for this strange finding could be that the additional linker and reporter tag 
change the properties of the serine protease inhibitor AEBSF. This indicates that a 
direct transformation of an inhibitor into an ABP is not trivial. An alternative 
explanation could be that AEBSF contrary to previous reports is not a selective 
active site inhibitor.  
The non-directed probe design strategy was used to obtain 13 aziridine and 2 
azirine-based probes. However, the evaluation of their labelling potential proved as 
difficult and it seems that they cannot be used as valuable probes (chapter 3.3). To 
date, there is only a limited number of non-directed probes available, probably as a 
result of difficult probe design. The results of this thesis suggest that indeed 
chemical reactivity of the synthesized probes is a key point in non-directed probe 
design as the generated probes have to be in a very narrow reactivity window, 
being reactive enough to bind to active site residues but being inactive enough to 
prevent unspecific labelling. Consequently, non-directed probe design strategies 
still need further improvement. 
 
Regarding the specificity of the reactive warheads towards certain enzyme 
classes, AOMKs proved as most specific, targeting only cysteine proteases as 
reported in the literature (chapter 3.5 and 3.6). -Lactones proved as a potential 
new warhead class, targeting many classes of hydrolases. Consequently, in order to 
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obtain specific -lactone based probes, chemical modifications e.g. of the linker 
moiety (chapter 3.1 and 3.2) are necessary. Finally, AEBSF, aziridine and azirine-
derived probes were demonstrated to be too active for specific labelling, thereby 
generally limiting their applicability for the development of ABPs (chapter 3.3 and 
3.4).  
 
In addition, 3 types of tags were studied. Biotin proved as a good affinity tag 
not only for detection but also specially for purification of the targets in vitro. 
However, the poor solubility and membrane permeability of biotin-tagged ABPs 
severely limited their use in ABPP applications.  
Fluorescent tags proved as very versatile and easy to apply in many labelling 
studies, nevertheless application is limited due to the incapability to purify the 
labelled targets.  
Click chemistry-based chemically orthogonal tags proved as an elegant way 
to balance the advantages and disadvantages of affinity and fluorescent tags. The 
targets of interest could be labelled first either in vivo or in vitro, and only then an 
affinity or fluorescent tag is coupled. The only disadvantage of this method is the 
required click chemistry-mediated reaction, in presence of copper, which could 
cause protein aggregation. 
 
Studies of different linker system have been performed to investigate the 
influence of labelling selectivity. The results showed that small changes of linker 
composition such as the addition of one glycine moiety is able to cause a different 
labelling pattern, highlighting the often-neglected role of linkers during probe 
design (chapter 3.4). To date, there are no general rules to evaluate proper linker 
design and further attempts in this direction are required in future. 
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Profiling experiments in this thesis were performed exclusively with 1D 
protein gels, which proved as very convenient for evaluating profiling efficiency 
and to quickly display a chemical proteome map. However, the proteins of interest 
could be studied further more by 2D gel profiling. The target identification of 
probes could be carried out via gel-based or gel-free strategies. 
4.3 Biological part 
The biological part of this thesis focuses on the roles of enzymes for plant-
pathogen interactions. Several literature reports highlight the roles of hydrolytic 
enzymes during plant defence processes. To monitor the changes of the activity 
states of these enzymes in normal, susceptible or diseased plant proteomes, several 
probe types were developed as described previously. While some probes failed to 
deliver suitable labelling properties, the syn--lactone protease probe could be used 
successfully to elucidate a transpeptidase mechanism of the Arabidopsis thaliana 
PLCP RD21 (chapter 3.2). The physiological meaning of this PTM will be studied 
further in future.  
Cloning of the Pseudomonas syringae PLCP AvrPphB and labelling 
experiments of this avirulence protein with an AOMK-based probe revealed several 
important properties of this enzyme. Especially the pH dependent activity of 
AvrPphB seems related with its physiological function in TTSS (chapter 3.5). 
Finally, the AOMK-based VPE probe has also been used to profile the 
activity of VPE in wild or mutant Arabidopsis strains (chapter 3.6). However, 
further studies on the implications of the observed different activity states are still 
required.  
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5 Zusammenfassung (German) 
Die vorliegende Doktorarbeit beschäftigt sich mit dem Studium und der 
Entwicklung geeigneter kleiner Moleküle zum ABPPs. Hierzu wurden vier Typen 
von ABPs entwickelt und sechs Substanzsammlungen generiert. Es wurden 150 
organische Verbindungen, entweder Zwischen- oder Endprodukte, charakterisiert; 
Ein Profiling von vier Proteomen, aus Pflanzen, Bakterien und Säugetieren, sowohl 
in vitro, als auch in vivo, erstellt; ungefähr 200 1D-SDS-PAGE und eine große 
Anzahl an MS-proteomischen Analysen wurden durchgeführt; einige der 
Zielproteine konnten durch die entwickelten Sonden identifiziert werden; 
zusätzlich konnte die dazugehörige genetische Arbeit der Klonierung und der in 
planta Proteinexpression abgeschlossen werden. 
 
Die Zusammenfassung der gesamten Doktorarbeit ist in drei Abschnitte 
unterteilt, um eine detailliertere Diskussion zu ermöglichen. Diese sind ein 
chemischer, ein chemisch-biologischer und ein biologischen Teil. 
5.1 Chemischer Teil 
Es wurde eine Vielzahl an Sonden und Inhibitoren mit verschiedenen 
reaktiven Gruppen synthetisiert, d.h. es wurden mit anti--Lactonen 3 Sonden und 
2 Inhibitoren (Kapitel 3.1), mit syn--Lactonen 9 Sonden und 8 Inhibitoren 
(Kapitel 3.2), mit Azirinen 2 Sonden (Kapitel 3.3), mit Aziridin 13 Sonden und 1 
Inhibitor (Kapitel 3.3), mit AEBSF 6 Sonden und 1 Inhibitor (Kapitel 3.4), mit 
AOMK 18 Sonden (Kapitel 3.5 und 3.6) hergestellt. Von diesen Verbindungen sind 
3 Fluoreszenssonden mit Rhodamin, 16 Affinitätssonden mit Biotin und 27 weitere 
chemisch orthogonale Sonden mit Azid oder Acetylen versehen worden. 
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Eine auf das Masamune-Auxiliar-basierende synthetische Strategie wurde 
genutzt, um die anti--Lacton-Verbindungen in hoher Enantioselektivität und 
Ausbeute zu generieren (Kapitel 3.1). Mit dieser Methodologie konnten Sonden mit 
verschiedenen chemischen Motiven generiert werden. Dennoch hat sich diese 
Vorgehensweise in späteren synthetischen Versuchen (Kapitel 3.7) für variierte 
Aldol Reaktionen als inkompatibel erwiesen, beispielsweise bei der 1,3 oder 1,5-
verschobenen Aldolreaktion. Dies liegt wahrscheinlich an der niedrigeren 
Reaktivität und Stabilität der auf Estern basierenden Masamune-
Aldolreaktionspartner, im Vergleich zu den auf Amiden basierenden Evans-
Aldolreaktionspartnern. 
Um eine Sammlung aus syn--Lacton-Sonden in kurzer Zeit zu generieren, 
erwies sich die Zyklisierung der Serine und Threonine, gefolgt von 
Peptidkupplungen als überzeugende Methode (Kapitel 3.2). 
Die asymmetrische Aza-Darzens-Synthese hat sich als vielseitige Methode 
erwiesen, um Aziridine und Azirine zu synthetisieren. Dieser Mechanismus führte 
zu Sulfinylimin-Intermediaten in guter Enantioselektivität, ist kompatibel mit 
vielen chemischen Resten und erlaubt die Verwendung des chiralen, kommerziell 
verfügbaren Menthyl-p-tolylsulfinat-Auxiliars. Daher erlaubte diese Methodologie 
die Erstellung einer kompletten Sondensammlung (Kapitel 3.3) mit Ausbeuten von 
30 bis 90%. 
Auch die auf AEBSF-basierenden-Sonden besitzen ein Sulfonylfluoridrest 
und sind synthetisch schnell verfügbar. Allerdings waren die Ausbeuten moderat, 
da sowohl unter den Bedingungen bei Peptidkupplungen, als auch bei der 
Aufreinigung eine Hydrolyse stattfand (Kapitel 3.4). 
Die AOMK-Derivate konnten schnell und einfach durch SPPS hergestellt 
werden. Dies ermöglichte die Synthese verschiedener peptidischer Sonden, die auf 
AOMK-Motiv basierten (Kapitel 3.5 und 3.6). 
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Abschließend wurde die Synthese von GNB ausgiebig studiert. Bishier sind 
vier verschiedene synthetische Strategien zur Synthese dieses Naturstoffes evaluiert 
worden; zwei dieser Strategien wurden in dieser Arbeit behandelt (Kapitel 3.7). 
Innerhalb der Doktorarbeit wurden zu diesem Zweck fast 40 Intermediate 
hergestellt. Jede neuerliche Evaluierung der synthetische Strategie erzielte 
Verbesserungen im Vergleich zu vorhergehenden Versuchen; dies führte zu einer 
effizienten Synthese in Bezug auf die Schutzgruppen und die Anzahl der 
Intermediate. Die neueste Retrosynthese basiert auf einer allylisch-anionischen, 
nukleophilen Substitutionsstrategie, auf diese Weise konnte die auf der 
Aldolreaktion basierende Retrosynthese erheblich verkürzt werden. Dies hat die 
Anzahl der benötigten Reaktionsschritte signifikant reduziert. Die 
prolinkatalysierte, asymmetrische Eintopfsynthese des 5-Hydroxy-(2E)-hexenal ist 
ein kurzer und effizienter Weg, um den benötigten Baustein zu synthetisieren. 
Obwohl die Totalsynthese noch nicht abgeschlossen werden konnte, sind alle 
Bausteine voll charakterisiert und können nun miteinander verknüpft werden. Da 
die verwendete Strategie äußerst vielversprechend erscheint, sollte ein Abschluss 
der Synthese bald erreicht werden können. 
5.2 Chemisch biologischer Teil 
Innerhalb dieser Doktorarbeit wurden vier Ansätze zur Generierung von 
ABP studiert. Diese sind das Design von direkten-, nicht-direkten-, naturstoff-
basierten- und Mechanismus-basierten Sonden. 
Die Naturstoffstrategie wurde genutzt, um zwei THL-basierte ABPs zu 
erhalten. Allerdings waren die Zielproteine dieser ABPs andere, als die der 
erwarteten Lipasezielstrukturen. Ein Grund für diese unterschiedlichen Zielproteine 
könnte die Modifikation des peptidischen Restes der THL-Seitenkette sein. Dies ist 
ein Anzeichen, dass selbst geringste chemische Veränderungen die Zielproteine 
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von Naturstoffen ändern können. Bei zukünftigen Planungen von Sonden sollten 
daher die synthetisierten Verbindungen dem Naturstoff so ähnlich wie möglich sein, 
auch wenn dies die Synthese erschwert. 
Mittels Mechanismus-basiertem Sondendesign konnten 9 syn--Lactone und 
18 AOMK-basierte Sonden erhalten werden. Interessanterweise erwiesen sich die 9 
syn--Lactone nicht als "klassische" ABPs, stattdessen erlaubten sie die 
Entdeckung der Transpeptidaseaktivität der bekannten Cysteinprotease RD21 
(Kapitel 3.2). Es konnte gezeigt werden, dass die 18-AOMK basierten Sonden für 
AvrPphB und VPE als ABPs fungieren und ihre Zielenzyme sehr spezifisch 
markieren (Kapitel 3.5 und 3.6). Die gegensätzlichen Ergebnisse der zwei 
Sondentypen geben Hinweise, dass "klassische" auf mechanismus basierende 
Sonden nur erhalten werden können, wenn die reaktive Gruppe irreversibel am 
Zielenzym bindet, während eine "vorübergehende", kovalente Bindung zu 
unerwarteten Resultaten führen kann. 
Dem direkten Sondendesign folgend wurden 6 AEBSF-basierte Sonden 
generiert. Diese Sonden erwiesen sich überrachender Weise nicht als ABPs 
(Kapitel 3.4). Dies könnte an dem zusätzlichen Linker und Reportertag liegen, der 
die Eigenschaften des Serinproteaseinhibitors AEBSF verändert. Dies deutet an, 
dass eine direkte Transformation eines Inhibitors in ein ABP nicht trivial ist. 
Außerdem wäre es möglich, dass entgegen bisherigen Erkenntnissen, AEBSF kein 
selektiver Inhibitor aktiver Zentren ist. 
Das nicht-direkte Sondendesign wurde genutzt, um 13 auf Aziridine und 2 
auf Azirine basierende Sonden zu synthetisieren. Allerdings hat sich die 
Evaluierung dieser Verbindungen als schwierig erwiesen und es scheint als könnten 
diese nicht als Sonden genutzt werden (Kapitel 3.3). Bis heute ist lediglich eine 
begrenzte Anzahl an nicht-direkten Sonden verfügbar, wahrscheinlich aufgrund der 
Schwierigkeiten beim Design der Sonden. Die Ergebnisse dieser Dissertation 
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weisen darauf hin, dass die chemische Reaktivität der synthetisierten Sonden 
absolut essentiell ist. Die Sonden haben ein enges Reaktivitätsfenster, sie müssen 
so reaktiv sein, dass sie am aktiven Zentrum binden, dürfen allerdings nicht so 
reaktiv sein, dass es zu unspezifischen Markierungen kommen kann. Nicht-direktes 
Sondendesign erfordert daher weitere Verbesserungen. 
 
In Bezug auf die Spezifität der reaktiven Gruppen zu bestimmten 
Enzymklassen haben sich AOMKs als am geeignetsten erwiesen. Wie in der 
Literatur angegeben, sind diese spezifisch gegenüber Cysteinproteasen (Kapitel 3.5 
und 3.6). -Lactone haben sich als neue Klasse für reaktive Gruppen erwiesen, da 
sie mit vielen Klassen der Hydrolasen interagieren. Um jedoch spezifische Sonden 
auf Basis von -Lactonen zu erhalten, sind chemische Modifikationen notwendig, 
Z.B. des Linkers (Kapitel 3.1 und 3.2). Abschließend hat es sich gezeigt, dass 
Sonden abgeleitet von AEBSF, Aziridinen und Azirinen zu reaktiv sind, um als 
spezifische Markierungen eingesetzt werden zu können; dies limitiert die 
Entwicklung und die Applikation dieser Verbindungen für ABPs generell (Kapitel 
3.3 und 3.4). 
 
Zusätzlich wurden drei Typen von Tags untersucht. Biotin hat sich als 
geeignetes Tag sowohl zur Detektion, als auch speziell zur Affinitätsaufreinigung 
der Zielproteine in vitro erwiesen. Die Nutzung von Biotin für ABPP-
Anwendungen ist jedoch aufgrund der schlechten Löslichkeit und 
Membranpermeabilität begrenzt. 
Fluoreszierende Sonden haben sich als vielseitig einsetzbar erwiesen und 
konnten in vielen Markierungsstudien verwendet werden. Dennoch ist die 
Anwendung eingeschränkt, da markierte Proteome nicht aufgereinigt werden 
können. 
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Auf Click-Chemie basierende, orthogonale Tags haben sich als vielseitige 
Alternative erwiesen. Sie besitzen eine gute Balance zwischen den Vor- und 
Nachteilen der Tags, die auf Affinität oder Fluoreszens basieren. Interessante 
Zielstrukturen konnten zunächst entweder in vivo oder in vitro markiert werden und 
dann in Abhängigkeit der jeweiligen Umstände mit einem Affinitäts- oder 
Fluoreszens Tag versehen werden. Der einzige Nachteil dieser Methode ist, dass 
die Click-Chemie-Reaktion Kupfer benötigt, welches Proteinaggregation 
verursachen kann. 
 
Des weiteren wurden Untersuchungen angestellt, um die Bedeutung 
verschiedener linker in Bezug auf die Selektivität der Markierungen aufzuklären. 
Die Ergebnisse haben gezeigt, dass kleine Änderungen im Aufbau des Linkers wie 
beispielsweise das Hinzufügen eines zusätzlichen Glycins, unterschiedliche 
Markierungsmuster zur Folge haben können. Dies zeigt, wie wichtig bei der 
Planung von Sonden die oft vernachlässigte Rolle des Linkers ist (Kapitel 3.4). Bis 
heute gibt es keine generellen Erkenntnisse zur Evaluierung des Designs von 
Linkern und künftig sind weitere Anstrengungen in diese Richtung notwendig. 
 
Alle Profiling-Experimente in dieser Doktorarbeit wurden ausschließlich mit 
1D-Proteingelen durchgeführt. Diese eignen sich sehr gut, um die Effiziens des 
Profiling zu evaluieren und zur schnellen kartographierung von Proteomen. Ein 
2D-Gelprofil könnte für ein gründlicheres Studium interessanter Proteine unter 
Umständen notwendig sein. Eine Identifikation der Zielstrukturen der Sonden 
könnte durch auf Gele basierende oder gelfreie Strategien durchgeführt werden. 
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5.3 Biologischer Teil 
Der biologische Teil dieser Doktorarbeit fokussiert sich auf die Rolle von 
Enzymen bei der Pflanzen-Pathogen Interaktion. Verschiedene Literaturquellen 
stellen die Rolle von hydrolytischen Enzymen bei Abwehrprozessen der Pflanzen 
heraus; um die Veränderungen der Aktivität dieser Enzyme in normalen, 
empfänglichen oder erkrankten Pflanzenproteomen zu überwachen, sind die zuvor 
erwähnten, unterschiedlichen Sondentypen entwickelt worden. Während einige 
Sonden nicht die notwendigen Eigenschaften zur Markierung aufwiesen, war es 
jedoch möglich die syn--Lacton-Sonde erfolgreich zu nutzen, um den 
Mechanismus der Transpeptidase von Arabidopsis thaliana PLCP RD21 (Kapitel 
3.2) zu studieren. Die physiologische Bedeutung dieser PTM wird in 
darauffolgenden Studien weiter untersucht werden. 
Die Klonierung der Pseudomonas syringae PLCP AvrPphB, sowie 
Markierungsexperimente dieses avirulenten Proteins mit AOMK-basierten Sonden 
haben einige wichtige Eigenschaften dieses Proteins offenbart. Insbesondere die 
pH-abhängige Aktivität von AvrPphB, welche anscheinend mit ihrer 
physiologischen Funktion im TTSS zusammenhängt (Kapitel 3.5) ist zu erwähnen. 
Außerdem konnte die AOMK basierte Sonde dazu genutzt werden, die 
Aktivität von VPE in wildtyp oder mutierten Arabidopsis-Stämmen zu untersuchen 
(Kapitel 3.6). Dennoch sind weitere Untersuchungen in Bezug auf die 
Implikationen der beobachteten verschiedenen Aktivitätsstadien notwendig. 
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6 Experimental section 
6.1 Chemical part 
6.1.1 Instruments and Reagents 
NMR Spectroscopy 
 
The NMR spectra were measured with the following machines 
 
Varian Mercury VX-400: 400 MHz 1H-NMR and 100.5 MHz 13C-NMR 
Bruker DRX 500:   500 MHz 1H-NMR and 125.7 MHz 13C-NMR 
 
Chemical shifts are expressed in parts per million (ppm) from internal deuterated 
solvent standard (CDCl3): H = 7.27 ppm, C = 77.16 ppm; CD3OD: H = 4.85 ppm, 
C = 49.00 ppm; DMSO: H = 2.48 ppm, C = 39.43 ppm; CD3CN: H =1.94 ppm, 
C = 1.24 ppm; CD3COCD3: H =2.04 ppm, C = 29.8 ppm). Coupling constants (J) 
are given in Hertz (Hz) and the following notations indicate the multiplicity of the 
signals: s (singlet), d (doublet), t (triplet), dd (doublet of doublet), m (multiplet), br 
(broad signal). 
 
Optical rotation 
 
Optical rotations were measured in a Schmidt&Haensch Polartronic HH8 
polarimeter at 589 nm. Concentrations of different substrates are given in g/100mL 
solvent. 
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High resolution mass spectrometry 
 
HRMS was measured by a HPLC Agilent 1100 Series with one mass spectrometer 
of LTQ Orbitrap and nano-electrospray for ionisation. A C18-Dionex column was 
applied. 
 
Reversed phase liquid chromatography – electrospray ionisation mass 
spectrometry (LC-MS) 
LC-MS measurements were carried out on a Agilent 1200 Series HPLC with a 
150/4.6 Eclipse XDB-C18 5 μM and a 125/4 Nucleodur C4 Gravity 5 μM. The 
ESI-mass spectrometer was a LCQ Advantage MAX from Thermo. 
The standard gradient is the following: 
Solvent A: 0.1 % HCOOH in H2O; solvent B: 0.1 % HCOOH in ACN; Flow rate: 1 
ml/min, 1 min 10 % B, linearly increasing to 100 % B in 9 min, and 2 min with 
100% B. 
 
Melting point determination 
 
Melting points were measured with a Buechi melting point B-540 apparatus with 
open capillary (uncorrected values were reported). 
 
Fourier transform infrared spectroscopy (FT-IR) 
 
IR spectra were measured in Bruker vector 22 with a diffuse reflectance head A527 
from Spectra Tech (KBr as a matrix) and a Bruker tensor 27 spectrometer with 
transmission and attenuated total reflection (ATR) and coupled with infrared 
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microscope from Spectra Tech (neat). The following notations indicate the intensity 
of the absorption bands: s = strong, m = middle, w = weak, b = broad. 
 
Thin layer chromatography (TLC) 
 
TLCs were carried out on Silica gel 60 F254 from Merck with ultraviolet light 
irradiation at 254/360 nm or the following staining agents:  
Staining solution A: Molybdatophosphoric acid (20g) in ethanol (100 ml); 
Staining solution B: KMnO4 (5 g), NaOH solution (100 mg) in H2O (100 ml); 
Staining solution C: Ninhydrin (100 mg) in ethanol (50 ml) and acetic acid (1 ml). 
 
Preparative reverse phase high performance liquid chromatography (prep 
HPLC) 
 
Purification of compounds was performed on an LC-8A from Shimatsu with VP 
125/21 Nucleodur C18 Gravity 5 μm column from Macherey-Nagel. 
The standard gradient is the following: 
Solvent A: 0.1 % TFA in H2O; solvent B: 0.1 % TFA in ACN; Flow rate: 20 
ml/min. 
 
Solvents and Reagents 
 
The reagents and solvents were purchased from Acros Chimica, Aldrich, Fluka, 
Merck, Novabiochem, Riedel de Haen, Roth and were used without further 
purification.  
 
Deionized water was obtained using a Millipore Q-plus System. 
Zhe Ming Wang Experimental section Doctoral Dissertation 2009 
 - 129 - Chemical Genomics Centre (CGC) 
Anhydrous solvents and reagents such as DCM, THF, diethyl ether, toluene, ACN, 
methanol, DMF, DMSO and DIPEA were purchased from Aldrich, Fluka or Acros 
Chimica. 
 
Triethylamine was distilled from CaH2 under argon and stored with KOH.  
 
NBS was recrystallized from water. 
 
Phosphate buffer pH 7.0: NaH2PO4H2O (2.9 g) and Na2HPO42H2O (5.15 g) were 
dissolved in water (50 ml). 
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6.1.2 Synthetic procedures 
(1S, 2R)-2-(N-Mesitylenesulfonyl)amino-1-phenyl-1-propanol (1) 
 
N
H
OHPh
S
O
O
Chemical Formula: C18H23NO3S
Molecular Weight: 333.4451
 
 
To a stirred solution of (1S,2R)-norephedrine (3.78 g, 25 mmol) and TEA (4.2 ml, 
30 mmol) in anhydrous DCM (100 ml) was added mesitylenesulfonyl chloride 
(5.47g, 25 mmol) at 0 °C. The reaction mixture was stirred at 0 °C for 50 min and 
at room temperature for another 1.5 h. The mixture was washed with water (50 ml), 
1N HCl (40 ml), water (30 ml), saturated NaHCO3 solution (40 ml) in sequence. 
The organic layer was separated and concentrated in vacuo to afford the product 1 
(yield: 8.29 g, 24.9 mmol, 99%) as a yellow oil, which was used in the next step 
without further purification (Recrystallization from DCM/hexane if crystal 
required).  
 
TLC (MeOH/DCM = 1:9): Rf = 0.82; LC-MS (ESI): tR = 8.95 min, calcd. for 
C18H23NO3S [M]
+, 333.45, found 333.78. 
 
(1S, 2R)-2-(N-benzyl-N-Mesitylenesulfonyl)amino-1-phenyl-1-propanol (2) 
 
N
OHPh
S
O
O Chemical Formula: C25H29NO3S
Molecular Weight: 423.5677
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A mixture of 1 (8.29 g, 24.9 mmol), benzyl bromide (3.5 ml, 30 mmol) and Cs2CO3 
(8.25 g, 37.5 mmol) in acetonitrile (100 ml) was refluxed for 0.5 h. The cooled 
mixture is filtered and the salt is washed with diethyl ether (30 ml) four times. 
Combined organic layers were concentrated and purified by flash chromatography 
(ethyl acetate/cyclohexane = 1:5) to afford the product 2 (yield: 10.05 g, 23.8 mmol, 
95 %) as a white powder and the side product N,O-dibenzyl compound (0.53 g).  
 
TLC (ethyl acetate/cyclohexane = 1:5): Rf = 0.63; 1H NMR (CDCl3)  = 7.34-6.93 
(m, 12H), 5.0 (s br, 1H), 4.77 (ABq, J = 16 Hz), 4.54 (ABq, J = 16 Hz), 3.83 (dd, J 
= 7.2 Hz), 2.65 (s, 6H), 2.29 (s, 3H), 2.12 (br s, 1H), 1.03 (d, J = 7.2 Hz, 3H); 13C 
NMR (CDCl3)  = 142.8, 142.3, 140.4, 138.8, 132.3, 128.8, 128.3, 127.9, 127.6, 
127.5, 125.7, 59.9, 49.3, 48.0, 23.2, 21.1, 10.1; LC-MS (ESI): tR = 8.95 min, calcd. 
for C25H29NO3S [M]
+, 423.57, found 423.86.  
 
Dicyclohexylborane (3) 
 
BH
Chemical Formula: C12H23B
Molecular Weight: 178.1220
 
 
Cyclohexene (3.34 ml, 33 mmol) and anhydrous diethyl ether (10 ml) were charged 
in a 50 ml round flask and kept at 0 °C under argon. Borane-dimethyl sulphide 
complex (2.94 ml, 16 mmol) was added dropwise. 5 minutes after addition of the 
borane, a precipitate was formed. The reaction mixture was stirred for 3 h at 0 °C, 
and the diethyl ether was removed as much as possible by a syringe. The remained 
solid was dried under reduced pressure to give the product 3 (yield: 2.8 g, 15.8 
mmol, 99%) as a white powder, which is used without further purification for the 
preparation of the triflate. 
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Dicyclohexylboron trifluoromethanesulfonate (4) 
 
B
O
S F
O
O
F
F
Chemical Formula: C13H22BF3O3S
Molecular Weight: 326.1832
 
 
To a suspension of 3 (2.8 g, 15.8 mmol) in anhydrous hexane (10 ml) was added 
dropwise via a glass drop funnel trifluoromethanesulfonic acid (1.42 ml, 16 mmol) 
under stirring, a gentle gas evolution occurred. The solid starting material gradually 
dissolved and after 5 min the solution turned clear and colourless. Stirring was 
continued at room temperature for 1.5 h. The reaction was completed when there 
was no gas evaporation any more. A slight amount of crystalline powder formed on 
the bottom of the flask, which was the acid precipitated from the hexane. After 
filtration, the filtrate was collected. (If crystals were needed, then the solution was 
placed in a -20°C freezer for 24 h. Larger crystals formed and the mother liquor 
was transferred via cannula to another flask. The crystals were dried under reduced 
pressure.) Hexane was removed at reduced pressure to obtain the product (yield 4.6 
g, 14.1 mmol, 89%) as colourless crystals. The isolated crystals could be preserved 
as an 1M hexane solution at 4 °C. 
 
Methyl 6-aminocaproate hydrochloride (5) 
 
H3N
OMe
O
Cl Chemical Formula: C7H16ClNO2
+
Molecular Weight: 181.6599  
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To a white suspension of 6-aminocaproic acid (2.62 g, 20 mmol) in ice-cooled 
anhydrous methanol (35 mL) was added dropwise thionyl chloride (2.04 mL, 28 
mmol). The reaction mixture was allowed to warm to room temperature and was 
subsequently stirred overnight. Removal of the volatiles under reduced pressure 
gave methyl 6-aminocaproate hydrochloride 5 (yield: 3.63 g, 20 mmol, 100%) as a 
colourless crystalline solid and was used in the next step without further 
purification. 
 
1H NMR (D2O)  = 3.59 (s, 3H), 2.89 (t, J = 7.6 Hz, 2H), 2.32 (t, J = 7.6 Hz, 2H), 
1.55 (m, 4H), 1.31 (m, 2H). 
 
Methyl (6-di-Boc-amino)caproate (6) 
 
(Boc)2N COOMe
Chemical Formula: C17H31NO6
Molecular Weight: 345.4311  
 
A solution of 5 (2.9 g, 20 mmol) in a mixture of dioxane (40 ml), water (20 ml) and 
Na2CO3 (2.12 g, 20 mmol) was stirred and cooled in an ice bath. Di-tert-butyl 
pyrocarbonate (4.8 g, 22 mmol) was added and stirred at room temperature for 
another 30 min. The solution was concentrated in vacuo to about 10 to 15 ml, 
cooled in an ice bath, covered with a layer of DCM (60 ml) and acidified with a 
dilute solution of KHSO4. The organic layer was separated, washed with NaHCO3 
aqueous solution (20 ml) and brine (20 ml), dried over Na2SO4 and concentrated in 
vacuo to obtain the product (6-mono-bocamino)caproate (yield 4.9 g, 20 mmol, 
100%) as a colourless oil.  
 
1H NMR (CDCl3)  = 4.5 (br s, 1H), 3.66 (s, 3H), 3.11 (q, J = 6.4 Hz, 2H), 2.31 (t, 
J = 7.2 Hz, 2H), 1.68-1.32 (m, 6H), 1.44 (s, 9H). 
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To a solution of above obtained methyl 6-(monobocamino)caproate (4.9 g, 20 
mmol) and DMAP (220 mg, 1.8  mmol) in THF (120 ml) was added a solution of 
Di-tert-butyl pyrocarbonate (6.54 g, 30 mmol) in THF (50 ml) and the mixture was 
refluxed for 16 h. Additional Di-tert-butyl pyrocarbonate (4.36 g, 20 mmol) was 
added and the heating was continued for 5 h. The deep orange colour reaction 
mixture was cooled down, concentrated, purified by column chromatography (ethyl 
acetate/cyclohexane = 3:97) to get the pure product 6 (yield: 6.2 g, 18 mmol, 90%) 
as a light yellow oil.  
 
TLC (ethyl acetate/cyclohexane = 3:97): Rf = 0.18; 1H NMR (CDCl3)  = 3.64 (s, 
3H), 3.53 (t, J = 7.5 Hz, 2H), 2.29 (t, J = 7.5 Hz, 2H), 1.66-1.53 (m, 4H), 1.48 (s, 
18H), 1.35-1.28 (m, 2H); 13C NMR (CDCl3)  = 173.8, 152.6, 81.9, 51.3, 46.1, 33.9, 
28.5, 27.9, 26.2, 24.5.  
 
(6-Di-Boc-amino)caproic acid (7) 
 
(Boc)2N CO2H
Chemical Formula: C16H29NO6
Molecular Weight: 331.4046  
 
6 (1.38 g, 4 mmol) in acetonitrile (20 ml) was cooled to 0°C. n-Bu4NOH  30 H2O 
(4.8 g, 6 mmol) was added under stirring (ACN/H2O = 2.5:1 to 6:1). The reaction 
was complete in 15 to 30 min. The organic layer was washed with 1N HCl and 
water, concentrated in vacuo to obtain the product 7 (yield 1.32 g, 4 mmol, 100 %) 
as a colourless oil.  
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1H NMR (CDCl3)  = 3.54 (t, J = 7.5 Hz, 2H), 2.35 (t, J = 7.5 Hz, 2H), 1.68-1.56 
(m, 4H), 1.49 (s, 18H), 1.45-1.35 (m, 2H); 13C NMR (CDCl3)  = 178.4, 152.6, 
82.0, 46.1, 33.8, 28.5, 27.9, 26.1, 24.5. 
 
(1S, 2R)-2-(N-benzyl-N-mesitylenesulfonyl)amino-1-phenyl-1-propanyl (6-di-
Boc-amino)caproate (8) 
 
(Boc)2N O
O
N
S
O
O Chemical Formula: C41H56N2O8S
Molecular Weight: 736.9569
 
 
To a solution of 7 (662 mg, 2 mmol), DCC (412 mg, 2 mmol) and DMAP (0.01 g, 
0.1 mmol) in DCM (10 ml), 2 (0.846 g, 2 mmol) was added. The reaction was 
stirred overnight, concentrated in vacuo, purified by column chromatography (ethyl 
acetate/cyclohexane = 1:9) to get the pure product 8 (yield: 1.4 g, 1.9 mmol, 95%) 
as a colourless oil.  
 
TLC (ethyl acetate/cyclohexane = 1:9): Rf = 0.2; 1H NMR (CDCl3)  = 7.33-7.29 
(m, 3H), 7.23-7.18 (m, 5H), 6.93-6.87 (m, 4H), 5.82/5.00 (d/d, 1H, J = 4 Hz), 
4.77/4.71 (d/d, J = 16.5 Hz, 1H), 4.59/4.54 (d/d, J = 16.5 Hz, 1H), 4.04/3.81 (q/q, J 
= 2.5 Hz, 1H), 3.55/3.50/3.19 (t/t/t, J = 7.5 Hz, 2H), 2.65/2.61/2.50 (s/s/s, 6H), 
2.29/2.27 (s/s, 3H), 2.18-2.02 (m, 2H), 1.81-1.68 (m, 2H), 1.51/1.49 (s/s, 18H), 
1.33-1.18 (m, 4H), 1.11/1.02/0.96 (d/d/d, J = 7 Hz, 3H); 13C NMR (CDCl3)  = 
171.9, 152.8, 142.6, 140.4, 138.8, 138.7, 133.5, 132.3, 128.5, 128.3, 127.9, 127.9, 
127.5, 127.4, 127.2, 126.1, 125.7, 82.2, 78.1, 56.8, 48.3, 46.3, 35.1, 34.3, 28.8, 28.2, 
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26.4, 24.5, 23.1, 21.0, 13.0; LC-MS (ESI): tR = 11.95 min, calcd. for 
C41H56N2O8SNa [M+Na]
+, 759.95, found 759.26. 
 
(6-Hydroxylhexyl)carbamic acid benzyl ester (9) 
 
OH
CbzHN
Chemical Formula: C14H21NO3
Molecular Weight: 251.3214  
 
6-Amino-1-hexanol (585 mg, 5 mmol) was dissolved in dioxane (7 ml) and sodium 
bicarbonate saturated aqueous solution (10 ml) at room temperature. To this 
solution, carbobenzoxy chloride (1 g, 6 mmol) in dioxane (3 ml) was added. The 
reaction was complete in 3 h and extracted with DCM and washed with brine, dried 
over sodium sulfate, purified by column chromatography (ethyl 
acetate/cyclohexane = 2:1) to get the pure product 9 (yield: 1.09 g, 4.3 mmol, 87%) 
as a colourless oil.  
 
TLC (ethyl acetate/cyclohexane = 2:1): Rf = 0.44; 1H NMR (CDCl3)  = 7.35-7.31 
(m, 5H), 5.09 (s, 2H), 4.74 (br s, 1H), 3.63 (t, J = 6.4 Hz, 3H), 3.19 (m, 2H), 1.58-
1.49 (m, 4H), 1.40-1.34 (m, 4H); 13C NMR (CDCl3)  =156.5, 136.79, 128.66, 
128.24, 66.76, 62.88, 41.05, 32.71, 30.11, 26.52, 25.44; HPLC: tR = 12.18 min. 
 
(6-Formylhexyl)carbamic acid benzyl ester (10) 
 
O
CbzHN
Chemical Formula: C14H19NO3
Molecular Weight: 249.3056  
 
To a solution of 9 (0.502 g, 2 mmol) in THF (7.5 ml) was added a solution of IBX 
[0.09 g/ml (DMSO), 7.5 ml, 2.4 mmol] at 0 °C. The clear reaction solution was 
Zhe Ming Wang Experimental section Doctoral Dissertation 2009 
 - 137 - Chemical Genomics Centre (CGC) 
then stirred at room temperature overnight. The reaction mixture was filtrated 
before extraction. The product was extracted with DEE, washed with brine, dried 
and purified by a short column chromatography (ethyl acetate) to get the pure 
product 10 (yield: 0.47 g, 1.9 mmol, 95%) as a colourless oil.  
 
TLC (ethyl acetate): Rf = 0.87; 1H NMR (CDCl3)  = 9.76 (s, 1H), 7.37-7.32 (m, 
5H), 5.10 (s, 2H), 4.77 (br s, 1H), 3.20 (m, 2H), 2.44 (t, J = 7.24 Hz, 3H), 1.66 (m, 
2H), 1.53 (m, 2H), 1.35 (m, 2H); 13C NMR (CDCl3)  = 202.49, 156.5, 136.75, 
128.66, 128.25, 66.77, 43.85, 40.93, 29.93, 26.34, 21.77; HPLC: tR = 14.04 min. 
 
(1S, 2R)-2-(N-benzyl-N-mesitylenesulfonyl)amino-1-phenyl-1-propanyl  
enanthate (11)  
 
O
O
N
S
O
O
Chemical Formula: C32H41NO4S
Molecular Weight: 535.7372
 
 
To a solution of enanthic acid (311 μl, 2.2 mmol), DCC (453 mg, 2.2 mmol) and 
DMAP (12 mg, 0.1 mmol) in DCM (10 ml), 2 (846 mg, 2 mmol) was added. The 
reaction mixutre was stirred overnight, concentrated in vacuo, purified by column 
chromatography (ethyl acetate/cyclohexane = 1:9) to get the pure product 11 (yield: 
0.92 g, 1.7 mmol, 86%) as a colourless oil. 
  
TLC (ethyl acetate/cyclohexane = 1:9): Rf = 0.33; 1H NMR (CDCl3)  = 7.34-7.33 (d, 
J = 7 Hz, 2H), 7.19-7.18 (m, 6H), 6.89-6.88 (m, 4H), 5.82 (d, J = 4 Hz, 1H), 4.74 
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(ABq, J = 16.5 Hz, 1H), 4.54 (ABq, J = 16.5 Hz, 1H), 4.04 (dd, J = 2.5, 4 Hz, 1H), 
2.51 (s, 6H), 2.28 (s, 3H), 2.17-2.09 (m, 2H), 1.5-1.48 (m, 2H), 1.23-1.22 (m, 6H), 
1.12 (d, J = 7 Hz, 3H), 0.86 (t, J = 7 Hz, 3H); 13C NMR (CDCl3)  = 171.9, 142.4, 
140.1, 138.6, 138.4, 133.3, 132.0, 128.3, 128.2, 127.7, 127.3, 127.0, 125.9, 77.8, 
56.6, 48.1, 34.1, 31.3, 28.6, 24.5, 22.9, 22.3, 20.8, 13.9, 12.8; LC-MS (ESI): tR = 
11.75 min, calcd. for C32H41NO4SNa [M+Na]
+, 558.72, found 558.26. 
 
(1S, 2R)-2-(N-benzyl-N-mesitylenesulfonyl)amino-1-phenyl-1-propanyl (4-
phenyl)butyrate (12) 
 
O
O
N
S
O
O
Chemical Formula: C35H39NO4S
Molecular Weight: 569.7535
 
 
Following the same protocol as above for 11 led to the pure product 12 (yield: 0.95 
g, 1.66 mmol, 83%) as a colourless oil. 
 
TLC (ethyl acetate/cyclohexane = 1:9): Rf = 0.32; 1H NMR (CDCl3)  = 7.34-7.27 
(d, 4H), 7.24-7.18 (m, 7H), 7.11-7.10 (d, J = 2.2 Hz, 2H), 6.92-6.88 (m, 4H), 5.83 
(d, J = 4 Hz, 1H), 4.74 (d, J = 16.5 Hz, 1H), 4.54 (d, J = 16.5 Hz, 1H), 4.04 (m, 1H), 
2.54 (t, J = 7.5 Hz, 2H), 2.51 (s, 6H), 2.28 (s, 3H), 2.17-2.09 (m, 2H), 1.82 (m, 2H), 
1.11 (d, J = 7 Hz, 3H), 0.86 (t, J = 7 Hz, 3H); 13C NMR (CDCl3)  = 171.8, 142.6, 
141.4, 140.4, 138.8, 138.7, 133.5, 132.3, 128.6, 128.5, 128.4, 127.5, 127.2, 126.2, 
126.1, 78.1, 56.8, 48.3, 35.1, 33.5, 27.1, 26.2, 23.2, 21.0, 13.0; LC-MS (ESI): tR = 
11.43 min, calcd. for C35H39NO4SNa [M+Na]
+, 592.74, found 592.23. 
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Anti--(S)-Hydroxyl--(S)-pentyl-(8-Cbz-amino)caprylic Masamune auxiliary 
ester (13) 
 
N
O
S
O
OO
OH
CbzHN
Chemical Formula: C46H60N2O7S
Molecular Weight: 785.0428
 
 
To a solution of 11 (474 mg, 884 μmol) in anhydrous DCM (15 ml) at -78 °C was 
added TEA (525 μl, 3.8 mmol) and 4 (1 M in hexane, 1.77 ml). After 2 h at -78 °C, 
10 (264 mg, 1.06 mmol) in anhydrous DCM (3 ml) was added dropwise. The 
reaction was stirred at -78 °C for 1 h and at 0 °C for another 1 h before quenched 
by adding pH 7 buffer (10 ml), MeOH (10 ml) and 30% H2O2 (10m ml). The 
heterogeneous mixture was stirred vigorously for 12 h and extracted with DCM 
thoroughly. The combined organic layers were dried over Na2SO4, concentrated in 
vacuo, purified by column chromatography (ethyl acetate/cyclohexane = 1:2) to get 
the pure product 13 (yield: 0.614 g, 0.78 mmol, 88%) as a colourless oil.  
 
[]20D = -20.8 (c = 4.38, CDCl3); TLC (ethyl acetate/cyclohexane = 1:2): Rf = 0.5; 
1H NMR (CDCl3)  = 7.33-7.11, 6.84 (m, 17H, Ar), 5.82 (d, J = 5.64 Hz, 1H), 5.09 
(s, 2H), 4.74 (ABq, J = 16.2 Hz, 1H), 4.70 (m, 1H), 4.49 (ABq, J = 16.2 Hz, 1H), 
4.16 (m, 1H), 3.62 (m, 1H), 3.16 (m, 2H), 2.42 (s/s, 6H/1H), 2.27 (s, 3H), 1.90 (m, 
2H), 1.73 (m, 2H), 1.49-1.02 (m, 25H), 1.13 (d, J = 2.16 Hz, 3H), 0.78 (t, J = 6.8 
Hz, 3H); 13C NMR (CDCl3)  = 174.7, 156.5, 149.5, 142.6, 140.5, 138.5, 138.0, 
136.8, 136.7, 133.3, 128.6, 128.5, 128.2, 128.0, 127.8, 127.4, 127.1, 126.8, 78.2, 
72.1, 70.4, 66.7, 56.5, 51.5, 48.2, 41.0, 35.7, 35.2, 31.8, 30.1, 29.7, 26.9, 26.7, 25.6, 
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25.3, 24.3, 23.0, 22.5, 21.0, 14.6, 14.0; LC-MS (ESI): tR = 11.63 min, calcd. for 
C46H60N2O7SNa [M+Na]
+, 807.04, found 807.21. 
 
Anti--(S)-hydroxyl--(S)-(2-phenylethyl)-(8-Cbzamino)caprylic masamune 
auxiliary ester (14) 
 
N
O
S
O
OO
OH
CbzHN
Chemical Formula: C49H58N2O7S
Molecular Weight: 819.0590
 
 
Following the same protocol as above for 13 led to the pure product 14 (yield: 
0.475 g, 0.58 mmol, 70%) as a colourless oil. 
 
[]20D = -27.6 (c = 4.5, CDCl3); TLC (ethyl acetate/cyclohexane = 1:2): Rf = 0.31; 
1H NMR (CDCl3)  = 7.35-7.11, 6.84 (m, 22H), 5.82 (d, J = 5.64 Hz, 1H), 5.09 (s, 
2H), 4.74 (ABq, J = 16.2 Hz, 1H), 4.70 (m, 1H), 4.49 (ABq, J = 16.2 Hz, 1H), 4.16 
(m, 1H), 3.62 (m, 1H), 3.16 (m, 2H), 2.45 (m, 1H), 2.42 (s, 6H), 2.27 (s, 3H), 2.05 
(s, 1H), 1.87 (m, 2H), 1.32-1.02 (m, 10H), 1.13 (d, J = 2.16 Hz, 3H); 13C NMR 
(CDCl3)  = 174.2, 156.6, 142.8, 142.7, 141.5, 141.3, 140.6, 138.4, 138.0, 136.9, 
133.3, 132.3, 128.7, 128.68, 128.66, 128.62, 128.59, 128.56, 128.51, 128.46, 
128.42, 128.31, 128.21, 127.99, 127.5, 127.1, 127.0, 126.9, 126.3, 78.4, 77.4, 72.1, 
66.8, 56.5, 51.2, 50.9, 41.1, 35.2, 33.4, 31.4, 27.2, 26.7, 26.6, 23.1, 21.1, 15.1, 14.8; 
LC-MS (ESI): tR = 17.51 min, calcd. for C49H58N2O7SNa [M+Na]
+, 842.04, found 
841.34. 
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Anti--(S)-hydroxyl--(S)-pentyl-(8-Cbzamino)caprylic acid (15) 
 
OH
O
OH
CbzHN
Chemical Formula: C21H33NO5
Molecular Weight: 379.4904
 
 
To a solution of 13 (395 mg, 0.5 mmol) in a THF/water mixture (2:1, 5 ml) was 
added LiOH  H2O (420 mg, 10 mmol). The reaction mixture was stirred at room 
temperature for 3 days and poured into water (10 ml) and extracted with ether to 
recover the auxiliary. The aqueous layer was acidified (pH 3) with 1N HCl and 
extracted with ether. The organic layer was carefully washed with brine, dried, and 
the solvent was removed at reduced pressure. The product 15 was nearly pure 
without additional purification (yield: 0.141 g, 0.37 mmol, 74.6%) as a colourless 
oil.  
 
TLC (ethyl acetate/cyclohexane = 1:2): Rf = 0.11; 1H NMR (CDCl3)  = 7.36-7.31 
(m, 5H), 5.09 (s, 2H), 4.78 (s br, 1H), 3.70 (m, 1H), 3.17 (m, 2H), 2.46 (m, 1H), 
1.73-1.30 (m, 16H), 0.89 (t, J = 6.44 Hz, 3H); 13C NMR (CDCl3)  = 182.96, 
156.87, 134.76, 131.41, 128.76, 128.75, 128.36, 72.00, 52.77, 51.00, 45.8, 43.44, 
38.41, 32.51, 31.9, 29.7, 27.2, 26.4, 22.66, 22.65, 14.21. 
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Anti--(S)-hydroxyl--(S)-(2-phenylethyl)-(8-Cbzamino)caprylic acid (16) 
 
OH
O
OH
CbzHN
Chemical Formula: C24H31NO5
Molecular Weight: 413.5066
 
 
Following the same protocol as above for 15 led to the pure product 16 (yield: 25 
mg, 0.06 mmol, 71%) as a colourless oil. 
 
TLC (ethyl acetate/cyclohexane = 1:2): Rf = 0.08; 1H NMR (CDCl3)  = 7.36-7.13 
(m, 10H), 5.09 (s, 2H), 4.82 (s br, 1H), 3.79/3.67 (m, 1H), 3.10 (m, 2H), 2.74-2.43 
(m, 3H), 2.03-1.99 (m, 1H), 1.86-1.79 (m, 1H), 1.42-1.23 (m, 9H); 13C NMR 
(CDCl3)  = 174.61, 156.89, 148.64, 141.72, 141.53, 136.78, 128.76, 128.72, 
128.66, 128.64, 128.35, 126.3, 126.27, 72.23, 72.09, 66.94, 51.04, 50.4, 41.01, 34.1, 
34.0, 33.76, 31.5, 30.57, 30.02, 26.55, 26.48, 25.54. 
 
(3S, 4S)-3-pentyl-4 -[(5-cbzamino)pentyl]-2-oxetanone (17) 
 
O
O NHCbz
Chemical Formula: C21H31NO4
Molecular Weight: 361.4751  
 
To a cooled and stirred solution of 15  (54.2 mg, 143 μmol) in anhydrous pyridine 
(5.15 mL), 2-nitrobenzenesulfonyl chloride (63.2 mg, 286 μmol) in pyridine (1.2 
ml) was added dropwise via a syringe at 0 °C. The light yellow solution was stirred 
for two days at 0 °C and diluted with ether (100 ml). Water (30 ml) was added, and 
the aqueous layer was extracted with ether (3 x 10 mL). The combined organic 
layers were washed once with water (20 ml) and dried over anhydrous Na2SO4, 
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concentrated in vacuo, purified by column chromatography (ethyl acetate/cyclo- 
hexane = 1:2) to get the pure product 17 (yield: 35.3 mg, 0.1 mmol, 70%) as a 
colourless oil.  
 
[]20D = -18.0 (c = 3.5, CD3CN); TLC (ethyl acetate/cyclohexane = 1:2): Rf = 0.51; 
1H NMR (CD3CN)  = 7.33-7.31 (m, 5H), 5.56 (s br, 1H), 5.09 (s, 2H), 4.25 (m, 
1H), 3.24 (m, 1H), 3.09 (m, 2H), 1.74-1.70 (m, 4H), 1.47-1.31 (m, 12H), 0.92 (t, J 
= 6.84 Hz, 3H); 13C NMR (CD3CN)  = 172.90, 157.37, 138.62, 129.44, 129.11, 
128.82, 128.67, 126.51, 79.00, 66.65, 56.75, 41.4, 34.8, 32.17, 30.4, 28.44, 27.3, 
27.03, 25.41, 23.11, 14.27; LC-MS (ESI): tR = 12.31 min, calcd. for C21H31NO4Na 
[M+Na]+, 384.46, found 384.13. 
 
(3S, 4S)-3-(2-phenylethyl)-4-[(5-Cbz-amino)pentyl]-2-oxetanone (18)  
 
O
O NHCbz
Chemical Formula: C24H29NO4
Molecular Weight: 395.4914  
 
Following the same protocol as above for 17 led to the product 18 (yield: 24.6 mg, 
0.06 mmol, 71%) as a colourless oil, however 40% of product was racemized.    
 
[]20D = -8.94 (c = 2.5, CD3CN); TLC (ethyl acetate/cyclohexane = 1:2): Rf = 0.36; 
1H NMR (CD3CN)  = 7.33-7.21 (m, 10H), 5.58 (s br, 1H), 5.09 (s, 2H), 
4.50(syn)/4.26(anti) (m/m, 1H), 3.66(syn)/3.24(anti) (m, 1H), 3.09 (m, 2H), 
2.8~2.65 (m/m, syn/anti, 2H), 2.05 (m, 2H), 1.72-1.64 (m, 2H), 1.46-1.31 (m, 6H); 
13C NMR (CD3CN)  = 173.38, 172.60, 154.45, 143.14, 142.05, 129.45, 129.44, 
129.41, 128.78, 128.63, 127.13, 127.09, 79.17(anti), 76.77(syn), 66.61, 56.19(anti), 
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52.66(syn), 41.35, 34.6, 34.1, 33.63, 30.55, 30.33, 30.27, 26.97, 26.93, 26.5, 25.94, 
25.37; LC-MS (ESI): tR = 14.03 min, calcd. for C24H29NO4Na [M+Na]
+, 418.48, 
found 418.05. 
 
(3S, 4S)-3-pentyl-4 -[(5-amino)pentyl]-2-oxetanone (19) 
 
O
O NH2
Chemical Formula: C13H25NO2
Molecular Weight: 227.3431  
 
17 (80 μmol, 28.9 mg) was weighted in a 10 ml flask with two necks equipped with 
gas catheters. Ethanol (2 ml), chloroform (25 μl) und Pd (10%) on active carbon (2 
mg, 2% mol) were added. The reaction mixture was heated by an oil bath to 40 °C 
and a hydrogen gas stream was applied. After 4 h, the suspesion was filtrated and 
the filtrate was concentrated in vacuo to obtain the pure product 19 (yield: 18 mg, 
80 μmol, 100%) as a colourless oil.  As free amino group could cause the 
degradation of the product, the product 19 was immediately transformed in a next 
step without further analyses.  
 
TLC (ethyl acetate/cyclohexane = 2:1): Rf = ~ 0. 
 
(3S, 4S)-3-(2-Phenylethyl)-4-[(5-amino)pentyl]-2-oxetanone (20) 
 
O
O NH2
Chemical Formula: C16H23NO2
Molecular Weight: 261.3593  
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Following the same protocol as above for 19 led to the racemized product 20 (yield: 
15.6 mg, 60 μmol, 100%) as a colourless oil. 
 
TLC (ethyl acetate/cyclohexane = 2:1): Rf = ~ 0. 
 
Methyl 6-(Biotinyl)-aminocaproate (21) 
 
OMe
H
N
O
O
S
N
H
NH
H
H
O
Chemical Formula: C17H29N3O4S
Molecular Weight: 371.4949
 
 
To a solution of 5 (284 mg, 1.56 mmol), biotin (366 mg, 1.5 mmol) and TEA (1.1 
mL) in acetonitrile (4 mL) was added HBTU (591 mg, 1.56 mmol) and HOBt (210 
mg, 1.56 mmol). After 30 min stirring at room temperature, a precipitate had 
formed. Water was added and the product was extracted with DCM. The organic 
phase was dried over anhydrous Na2SO4, evaporated to dryness and the crude 
product was purified by silica gel chromatography (MeOH/DCM = 1:9) to obtain 
21 (yield: 434 mg, 1.17 mmol, 78%) as a white powder.  
 
TLC (MeOH/DCM = 1:9): Rf = 0.63; 1H NMR (CDCl3):  = 6.46 (s, 1H), 6.15 (br 
s, 1H), 5.56 (br s, 1H), 4.52 (m, 1H), 4.31 (m, 1H), 3.66 (s, 3H), 3.32 (q, J = 6.8 Hz, 
2H), 3.15 (m, 1H), 2.91 (dd, J = 4.9, 8 Hz, 1H), 2.73 (d, J = 12.7 Hz, 1H), 2.32 (t, J 
= 7.6 Hz, 2H), 2.21 (t, J = 7.6 Hz, 2H), 1.6–1.3 (m, 13H); 13C NMR (CDCl3):  = 
174.4, 173.4, 164.2, 62.0, 60.4, 55.9, 51.8, 40.8, 39.4, 36.3, 34.1, 29.5, 28.4, 28.3, 
26.6, 25.9, 24.7; LC-MS (ESI): tR = 11.74 min, calcd. for C17H30N3O4S [M+H]
+, 
372.19, found 372.18. 
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6-(Biotinyl)-aminocaproic acid (22) 
 
OH
H
N
O
O
S
N
H
NH
H
H
O Chemical Formula: C16H27N3O4S
Molecular Weight: 357.4683
 
 
21 (434 mg, 1.17 mmol) was dissolved in acetonitrile (7.5 mL) and cooled to 0 °C. 
(n-Bu4N)OH  30 H2O (1.80 g, 2.25 mmol) was added under vigorous stirring. 
After 40 min, the reaction mixture was acidified by addition of 1 M HCl. The 
desired product 22 precipitated as a white solid. It was filtered off, washed with 
water and dried to obtain 22 (yield: 350 mg, 0.98 mmol, 84 %) as a white solid. 
 
1H NMR (DMSO-d6):  = 11.96 (br s, 1H), 7.71 (s, 1H), 6.40 (s, 1H), 6.34 (s, 1H), 
4.28 (m, 1H), 4.11 (m, 1H), 3.08 (m, 1H), 2.97 (q, J = 6.8 Hz, 2H), 2.82 (dd, J = 4.9, 
8 Hz, 1H), 2.73 (d, J = 12.7 Hz, 1H), 2.12 (t, J = 7.6 Hz, 2H), 2.01 (t, J = 7.6 Hz, 
2H), 1.6 – 1.3 (m, 13H); 13C NMR (DMSO-d6):  = 174.4, 171.7, 162.7, 61.0, 59.2, 
55.4, 38.2, 35.2, 33.6, 28.9, 28.2, 28.0, 26.0, 25.3, 24.2. 
 
(3S, 4S)-3-Pentyl-4 -[(5-(6-biotinylamino)caproylamino)pentyl]-2-oxetanone 
(23) 
 
O
HN
OS
NH
HN
O
H
H
O
O
H
N
Chemical Formula: C29H50N4O5S
Molecular Weight: 566.7961
 
Zhe Ming Wang Experimental section Doctoral Dissertation 2009 
 - 147 - Chemical Genomics Centre (CGC) 
To a solution of 22 (13.4 mg, 37.6 μmol) and TEA (14.3 μl, 103 μmol) in DMSO 
(500 μl), PyBOP (19.8 mg, 38 μmol) and HOBt hydrate (5.1 mg, 38 μmol) were 
added at room temperature. After 15 min, 19 (7.76 mg, 34.2 μmol) in DMSO (200 
μl) was added. The reaction was completed overnight.  Because of the poor 
solubility in many organic solvents, the product was precipitated with ethyl 
acetate/diethyl ether 10 ml (1:1), washed with sodium bicarbonate solution, ethyl 
ether and dried over Na2SO4 (yield: 13.6 mg, 24 μmol, 70%) as a white solid.  
 
1H NMR (DMSO-d6)  = 6.40 (s, 1H), 6.34 (m, 1H), 4.33 (m, 2H), 4.12 (m, 1H), 
3.09 (m, 1H), 3.01 (m, 4H), 2.83 (dd, J = 12.5 Hz, 4.95 Hz, 1H), 2.57 (d, J = 12.5 
Hz, 1H), 2.2~2.0 (m, 4H), 1.74 ~1.27 (m, 28H), 0.86 (t, J = 6.6 Hz, 3H); 13C NMR 
(DMSO-d6)  =172.44, 166.94, 161.26, 157.12, 83.09, 78.29, 61.74, 59.89, 56.12, 
50.93, 49.36, 41.14, 38.9, 35.9, 31.55, 29.67, 28.9, 28.72, 27.67, 26.63, 26.0, 24.86, 
22.54, 17.56; LC-MS (ESI): tR = 7.99 min, calcd. for C29H51N4O5S [M+H]
+, 567.80, 
found 567.41. 
 
(3S, 4S)-3-(2-Phenylethyl)-4-[(5-(6-biotinylamino)caproylamino)pentyl]-2-
oxetanone (24) 
 
O
HN
OS
NH
HN
O
H
H
O
O
H
N
Chemical Formula: C32H48N4O5S
Molecular Weight: 600.8123
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Following the same protocol as above for 23 led to the racemized product 24 (yield: 
16.2 mg, 27 μmol, 65%) as a colourless oil. 
 
1H NMR (DMSO-d6)  = 7.32-7.27 (m, 5H), 6.40 (s, 1H), 6.33 (s, 1H), 4.34 (m, 
1H), 4.27 (m, 1H), 4.11 (m, 1H), 3.09 (m, 1H), 3.01 (m, 4H), 2.83 (dd, J = 12.5 Hz, 
4.95 Hz, 1H), 2.57 (d, J = 12.5 Hz, 1H), 2.04 (m, 6H), 1.74-1.19 (m, 25H); 13C 
NMR (DMSO-d6)  =172.44, 172.24, 168.83, 168.41, 163.39, 163.37, 162.98, 
141.44, 131.27, 129.08, 129.06, 128.87, 128.4, 127.93, 126.77, 76.96, 59.89, 56.11, 
55.3, 49.43, 47.46, 46.53, 39.0, 35.9, 34.05, 33.03, 29.68, 28.9, 28.72, 26.83, 25.78; 
LC-MS (ESI): tR = 7.93 min, calcd. for C32H48N4O5S [M+H]
+, 601.81, found 
601.30. 
 
(3S, 4S)-3-Pentyl-4 -[(5-acetylamino)pentyl]-2-oxetanone (25) 
 
O
O
H
N
O
Chemical Formula: C15H27NO3
Molecular Weight: 269.3798
 
 
Acetic anhydride (14.28 mg, 140 μmol) and DIPEA (14.6 μl, 84 μmol) were 
dissolved in anhydrous DCM (280 μl) at room temperature. To this solution, 19 
(6.29 mg, 27.7 μmol) in anhydrous DCM (100 μl) was added. The reaction was 
stirred overnight and the mixture was purified directly by a short column 
chromatography (ethyl acetate/cyclohexane = 5:1) to get the pure product 25 (yield: 
4 mg, 15 μmol, 54%) as a colourless oil.  
 
TLC (ethyl acetate/cyclohexane = 2:1): Rf = 0.1; 1H NMR (CD3CN)  = 6.3 (s br, 
1H), 4.26 (m, 1H), 3.26 (m, 1H), 3.09 (m, 2H), 1.82 (s, 3H), 1.74-1.70 (m, 4H), 
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1.47-1.31 (m, 12H), 0.92 (t, J = 6.84 Hz, 3H); 13C NMR (CD3CN)  = 180.09, 
153.68, 79.00, 56.71, 39.68, 34.8, 32.14, 30.1, 28.4, 27.3, 27.2, 25.4, 23.1, 23.04, 
14.22. 
 
(3S, 4S)-3-(2-phenylethyl)-4-[(5-acetylamino)pentyl]-2-oxetanone (26) 
 
O
O
H
N
O
Chemical Formula: C18H25NO3
Molecular Weight: 303.3960
 
 
Following the same protocol as above for 25 led to the racemized product 26 (yield: 
3.7 mg, 12 μmol, 59%) as a colourless oil. 
 
TLC (ethyl acetate/cyclohexane = 2:1): Rf = 0.08; 1H NMR (CD3CN)  = 
7.38~7.23 (m, 5H), 6.3 (s br, 1H), 4.55(syn)/4.29(anti) (m/m, 1H), 3.69(syn) 
/3.27(anti) (m, 1H), 3.09 (m, 2H), 2.8~2.65 (m/m, syn/anti, 2H), 2.05 (m, 2H), 1.84 
(s, 3H), 1.72~1.66 (m, 2H), 1.46~1.31 (m, 6H); 13C NMR (CD3CN)  = 183.3, 
147.67, 142.11, 136.64, 129.5, 129.4, 127.18, 85.97, 83.62, 70.61, 65.02, 66.61, 
51.73, 39.73, 34.66, 33.67, 30.07, 27.21, 27.18, 26.56, 25.46, 23.08. 
 
(3S, 4S)-3-Pentyl-4 -[(5-pentynylamino)pentyl]-2-oxetanone (27) 
 
O
O
H
N
O
Chemical Formula: C18H29NO3
Molecular Weight: 307.4278
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To a solution of 4-pentynoic acid (4.6 μmol, 0.5 mg) in anhydrous DCM (100 μl) 
were added HOBt (4.6 μmol, 0.6 mg) and DIC (6 μmol, 1 μl). After a short time, 
19 (0.9 mg, 4 μmol) in anhydrous DCM (100 μl) was added to this reaction mixture. 
The resulting reaction was stirred for 3 h and directly purified by HPLC to get the 
pure product 27 (yield: 0.5 mg, 1.6 μmol, 40%) as a yellow oil. 
 
TLC (ethyl acetate/cyclohexane = 2:1): Rf = 0.15; 1H NMR (CDCl3)  = 5.61 (m, 
1H), 4.20 (m 1H), 3.28 (t, J = 6.44 Hz, 2H), 3.16 (m, 1H), 2.53 (t, J = 6.84 Hz, 2H), 
2.38 (t, J = 6.84 Hz, 2H), 2.01 (t, J = 2.52 Hz, 1H), 1.72-1.25 (m, 16H), 0.89 (t, J = 
6.8 Hz, 3H); LC-MS (ESI): tR = 7.25 min, calcd. for C18H30NO3 [M+H]
+, 308.43, 
found 308.52. 
 
(3S,4R)-3-[(tert-Butyloxycarbonyl)amino]-4-methyloxetan-2-one (28) 
 
O
OBocHN
Chemical Formula: C9H15NO4
Molecular Weight: 201.2197  
 
To a mixture of Boc-L-Thr-OH (205 mg, 1 mmol), and PyBOP (0.624 g, 1.2 mmol) 
in anhydrous DCM (20 mL), TEA (0.42 mL, 3 mmol) was added dropwise at 0 °C. 
The reaction mixture was stirred at 0 °C for 30 min and then warmed to room 
temperature. After stirring for 6 h, it was concentrated in vacuo and purified by 
column chromatography (ethyl acetate/cyclohexane = 1:6) to get the pure product 
28 (yield: 0.159 g, 0.79 mmol, 85%) as a white solid.  
 
M.p. = 141-142 °C; []20D = +20.4 (c = 1.16, CHCl3); TLC (ethyl 
acetate/cyclohexane = 1:1): Rf = 0.53; 1H NMR (CDCl3):  = 5.43-5.40 (m, 1H), 
5.25 (br s, 1H), 4.84 (p, J = 6.2 Hz, 1H), 1.46 (s, 9 H), 1.41 (d, 6.3 Hz, 3 H); 13C 
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NMR (CDCl3):  = 169.2, 154.4, 81.3, 74.8, 60.1, 28.1, 15.0; HRMS (ESI) calcd. 
for C9H16NO4 [M+H]
+, 202.1071, found 202.1079. 
 
(3S,4R)-3-amino-4-methyloxetan-2-one p-toluenesulfonate salt (29) 
 
O
H3N OTos Chemical Formula: C11H15NO4S
Molecular Weight: 257.3061  
 
To a mixture of para-toluenesulfonic acid (0.334 g, 1.94 mmol) and TFA (5 mL), 
28 (0.368 g, 1.83 mmol) was added dropwise at 0 °C and the resulting mixture was 
stirred for 15 min. TFA was removed in vacuo and the remaining residue was co-
evaporated twice with toluene. Dry ether was added to the residue, the white solid 
29 was filtered, washed twice with dry ether and used in the subsequent reaction 
without further purification (yield: 0.457 g, 1.78 mmol, 97%). 
 
General method for syntheses of 30 – 34 
 
Method A 
To a solution of N-Boc protected amino acid (0.5 mmol) in anhydrous DCM (4 mL) 
was added at -5 °C TEA (51 mg, 0.5 mmol) and ethyl chloroformate (54 mg, 0.5 
mmol). After stirring for 20 min, 29 (0.128 g, 0.5 mmol) and pyridine (79 mg, 1 
mmol) were added. After further 30 min stirring at -5 °C, the reaction mixture was 
warmed to room temperature and stirred overnight. The solvent was removed and 
the residue was dissolved in ethyl acetate, washed with water, dried over anhydrous 
Na2SO4 and concentrated to dryness. The residue was purified by silica gel column 
chromatography with ethyl acetate/cyclohexane. 
Method B 
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To a solution of the N-Boc protected amino acid (1.05 mmol), PyBOP (1.1 mmol), 
HOBt (1.1 mmol) and DIEA (0.42 mL) in DMF/DCM (1:1, 5 mL), 29 (0.256 g, 1 
mmol) was added at 0 °C. The reaction mixture was slowly warmed to room 
temperature and stirred for 4 h. Solvents were removed in vacuo, the residue was 
dissolved in ethyl acetate, washed with water, dried over anhydrous Na2SO4 and 
concentrated to dryness. The remaining residue was purified by silica gel column 
chromatography with ethyl acetate/cyclohexane.  
 
(3S,4R)-3-[(N-Boc prolinyl)amidyl]-4-methyloxetan-2-one (30) 
 
H
N
O O
O
N
Boc Chemical Formula: C14H22N2O5
Molecular Weight: 298.3349
 
 
Method A was followed, yield: 0.128g, 0.43 mmol, 86%; white solid.  
 
M.p. = 136-137 °C; []20D = -71.4 (c = 1.55, CHCl3); TLC (ethyl 
acetate/cyclohexane = 1:1): Rf = 0.28; 1H NMR (CDCl3):  = 8.15 (br s, 1H), 5.58 
(br s, 1H), 4.82 (p, J = 6.2 Hz, 1H), 4.32-4.21 (m, 1H), 3.53-3.25 (m, 2H), 2.35-
1.85 (m, 4H), 1.42 (s, 9H), 1.36 (d, J = 6.2 Hz, 3H); 13C NMR (CDCl3):  = 171.8, 
169.0, 156.1, 80.7, 74.3, 59.2, 58.6, 47.0, 28.2, 27.3, 24.6, 14.9; HRMS calcd. for 
C14H23N2O5 [M+H]
+, 299.1607, found 299.1588. 
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(3S,4R)-3-[(N-Boc glutaminyl)amidyl]-4-methyloxetan-2-one (31) 
 
BocHN
H
N
O O
O
O NH2
Chemical Formula: C14H23N3O6
Molecular Weight: 329.3489
 
 
Method A was followed, yield: 0.11 g, 0.33 mmol, 67%; white solid. 
 
M.p. = 144-145 °C; []20D = +8.6 (c = 1.09, CH3OH), TLC (ethyl acetate): Rf = 
0.15; 1H NMR (CD3OD):  = 5.51 (d, J = 5.8 Hz, 1H), 4.86 (p, J = 6.2 Hz, 1H), 
4.07 (dd, J = 8.5, 5.4 Hz, 1H), 2.32 (t, J = 7.4 Hz, 2H), 2.07-1.99 (m, 1H), 1.92-
1.85 (m, 1H), 1.43 (s, 9H), 1.40 (d, J = 6.4 Hz, 3H); 13C NMR (CD3OD):  = 178.5, 
175.9, 171.4, 158.6, 81.6, 76.9, 60.8, 56.4, 33.4, 29.7, 29.5, 16.1; HRMS calcd. for 
C14H24N3O6 [M+H]
+, 330.1665, found 330.1649. 
 
(3S,4R)-3-[(N-Boc tryptophanyl)amidyl]-4-methyloxetan-2-one (32) 
 
BocHN
H
N
O O
O
HN
Chemical Formula: C20H25N3O5
Molecular Weight: 387.4296
 
 
Method B was followed, yield: 0.325 g, 0.84 mmol, 84%; white solid.  
 
M.p. = 135-136 °C; []20D = +10.4 (c = 1.03, CH3OH), TLC (ethyl 
acetate/cyclohexane = 1:1): Rf = 0.26; 1H NMR (CD3OD)  = 7.63 (d, J = 6.2 Hz, 
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1H), 7.36 (d, J = 6.4 Hz, 1H), 7.13-7.03 (m, 3H), 5.47 (d, J = 4.6 Hz, 1H), 4.80 (p, J 
= 5.0 Hz, 1H), 4.44 (t, J = 5.5 Hz, 1H), 3.26 (dd, J = 11.5, 4.7 Hz, 1H), 3.13 (dd, J 
= 11.5, 6.1 Hz, 1H), 1.40 (s, 9H), 1.30 (d, J = 5.0 Hz, 3H); 13C NMR (CD3OD):  = 
175.9, 171.2, 158.3, 138.8, 129.6, 125.4, 123.3, 120.7, 120.2, 113.1, 111.4, 81.5, 
76.8, 60.8, 57.5, 29.9, 29.5, 15.9; HRMS calcd. for C20H25N3O5 [M]
+, 387.1794, 
found 387.1786. 
(3S,4R)-3-[(N-Boc phenylalaninyl)amidyl]-4-methyloxetan-2-one (33) 
 
BocHN
H
N
O O
O
Chemical Formula: C18H24N2O5
Molecular Weight: 348.3936  
 
Method B was followed, yield: 0.24 g, 0.69 mmol, 69%; white solid.  
 
M.p. = 141-143 °C; []20D = +10.3 (c = 1.01, CHCl3), TLC (ethyl 
acetate/cyclohexane = 1:1): Rf = 0.36; 1H NMR (CD3OD):  = 7.32-7.18 (m, 5H), 
7.14 (d, J = 7.7 Hz, 1H), 5.52 (dd, J = 8.0, 6.1 Hz, 1H), 5.07 (d, J = 7.8 Hz, 1H), 
4.84 (p, J = 6.2 Hz, 1H), 4.37 (q, J = 7.2 Hz, 1H), 3.11 (dd, J = 13.9, 6.5 Hz, 1H), 
3.01 (dd, J = 13.9, 7.6 Hz, 1H), 1.40 (s, 9H), 1.32 (d, J = 6.3 Hz, 3H); 13C NMR 
(CDCl3):  = 171.7, 168.4, 155.7, 136.1, 129.2, 128.8, 127.2, 81.4, 74.4, 58.8, 55.6, 
37.4, 28.2, 14.9; HRMS calcd. for C18H25N2O5 [M+H]
+, 349.1763, found 349.1732. 
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(3S,4R)-3-[(N-Boc leucinyl)amidyl]-4-methyloxetan-2-one (34) 
 
BocHN
H
N
O O
O
Chemical Formula: C15H26N2O5
Molecular Weight: 314.3773
 
 
Method B was followed, yield: 0.267 g, 0.85 mmol, 85%; white solid. 
 
M.p. = 139-140 °C; []20D = -10.6 (c = 1.28, CHCl3); TLC (ethyl 
acetate/cyclohexane = 1:3): Rf = 0.18; 1H NMR (CDCl3):  = 8.39 (d, J = 8.2 Hz, 
1H), 5.90 (d, J = 8.2 Hz, 1H), 5.58 (dd, J = 8.5, 5.9 Hz, 1H), 4.90 (p, J = 6.0 Hz, 
1H), 4.26-4.20 (m, 1H), 1.71-1.50 (m, 3H), 1.38 (s, 9H), 1.29 (d, J = 6.1 Hz, 3H), 
0.89 (d, J = 6.6 Hz, 3H), 0.88 (d, J = 6.6 Hz, 3H); 13C NMR (CDCl3):  = 173.7, 
169.0, 155.8, 79.8, 74.8, 58.8, 52.9, 40.1, 28.3, 24.6, 22.7, 21.9, 14.7; HRMS calcd. 
for C15H27N2O5 [M+H]
+, 315.1920, found 315.1913. 
 
(3S,4R)-3-[(N-Boc serinyl)amidyl]-4-methyloxetan-2-one (35) 
 
BocHN
H
N
O O
O
HO
Chemical Formula: C12H20N2O6
Molecular Weight: 288.2970
 
 
Method B was followed, yield: 0.225 g, 0.78 mmol, 78%; colourless oil. 
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(3S,4R)-3-[(N-Boc formyltryptophanyl)amidyl]-4-methyloxetan-2-one (36) 
 
BocHN
H
N
O O
O
N
O
H
Chemical Formula: C21H25N3O6
Molecular Weight: 415.4397
 
 
Method B was followed, yield: 0.341 g, 0.82 mmol, 82%; colourless oil. 
 
(3S,4R)-3-[(N-Boc leucinyl)methylamidyl]-4-methyloxetan-2-one (37) 
 
BocHN
N
O O
O
Chemical Formula: C16H28N2O5
Molecular Weight: 328.4039
 
 
Method B was followed, yield: 0.246 g, 0.75 mmol, 75%; white solid. 
 
(3S,4R)-3-[(N-biotinyl prolinyl)amidyl]-4-methyloxetan-2-one (38) 
 
O
O
H
N
N
H
N
O
O
O
S
N
H
NH
H
H
O Chemical Formula: C25H39N5O6S
Molecular Weight: 537.6721
 
 
30 (44.7 mg, 150 μmol) was dissolved in DCM (2 mL). A mixture of 
triisopropylsilane (100 μL) and TFA (2 mL) was added and the resulting solution 
was stirred for 30 min. Evaporation to dryness, followed by co-evaporation in 
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presence of toluene delivered the deprotected intermediate which was used without 
further purification (yield: 46.8 mg, >98%).  
22 (53.6 mg, 150 μmol) was dissolved in acetonitrile (3 mL). TEA (62.3 L, 450 
mmol) and few drops of DMSO were added. PyBOP (85.8 mg, 165 μmol) and 
HOBt hydrate (25.2 mg, 165 μmol) were then added and the resulting solution was 
stirred for further 15 min, after which deprotected 30 (46.8 mg, 150 μmol) 
dissolved in acetonitrile (1 mL) was added. The resulting reaction mixture was 
heated to 50 °C for 5 min and then stirred at room temperature overnight. The 
mixture was evaporated to dryness, the residue was taken up in a small amount of 
DCM and precipitated by addition of ethylacetate/diethyl ether (1:1, 20 mL) at -20 
°C over two days. The precipitate was then purified by preparative HPLC (0 to 5 
min, 10% aq. acetonitrile (0.1% TFA), 5 to 35 min, from 10% aq. acetonitrile to 
70% aq. acetonitrile (0.1% TFA), 35 to 42 min, from 70% aq. acetonitrile to 100% 
acetonitrile (0.1% TFA)) to yield pure 38 (yield: 56.4 mg, 100 μmol, 67%) as a 
white powder. 
 
1H NMR (DMSO-d6):  = 6.42 (s, 1H), 6.36 (s, 1H), 4.30 (m, 1H), 4.13 (m, 1H), 
3.09 (m, 4H), 3.00 (m, 4H), 2.80 (dd, J = 4, 10 Hz, 1H), 2.56 (d, J = 10 Hz, 1H), 
2.18 (m, 2H), 2.04 (m, 2H), 1.89 – 1.25 (m, 21H); 13C NMR (DMSO-d6)  = 173.4, 
170.8, 169.9, 161.7, 73.6, 60.1, 58.2, 57.2, 54.4, 44.9, 37.3, 34.2, 32.6, 28.1, 27.2, 
24.9, 24.3, 23.2, 13.7; LC-MS (ESI): tR = 5.94 min, calcd. for C25H39N5O6S 
[M+H]+, 538.26, found 538.53. 
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(3S,4R)-3-[(N-biotinyl glutaminyl)amidyl]-4-methyloxetan-2-one (39) 
 
O
O
H
N
N
H
H
N
O
O
O
S
N
H
NH
H
H
O
OH2N
Chemical Formula: C25H40N6O7S
Molecular Weight: 568.6861
 
 
31 (20 mg, 60.8 μmol) was dissolved in DCM (1 mL). A mixture of 
triisopropylsilane (50 μL) and TFA (1 mL) was added and the resulting solution 
was stirred for 30 min. Evaporation to dryness, followed by co-evaporation in 
presence of toluene delivered the deprotected intermediate which was used without 
further purification (yield: 20.8 mg, >98%).  
22 (21.8 mg, 61 μmol) was dissolved in acetonitrile (1.2 mL). TEA (25.3 L, 183 
mmol) and few drops of DMSO were then added. PyBOP (34.9 mg, 67.1 μmol) 
and HOBt hydrate (10.3 mg, 67.1 μmol) were added and the resulting solution was 
stirred for further 15 min, after which deprotected 31 (20.8 mg, 60.8 μmol) 
dissolved in acetonitrile (400 μL) was added. The resulting reaction mixture was 
heated to 50 °C for 5 min and then stirred at room temperature overnight. The 
mixture was evaporated to dryness, the residue was taken up in a small amount of 
DCM and precipitated by addition of ethylacetate/diethyl ether (1:1, 20 mL) at -20 
°C over two days. The precipitate was then purified by preparative HPLC (0 to 5 
min, 10% aq. acetonitrile (0.1% TFA), 5 to 40 min, from 10% aq. acetonitrile to 
75% aq. acetonitrile (0.1% TFA), 40 to 46 min, from 75% aq. acetonitrile to 100% 
acetonitrile (0.1% TFA)) to yield pure 39 (yield: 23.8 mg, 42 μmol, 69%) as a 
white powder.  
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LC-MS (ESI): tR = 9.95 min, calcd. for C25H40N6O7S [M+H]
+, 569.27, found 
569.22. 
 
(3S,4R)-3-[(N-biotinyl tryptophanyl)amidyl]-4-methyloxetan-2-one (40) 
 
O
O
H
N
N
H
H
N
O
O
O
S
N
H
NH
H
H
O
H
N
Chemical Formula: C31H42N6O6S
Molecular Weight: 626.7668
 
32 (15.5 mg, 40 μmol) was dissolved in DCM (1 mL). A mixture of 
triisopropylsilane (50 μL) and TFA (1 mL) was added and the resulting solution 
was stirred for 30 min. Evaporation to dryness, followed by co-evaporation in 
presence of toluene delivered the deprotected intermediate which was used without 
further purification (yield: 16.0 mg, >98%).  
22 (14.3 mg, 40 μmol) was dissolved in acetonitrile (1 mL). TEA (16.6 L, 120 
mmol) and few drops of DMSO were then added. PyBOP (22.8 mg, 44 μmol) and 
HOBt hydrate (6.7 mg, 44 μmol) were added and the resulting solution was stirred 
for further 15 min, after which deprotected 32 (16.0 mg, 40 μmol) dissolved in 
acetonitrile (400 μL) was added. The resulting reaction mixture was heated to 50 
°C for 5 min and then stirred at room temperature overnight. The mixture was 
evaporated to dryness, the residue was taken up in a small amount of DCM and 
precipitated by addition of ethylacetate/diethyl ether (1:1, 20 mL) at -20 °C over 
two days. The precipitate was then purified by preparative HPLC (0 to 5 min, 10% 
aq. acetonitrile (0.1% TFA), 5 to 40 min, from 10% aq. acetonitrile to 75% aq. 
acetonitrile (0.1% TFA), 40 to 46 min, from 75% aq. acetonitrile to 100% 
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acetonitrile (0.1% TFA)) to yield pure 40 (yield: 16.7 mg, 26.6 μmol, 67%) as a 
white powder. 
 
1H NMR (DMSO-d6):  = 7.97-7.73 (m, 5H), 6.40 (s, 1H), 6.34 (s, 1H), 5.52 (m, 
1H), 4.85 (t, J = 6.2 Hz, 1H), 4.63 (m, 1H), 4.29 (m, 1H), 4.12 (m, 1H), 3.09 (m, 
4H), 3.01 (m, 4H), 2.81 (dd, J = 5, 12.3 Hz, 1H), 2.57 (d, J = 12.3 Hz, 1H), 2.04 (m, 
4H), 1.49 – 1.31 (m, 16H); 13C NMR (DMSO-d6)  = 177.1, 172.5, 171.5, 162.4, 
152.7, 145.9, 136.1, 118.8, 113.5, 112.6, 111.1, 95.7, 83.3, 81.7, 77.1, 74.2, 74.1, 
63.9, 81.7, 77.1, 74.2, 63.9, 60.8, 58.9, 56.5, 55.1, 45.5, 34.9, 28.7, 27.9, 25.0, 24.5, 
14.0; LC-MS (ESI): tR = 6.93 min, calcd. for C31H42N6O6S [M+H]
+, 627.29, found 
627.47.  
 
(3S,4R)-3-[(N-biotinyl phenylalaninyl)amidyl]-4-methyloxetan-2-one (41) 
 
O
O
H
N
N
H
H
N
O
O
O
S
N
H
NH
H
H
O
Chemical Formula: C29H41N5O6S
Molecular Weight: 587.7307
 
 
33 (20 mg, 57.5 μmol) was dissolved in DCM (1 mL). A mixture of 
triisopropylsilane (50 μL) and TFA (1 mL) was added and the resulting solution 
was stirred for 30 min. Evaporation to dryness, followed by co-evaporation in 
presence of toluene delivered the deprotected intermediate which was used without 
further purification (yield: 20.8 mg, >98%).  
22 (20.7 mg, 58 μmol) was dissolved in acetonitrile (1.5 mL). TEA (24 L, 174 
mmol) and few drops of DMSO were then added. PyBOP (33.2 mg, 63.8 μmol) 
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and HOBt hydrate (9.7 mg, 63.8 μmol) were added and the resulting solution was 
stirred for further 15 min, after which deprotected 33 (20.8 mg, 57.5 μmol) 
dissolved in acetonitrile (400 μL) was added. The resulting reaction mixture was 
heated to 50 °C for 5 min and then stirred at room temperature overnight. The 
mixture was evaporated to dryness, the residue was taken up in a small amount of 
DCM and precipitated by addition of ethylacetate/diethyl ether (1:1, 20 mL) at -20 
°C over two days. The precipitate was then purified by preparative HPLC (0 to 5 
min, 20% aq. acetonitrile (0.1% TFA), 5 to 40 min, from 20% aq. acetonitrile to 
80% aq. acetonitrile (0.1% TFA), 40 to 46 min, from 80% aq. acetonitrile to 100% 
acetonitrile (0.1% TFA)) to yield pure 41 (yield: 23.9 mg, 41 μmol, 71%) as a 
white powder. 
 
1H NMR (DMSO-d6):  = 7.26-7.18 (m, 5H), 6.42 (s, 1H), 6.35 (s, 1H), 5.48 (m, 
1H), 4.84 (t, J = 5 Hz, 1H), 4.53 (m, 1H), 4.29 (m, 1H), 4.12 (m, 1H), 3.08 (m, 2H), 
2.99 (m, 4H), 2.82 (m, 2H), 2.55 (d, J = 10 Hz, 1H), 2.02 (m, 4H), 1.74 – 1.45 (m, 
16H); 13C NMR (DMSO-d6):  = 172.0, 171.9, 169.0, 162.7, 137.7, 129.1, 128.0, 
126.3, 65.0, 61.0, 59.2, 58.3, 55.4, 53.7, 45.9, 38.3, 37.4, 35.2, 28.9, 28.2, 25.9, 
24.9, 14.6; LC-MS (ESI): tR = 6.88 min, calcd. for C29H41N5O6S [M+H]
+, 588.28, 
found 588.40. 
 
(3S,4R)-3-[(N-biotinyl leucinyl)amidyl]-4-methyloxetan-2-one (42) 
 
O
O
H
N
N
H
H
N
O
O
O
S
N
H
NH
H
H
O Chemical Formula: C26H43N5O6S
Molecular Weight: 553.7145
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34 (12.6 mg, 40 μmol) was dissolved in DCM (1 mL). A mixture of 
triisopropylsilane (50 μL) and TFA (1 mL) was added and the resulting solution 
was stirred for 30 min. Evaporation to dryness, followed by co-evaporation in 
presence of toluene delivered the deprotected intermediate which was used without 
further purification (yield: 13.1 mg, >98%).  
22 (14.3 mg, 40 μmol) was dissolved in acetonitrile (1.5 mL). TEA (16.6 L, 120 
mmol) and few drops of DMSO were then added. PyBOP (22.8 mg, 44 μmol) and 
HOBt hydrate (6 mg, 44 μmol) were added and the resulting solution was stirred 
for further 15 min, after which deprotected 34 (13.1 mg, 40 μmol) dissolved in 
acetonitrile (400 μL) was added. The resulting reaction mixture was heated to 50 
°C for 5 min and then stirred at room temperature overnight. The mixture was 
evaporated to dryness, the residue was taken up in a small amount of DCM and 
precipitated by addition of ethylacetate/diethyl ether (1:1, 20 mL) at -20 °C over 
two days. The precipitate was then purified by preparative HPLC (0 to 5 min, 10% 
aq. acetonitrile (0.1% TFA), 5 to 35 min, from 10% aq. acetonitrile to 65% aq. 
acetonitrile (0.1% TFA), 35 to 40 min, from 65% aq. acetonitrile to 100% 
acetonitrile (0.1% TFA)) to yield pure 42 (yield: 13.7 mg, 24.8 μmol, 62%) as a 
white powder. 
 
1H NMR (DMSO-d6):  = 6.38 (s, 1H), 6.32 (s, 1H), 5.52 (m, 1H), 4.82 (t, J = 6.2 
Hz, 1H), 4.28 (m, 1H), 4.11 (m, 1H), 3.07 (m, 4H), 2.99 (m, 4H), 2.80 (dd, J = 5.1, 
12.3 Hz, 1H), 2.54 (d, J = 12.3 Hz, 1H), 2.08 (m, 4H), 1.73 – 1.14 (m, 17H), 0.86 
(d J = 6.4 Hz, 3H), 0.82 (d J = 6.4 Hz, 3H); 13C NMR (DMSO-d6)  = 177.3, 172.2, 
171.7, 169.7, 162.7, 76.1, 61.1, 59.2, 55.4, 54.9, 49.4, 45.8, 35.2, 33.4, 32.8, 28.2, 
25.9, 25.3, 24.9, 21.5, 14.5; LC-MS (ESI): tR = 5.61 min, calcd. for C26H43N5O6S 
[M+H]+, 554.29, found 554.47. 
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(3S,4R)-3-[(N-biotinyl serinyl)amidyl]-4-methyloxetan-2-one (43) 
 
O
O
H
N
N
H
H
N
O
O
O
S
N
H
NH
H
H
O
OH
Chemical Formula: C23H37N5O7S
Molecular Weight: 527.6342
 
 
35 (43.2 mg, 150 μmol) was dissolved in DCM (2 mL). A mixture of 
triisopropylsilane (100 μL) and TFA (2 mL) was added and the resulting solution 
was stirred for 30 min. Evaporation to dryness, followed by co-evaporation in 
presence of toluene delivered the deprotected intermediate which was used without 
further purification (yield: 45.3 mg, >98%).  
22 (53.6 mg, 150 μmol) was dissolved in acetonitrile (3 mL). TEA (62.3 L, 450 
mmol) and few drops of DMSO were then added. PyBOP (85.8 mg, 165 μmol) and 
HOBt hydrate (25.2 mg, 165 μmol) were added and the resulting solution was 
stirred for further 15 min, after which deprotected 35 (45.3 mg, 150 μmol) 
dissolved in acetonitrile (1000 μL) was added. The resulting reaction mixture was 
heated to 50 °C for 5 min and then stirred at room temperature overnight. The 
mixture was evaporated to dryness, the residue was taken up in a small amount of 
DCM and precipitated by addition of ethylacetate/diethyl ether (1:1, 20 mL) at -20 
°C over two days. The precipitate was then purified by preparative HPLC (0 to 5 
min, 10% aq. acetonitrile (0.1% TFA), 5 to 35 min, from 10% aq. acetonitrile to 
65% aq. acetonitrile (0.1% TFA), 35 to 45 min, from 65% aq. acetonitrile to 100% 
acetonitrile (0.1% TFA)) to yield pure 43 (yield: 43.4 mg, 82 μmol, 55%) as a 
white powder. 
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1H NMR (DMSO-d6):  = 6.42 (s, 1H), 6.35 (s, 1H), 4.28 (m, 1H), 4.12 (m, 1H), 
3.08 (m, 4H), 3.01 (m, 4H), 2.81 (dd, J = 4.9, 9.9 Hz, 1H), 2.56 (d, J = 9.9 Hz, 1H), 
2.17 (m, 2H), 2.03 (m, 2H), 1.72 – 1.16 (m, 21H); 13C NMR (DMSO-d6):  = 171.8, 
164.3, 162.7, 61.0, 59.2, 57.0, 55.4, 45.8, 38.2, 35.2, 33.6, 29.0, 28.2, 25.9, 25.3, 
18.9; LC-MS (ESI): tR = 6.03 min, calcd. for C23H37N5O7S [M+H]
+, 528.24, found 
528.40. 
 
(3S,4R)-3-[(N-biotinyl formyltryptophanyl)amidyl]-4-methyloxetan-2-one (44) 
 
O
O
H
N
N
H
H
N
O
O
O
S
N
H
NH
H
H
O
N
H O
Chemical Formula: C32H42N6O7S
Molecular Weight: 654.7769
 
 
Following the same protocol as above for 40 led to the product 44 (yield: 17.7 mg, 
27 μmol, 66%) as a colourless oil. 
 
(3S,4R)-3-[(N-biotinyl leucinyl)methylamidyl]-4-methyloxetan-2-one (45) 
 
O
ON
N
H
H
N
O
O
O
S
N
H
NH
H
H
O
Chemical Formula: C27H45N5O6S
Molecular Weight: 567.7411
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Following the same protocol as above for 42 led to the product 45 (yield: 15.9 mg, 
28 μmol, 70%) as a colourless oil. 
 
(3S,4R)-3-[(N-azidoacetyl leucinyl)amidyl]-4-methyloxetan-2-one (46) 
 
O
O
H
N
HN
O
O
N3
Chemical Formula: C12H19N5O4
Molecular Weight: 297.3104
 
 
34 (24.3 mg, 77 μmol) was dissolved in DCM (2 mL). A mixture of 
triisopropylsilane (90 μL) and TFA (2 mL) was added and the resulting solution 
was stirred for 30 min. Evaporation to dryness, followed by co-evaporation in 
presence of toluene delivered the deprotected intermediate which was used without 
further purification (yield: 25.3 mg, >98%).  
Azidoacetic acid (8 mg, 80 μmol) was dissolved in DCM (1 mL). TEA (38 L, 280 
mmol) and PyBOP (41.6 mg, 80 μmol) were added and the resulting solution was 
stirred for further 15 min, after which deprotected 34 (25.3 mg, 77 μmol) dissolved 
in DCM (200 μL) was added. The resulting reaction mixture was heated to 50 °C 
for 5 min and then stirred at room temperature overnight. The mixture was 
evaporated to dryness, the residue was then direct purified by a short column (ethyl 
acetate/cyclohexane = 1:1) to yield pure 46 (yield: 15.1 mg, 50.8 μmol, 66%) as a 
light yellow oil. 
 
TLC (ethyl acetate/cyclohexane = 1:1): Rf = 0.38; LC-MS (ESI): tR = 6.74 min, 
calcd. for C12H20N5O4 [M+H]
+, 298.31, found 298.52. 
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5-Hexyn-1-OTs (47) 
 
TsO Chemical Formula: C13H16O3S
Molecular Weight: 252.3293  
 
Tosyl chloride (380 mg, 2 mmol) was added to pyridine (5 ml) at 0 °C. After a 
short time, 5-Hexyn-1-ol (217 μl, 2 mmol) was added. The reaction was stirred 
overnight and the product was extracted by DCM and washed with brine. The 
organic phase was dried over anhydrous Na2SO4, evaporated to dryness and the 
crude product was purified by silica gel chromatography (ethyl acetate/cyclohexane 
= 2:1) to obtain 47 (yield: 271.6 mg, 1.08 mmol, 54%) as a colourless oil. 
 
TLC (ethyl acetate/cyclohexane = 2:1): Rf = 0.76; 1H NMR (CDCl3)  = 7.79 (d, J 
= 8 Hz), 7.35 (d, J = 8 Hz, 2H), 4.06 (t, J = 6.2 Hz, 2H), 2.45 (s, 3H), 2.17 (m, 2H), 
1.92 (s, 1H), 1.78 (m, 2H), 1.56 (m, 2H); 13C NMR (CDCl3)  144.86, 133.19, 
129.95, 127.96, 83.48, 70.02, 69.06, 27.86, 24.32, 21.71, 17.82; LC-MS (ESI): tR = 
14.85 min, calcd. for C20H25N5S2 [M+Ts+H]
+, 409.53, found 409.21. 
 
4-(5-hexyn-1-oxy)-benzaldhyde (48) 
 
O
O
Chemical Formula: C13H14O2
Molecular Weight: 202.2491  
 
4-Hydroxybenzaldehyde (73.2 mg, 0.6 mmol) was added to 47 (151 mg, 0.6 mmol) 
and Cs2CO3 (292 mg, 0.9 mmol) in DMF (2 ml) under argon. The mixture was 
heated to 100 °C for 16 h, poured into water (5 ml) and extracted with diethyl ether. 
The crude product was purified by silica gel chromatography (ethyl 
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acetate/cyclohexane = 1:5) to obtain 48 (yield: 105.3 mg, 0.52 mmol, 87%) as a 
colourless oil.  
 
 TLC (ethyl acetate/cyclohexane = 1:5): Rf = 0.23; 1H NMR (CDCl3)  = 9.88 (s, 
1H), 7.82 (d, J = 8 Hz, 2H), 6.68 (d, J = 8 Hz, 2H), 4.06 (t, J = 6.2 Hz, 2H), 2.28 (m, 
2H), 1.96 (m, 3H), 1.71 (m, 2H); 13C NMR (CDCl3)  = 190.96, 164.3, 132.2, 
130.14, 114.97, 84.06, 69.04, 67.94, 28.28, 25.14, 18.34; LC-MS (ESI): tR = 8.95 
min, calcd. for C13H15O2 [M+H]
+, 202.25, found 203.30. 
 
4-(5-hexyn-1-oxy)-phenyl sulfinate imine (49) 
 
O
N S O
Chemical Formula: C20H21NO2S
Molecular Weight: 339.4512
 
 
(1R, 2S, 5R)-(-)-menthyl (S)-p-toluenesulfinate (135.7 mg, 0.46 mmol) was 
dissolved in anhydrous THF (2.5 ml) at -78 °C. A solution of LiHMDS (0.6 mmol, 
1.0 M in THF) (0.6 ml) was added dropwise and the reaction mixture is allowed to 
warm to rt with stirring. After 5 h, the reaction mixture was cooled to -78 °C again 
and 48 (103.2 mg, 0.51 mmol) was added and stirred for 2 h at -78 °C. The reaction 
mixture was quenched with water (0.6 ml), diluted with ethyl ether (5 ml) and 
warmed to room temperature. The organic layer was washed with water and brine, 
dried, and the crude product was purified by silica gel chromatography (ethyl 
acetate/cyclohexane = 1:5) to obtain pure product 49 (yield: 56.8 mg, 0.17 mmol, 
37%) as a white solid. As the product is an instable imine, it was directly 
transferred into the next product and no detailed analysis was carried out.  
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TLC (ethyl acetate/cyclohexane = 1:5): Rf = 0.33; 1H NMR (CDCl3)  = 8.67 (s, 
1H), 7.78 (d, J = 8 Hz, 2H), 7.62 (d, J = 8 Hz, 2H), 7.30 (d, J = 8 Hz, 2H), 6.93 (d, J 
= 8 Hz, 2H), 4.03 (t, J = 6.2 Hz, 2H), 2.39 (s, 3H), 2.28 (m, 2H), 1.96 (m, 3H), 1.71 
(m, 2H).  
 
Aziridine (50) 
 
N
H
H3CO2C H
S O
O
Chemical Formula: C23H25NO4S
Molecular Weight: 411.5139
 
 
49 (56.8 mg, 0.17 mmol) in anhydrous THF (1 ml) was cooled to -78 °C and 
methyl -bromoacetate (30.9 μl, 0.336 mmol) was added. After 3 min, LiHMDS 
(219 μl, 1M in THF) was added dropwise. The reaction was stirred at – 78 °C for 
20 min, quenched with water (1 ml) and diluted with ethyl acetate (3 ml). The 
organic layer was separated and the aqueous phase was washed with ethyl acetate. 
The combined organic layer was washed with brine, dried and the crude product 
was purified by silica gel chromatography (ethyl acetate/cyclohexane = 5:1) to 
obtain pure product 50 (yield: 49.3 mg, 0.12 mmol, 70.6%) as a white solid.  
 
TLC (ethyl acetate/cyclohexane = 5:1): Rf = 0.14; 1H NMR (CDCl3)  = 7.71 (d, J 
= 8 Hz, 2H), 7.37 (d, J = 8 Hz, 2H), 7.32 (d, J = 8 Hz, 2H), 6.84 (d, J = 8 Hz, 2H), 
3.97 (t, J = 6.2 Hz, 2H), 3.81 (d, J = 7.32 Hz, 1H), 3.45 (d, J = 7.32 Hz, 1H), 3.41 (s, 
3H), 2.42 (s, 3H), 2.28 (m, 2H), 1.96 (m, 3H), 1.71 (m, 2H); 13C NMR (CDCl3)  = 
166.52, 159.31, 142.4, 141.15, 135.83, 135.82, 129.96, 129.24, 125.47, 124.73, 
114.39, 84.28, 68.89, 67.5, 52.27, 52.26, 47.65, 42.22, 35.09, 28.48, 25.26, 21.72, 
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18.38; LC-MS (ESI): tR = 5.45 min, calcd. for C23H26NO4S [M+H]
+, 412.51, found 
412.14. 
 
Azirine (51) 
 
N
CO2CH3
H
O
TMS
Chemical Formula: C19H25NO3Si
Molecular Weight: 343.4922  
 
To a solution of 50 (41.1 mg, 0.1 mmol) in anhydrous THF (2 ml), TMSCl (77 μl, 
0.6 mmol) was added at -78 °C. 2 min later, LDA (0.3 ml, 0.3 mmol, 1.0 M in THF) 
was added dropwise. The reaction was stirred at -78 °C for 15 min, quenched with 
water (1 ml), and diluted with ethyl acetate (5 ml). The organic phase was 
separated and aqueous phase was washed with ethyl acetate. The combined organic 
layer was washed with brine, dried and the crude product was purified by silica gel 
chromatography (ethyl acetate/cyclohexane = 1:5) to obtain pure product 51 (yield: 
16.5 mg, 48 μmol, 48%) as a colourless oil. 
 
TLC (ethyl acetate/cyclohexane = 1:5): Rf = 0.46; 1H NMR (CDCl3)  = 7.74 (d, J 
= 8.7 Hz, 2H), 7.03 (d, J = 8.7 Hz, 2H), 4.07 (t, J = 6.3 Hz, 2H), 3.67 (S, 3H), 2.32 
(t, J = 7 Hz, 3H), 1.94 (m, 2H), 1.72 (m, 2H), 0.14 (s, 9H); 13C NMR (CDCl3)  = 
174.52, 163.41, 132.47, 115.47, 106.79; 85.28, 67.93, 52.11, 31.27, 28.26, 25.18, 
19.68, 0.28; LC-MS (ESI): tR = 7.62 min, calcd. for C19H26NO3Si [M+H]
+, 344.49, 
found 344.76. 
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5-hexynyl alpha-bromoacetate (52) 
 
Br
O
O
Chemical Formula: C8H11BrO2
Molecular Weight: 219.0757  
 
In a 25 ml flask, Bromoacetic acid (304 mg, 2.2 mmol), DCC (453 mg, 2.2 mmol) 
and DMAP (12.2 mg, 0.1 mmol) were dissolved in DCM (10 ml). To this mixture, 
5-Hexyn-1-ol (217 μl, 2 mmol) was added. The reaction was completed overnight. 
The organic layer was washed with brine, dried and the crude product was purified 
by silica gel chromatography (ethyl acetate/cyclohexane = 1:2) to obtain pure 
product 52 (yield: 246 mg, 1.12 mmol, 56%) as a yellow oil.  
 
TLC (ethyl acetate/cyclohexane = 1:2): Rf = 0.6; 1H NMR (CDCl3)  = 4.21 (t, J = 
8.05 2H), 3.82 (s, 2H), 2.25 (m, 2H), 1.96 (t, J = 3.4 Hz, 1H), 1.81 (m, 2H), 1.64 (m, 
2H); 13C NMR (CDCl3)  = 167.41, 83.8, 69.01, 65.9, 27.59, 25.94, 24.87, 18.17. 
 
trans-2-tridencenyl sulfinate imine (53) 
 
C10H21 N S OH
Chemical Formula: C20H31NOS
Molecular Weight: 333.5312  
 
Following the same protocol as above for 49 led to the pure product 53 (yield: 130 
mg, 0.39 mmol, 85%) as a white solid. 
 
TLC (ethyl acetate/cyclohexane = 1:5): Rf = 0.61; 1H NMR (CDCl3)  = 8.33 (d, J 
= 9.5 Hz, 1H), 7.56 (d, J = 8.25 Hz, 2H), 7.29 (d, J = 8.25 Hz, 2H), 6.55 (m, 1H), 
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6.38 (m, 1H), 2.39 (s, 3H), 2.25 (m, 2H), 1.45 (m, 2H), 1.26 (m, 16H), 0.87 (t, J = 
6.7 Hz, 3H); 13C NMR (CDCl3)  = 162.2, 152.7, 141.8, 130.0, 128.7, 124.8, 45.2, 
33.2, 32.0, 29.7, 29.5, 29.3, 28.3, 22.8, 21.6, 14.3; LC-MS (ESI): tR = 15.26 min, 
calcd. for C20H32NOS [M+H]
+, 334.53, found 334.03.  
 
Aziridine (54) 
 
NH H
S
C10H21
O
O
O
Chemical Formula: C28H41NO3S
Molecular Weight: 471.6950
 
 
Following the same protocol as above for 50 led to the pure product 54 (yield: 99 
mg, 0.21 mmol, 87%) as a colourless oil. 
 
TLC (ethyl acetate/cyclohexane = 1:5): Rf = 0.52; 1H NMR (CDCl3)  = 7.59 (m, 
2H), 7.31 (m, 2H), 6.02 (m, 1H), 5.38 (m, 1H), 4.20 (m, 2H), 4.03 (t, J = 6.2 Hz, 
1H), 3.59 (m, 1H), 3.27 (d, J = 3.75 Hz, 1H), 2.41 (s, 3H), 2.23 (m, 2H), 2.14 (m, 
2H), 2.08 (m, 2H), 1.96 (m, 1H), 1.81 (m, 2H), 1.61 (m, 4H), 1.41-1.26 (m, 11H), 
0.89 (t, J = 6.12 Hz, 3H); LC-MS (ESI): tR = 11.16 min, calcd. for C28H42NO3S 
[M+H]+, 472.70, found 472.24. 
 
6-azido hexyl bromo acetate (55) 
 
Br
O
O
N3
Chemical Formula: C8H14BrN3O2
Molecular Weight: 264.1197  
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Following the same protocol as above for 52 led to the pure product 55 (yield: 279 
mg, 1.06 mmol, 53%) as a yellow oil.  
 
TLC (ethyl acetate/cyclohexane = 1:5): Rf = 0.42; 1H NMR (CDCl3)  = 4.19 (t, J = 
6.64 Hz, 2H), 3.84 (s, 2H), 3.28 (t, J = 6.84 Hz, 2H), 1.68 (m, 2H), 1.61 (m, 2H), 
1.42 (m, 4H); 13C NMR (CDCl3)  = 167.4, 66.3, 51.5, 28.9, 28.4, 26.5, 26.0, 25.5. 
 
hexyl bromo acetate (56) 
 
Br
O
O
Chemical Formula: C8H15BrO2
Molecular Weight: 223.1075  
 
Following the same protocol as above for 52 led to the pure product 56 (yield: 227 
mg, 1.02 mmol, 51%) as a light lemon oil.  
 
TLC (ethyl acetate/cyclohexane = 1:5): Rf = 0.53; 1H NMR (CDCl3)  = 4.23 (t, J = 
6.64 Hz, 2H), 4.05 (s, 2H), 1.65 (m, 2H), 1.53 (m, 2H), 1.31 (m, 4H), 0.89 (t, J = 
6.8 Hz, 3H); 13C NMR (CDCl3)  = 167.1, 63.6, 30.5, 28.7, 26.2, 25.3, 22.4, 15.3. 
 
S-trans-2-tridencenyl sulfinate imine (57) 
 
N
S O
C10H21
Chemical Formula: C20H31NOS
Molecular Weight: 333.5312
 
 
Zhe Ming Wang Experimental section Doctoral Dissertation 2009 
 - 173 - Chemical Genomics Centre (CGC) 
Following the same protocol as above for 49 led to the pure product 57 (yield: 130 
mg, 0.39 mmol, 85%) as a white solid. 
 
TLC (ethyl acetate/cyclohexane = 1:5): Rf = 0.61; 1H NMR (CDCl3)  = 8.33 (d, J 
= 9.5 Hz, 1H), 7.56 (d, J = 8.25 Hz, 2H), 7.29 (d, J = 8.25 Hz, 2H), 6.55 (m, 1H), 
6.38 (m, 1H), 2.39 (s, 3H), 2.25 (m, 2H), 1.45 (m, 2H), 1.26 (m, 16H), 0.87 (t, J = 
6.7 Hz, 3H); 13C NMR (CDCl3)  = 162.2, 152.7, 141.8, 130.0, 128.7, 124.8, 45.2, 
33.2, 32.0, 29.7, 29.5, 29.3, 28.3, 22.8, 21.6, 14.3; LC-MS (ESI): tR = 15.26 min, 
calcd. for C20H32NOS [M+H]
+, 334.53, found 334.03. 
 
R-trans-2-tridencenyl sulfinate imine (58) 
 
N
S
O
C10H21
Chemical Formula: C20H31NOS
Molecular Weight: 333.5312
 
 
Following the same protocol as above for 49, but with (1S, 2R, 5S)-(+)-menthyl 
(R)-p-toluenesulfinate led to the pure enatiomer 58 (yield: 138 mg, 0.42 mmol, 
90%) as a white solid. 
 
TLC (ethyl acetate/cyclohexane = 1:5): Rf = 0.61; 1H NMR (CDCl3)  = 8.34 (d, J 
= 9.16 Hz, 1H), 7.57 (d, J = 8.2 Hz, 2H), 7.30 (d, J = 8.2 Hz, 2H), 6.55 (m, 1H), 
6.42 (m, 1H), 2.40 (s, 3H), 2.27 (m, 2H), 1.45 (m, 2H), 1.26 (m, 16H), 0.88 (t, J = 
6.7 Hz, 3H); LC-MS (ESI): tR = 15.34 min, calcd. for C20H31NOS [M+H]
+, 334.53, 
found 334.32. 
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S-trans-crotonyl sulfinate imine (59) 
 
N
S O
Chemical Formula: C11H13NOS
Molecular Weight: 207.2920
 
 
Following the same protocol as above for 49 led to the product 59 (yield: 93.1 mg, 
0.45 mmol, 45%) as a white solid. 
 
TLC (ethyl acetate/cyclohexane = 1:5): Rf = 0.3; 1H NMR (CDCl3)  = 8.34 (d, J = 
9.16 Hz, 1H), 7.55 (d, J = 8 Hz, 2H), 7.28 (d, J = 8 Hz, 2H), 6.56 (m, 1H), 6.39 (m, 
1H), 2.38 (s, 3H), 1.95 (d, J = 5.6 Hz, 3H); 13C NMR (CDCl3)  = 161.7, 147.1, 
141.9, 141.6, 130.1, 129.8, 124.5, 34.5, 23.1, 20.9. 
 
R-trans-crotonyl sulfinate imine (60) 
 
N
S
O
Chemical Formula: C11H13NOS
Molecular Weight: 207.2920
 
 
Following the same protocol as above for 49, but with (1S, 2R, 5S)-(+)-menthyl 
(R)-p-toluenesulfinate led to the enantiomer 60 (yield: 107 mg, 0.52 mmol, 52%) as 
a white solid. 
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TLC (ethyl acetate/cyclohexane = 1:5): Rf = 0.3; 1H NMR (CDCl3)  = 8.34 (d, J = 
9.16 Hz, 1H), 7.55 (d, J = 8 Hz, 2H), 7.28 (d, J = 8 Hz, 2H), 6.56 (m, 1H), 6.39 (m, 
1H), 2.38 (s, 3H), 1.95 (d, J = 5.6 Hz, 3H). 
 
S-phenyl sulfinate imine (61) 
 
N
S O
Chemical Formula: C14H13NOS
Molecular Weight: 243.3241
 
 
Following the same protocol as above for 49 led to the product 61 (yield: 211 mg, 
0.87 mmol, 87%) as a light yellow solid. 
 
TLC (ethyl acetate/cyclohexane = 1:5): Rf = 0.41; 1H NMR (CDCl3)  = 8.77 (s, 
1H), 7.85 (d, J = 7.44 Hz, 2H), 7.64 (d, J = 8.2 Hz, 2H), 7.49 (m, 3H), 7.32 (m, 2H), 
2.41 (s, 3H); 13C NMR (CDCl3)  = 160.8, 141.9, 141.9, 134.1, 132.7, 130.0, 129.7, 
129.0, 124.9, 21.6. 
 
R-phenyl sulfinate imine (62) 
 
N
S
O
Chemical Formula: C14H13NOS
Molecular Weight: 243.3241
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Following the same protocol as above for 49, but with (1S, 2R, 5S)-(+)-menthyl 
(R)-p-toluenesulfinate led to the enatiomer 62 (yield: 218 mg, 0.9 mmol, 90%) as a 
light yellow solid. 
 
TLC (ethyl acetate/cyclohexane = 1:5): Rf = 0.41; 1H NMR (CDCl3)  = 8.77 (s, 
1H), 7.84 (d, J = 7.44 Hz, 2H), 7.62 (d, J = 8.2 Hz, 2H), 7.48 (m, 3H), 7.32 (m, 2H), 
2.41 (s, 3H); 
 
S-decanyl sulfinate imine (63) 
 
C10H21
N
S O Chemical Formula: C18H29NOS
Molecular Weight: 307.4940
 
 
Following the same protocol as above for 49 led to the product 63 (yield: 98 mg, 
0.32 mmol, 32%) as a white solid. 
 
TLC (ethyl acetate/cyclohexane = 1:5): Rf = 0.35; 1H NMR (CDCl3)  = 8.22 (t, J = 
5.2 Hz, 1H), 7.54 (d, J = 7.44 Hz, 2H), 7.28 (d, J = 8.2 Hz, 2H), 2.39 (s, 3H), 1.58-
1.42 (m, 18H), 0.89 (t, J = 6.5 Hz, 3H). 
 
R-decanyl sulfinate imine (64) 
 
C10H21
N
S
O
Chemical Formula: C18H29NOS
Molecular Weight: 307.4940
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Following the same protocol as above for 49, but with (1S, 2R, 5S)-(+)-menthyl 
(R)-p-toluenesulfinate led to the enatiomer 64 (yield: 92 mg, 0.3 mmol, 30%) as a 
white solid. 
 
TLC (ethyl acetate/cyclohexane = 1:5): Rf = 0.35; 1H NMR (CDCl3)  = 8.22 (t, J = 
5.2 Hz, 1H), 7.52 (d, J = 7.44 Hz, 2H), 7.26 (d, J = 8.2 Hz, 2H), 2.39 (s, 3H), 1.58-
1.42 (m, 18H), 0.89 (t, J = 6.5 Hz, 3H). 
 
S-cyclohexyl sulfinate imine (65) 
 
N
S O Chemical Formula: C14H19NOS
Molecular Weight: 249.3718
 
 
Following the same protocol as above for 49 led to the product 65 (yield: 204 mg, 
0.82 mmol, 82%) as a white solid. 
 
TLC (ethyl acetate/cyclohexane = 1:5): Rf = 0.34; 1H NMR (CDCl3)  = 8.09 (d, J 
= 4.8 Hz, 1H), 7.52 (d, J = 8 Hz, 2H), 7.27 (d, J = 8 Hz, 2H), 2.37 (s, 3H), 1.95 (m, 
1H), 1.93 (m, 2H), 1.89 (m, 2H), 1.83 (m, 2H), 1.74 (m, 4H); 13C NMR (CDCl3)  
= 170.6, 142.4, 141.8, 130.0, 124.9, 50.4, 45.3, 43.9, 29.4, 26.0, 25.5, 21.2. 
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R-cyclohexyl sulfinate imine (66) 
 
N
S
O
Chemical Formula: C14H19NOS
Molecular Weight: 249.3718
 
 
Following the same protocol as above for 49, but with (1S, 2R, 5S)-(+)-menthyl 
(R)-p-toluenesulfinate led to the enatiomer 66 (yield: 212 mg, 0.85 mmol, 85%) as 
a white solid. 
 
TLC (ethyl acetate/cyclohexane = 1:5): Rf = 0.34; 1H NMR (CDCl3)  = 8.09 (d, J 
= 4.8 Hz, 1H), 7.52 (d, J = 8 Hz, 2H), 7.27 (d, J = 8 Hz, 2H), 2.37 (s, 3H), 1.95 (m, 
1H), 1.93 (m, 2H), 1.89 (m, 2H), 1.83 (m, 2H), 1.74 (m, 4H). 
 
S-(3-phenyl propyl) sulfinate imine (67) 
 
N
S O
Chemical Formula: C16H17NOS
Molecular Weight: 271.3773
 
 
Following the same protocol as above for 49 led to the product 67 (yield: 67.3 mg, 
0.33 mmol, 33%) as a white solid. 
 
TLC (ethyl acetate/cyclohexane = 1:5): Rf = 0.22; 1H NMR (CDCl3)  = 8.28 (t, J = 
5.3 Hz, 1H), 7.42 (d, J = 8 Hz, 2H), 7.27 (d, J = 8 Hz, 2H), 7.13 (m, 3H), 7.04 (m, 
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2H), 2.37 (s, 3H), 1.95 (m, 2H), 1.93 (m, 2H); 13C NMR (CDCl3)  = 165.9, 148.5, 
142.1, 140.9, 139.0, 138.1, 129.3, 128.3, 127.5, 44.8, 34.3, 31.4, 21.9. 
 
S-(3-phenyl propyl) sulfinate imine (68) 
 
N
S
O
Chemical Formula: C16H17NOS
Molecular Weight: 271.3773
 
 
Following the same protocol as above for 49, but with (1S, 2R, 5S)-(+)-menthyl 
(R)-p-toluenesulfinate led to the enatiomer 68 (yield: 92 mg, 0.34 mmol, 34%) as a 
white solid. 
 
TLC (ethyl acetate/cyclohexane = 1:5): Rf = 0.22; 1H NMR (CDCl3)  = 8.21 (t, J = 
5.3 Hz, 1H), 7.42 (d, J = 8 Hz, 2H), 7.24 (d, J = 8 Hz, 2H), 7.13 (m, 3H), 7.04 (m, 
2H), 2.31 (s, 3H), 1.95 (m, 2H), 1.93 (m, 2H); 13C NMR (CDCl3)  = 165.9, 148.5, 
142.1, 140.9, 139.0, 138.1, 129.3, 128.3, 127.5, 44.8, 34.3, 31.4, 21.9. 
 
Aziridine (69) 
 
N
S
C10H21
O
O
O
N3
Chemical Formula: C28H44N4O3S
Molecular Weight: 516.7390
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To a solution of 57 (186.5 mg, 0.56 mmol) in anhydrous THF (3 ml), 55 (297 mg, 
1.13 mmol) in anhydrous THF (3 ml) was added at -78 °C. After 3 min, LiHMDS 
(0.73 ml, 0.73 mmol, 1.0 M in THF) was added dropwise. The reaction was stirred 
at -78 °C for 1 h and warmed up to -38°C for another 1 h, quenched with water (0.5 
ml) and diluted with ethyl acetate (3 ml). The organic layer was separated and the 
aqueous phase was washed with ethyl acetate. The combined organic layer was 
washed with brine, dried and the crude product was purified by silica gel 
chromatography (ethyl acetate/cyclohexane = 5:1) to obtain pure product 69 (yield: 
245 mg, 0.47 mmol, 85%) as a yellow oil.  
 
TLC (ethyl acetate/cyclohexane = 1:5): Rf = 0.42; 1H NMR (CDCl3)  = 7.59 (m, 
2H), 7.30 (m, 2H), 6.00 (m, 1H), 5.50 (m, 1H), 4.17 (t, J = 6.44 Hz, 1H), 3.99 (m, 
2H), 3.25 (m, 5H), 2.39 (s, 3H), 2.05 (m, 2H), 1.56-1.25 (m, 22H), 0.87 (t, J = 6.64 
Hz, 3H); 13C NMR (CDCl3)  = 167.3, 142.3, 141.3, 139.5, 129.9, 125.4, 125.2, 
122.2, 66.3, 65.2, 64.3, 51.5 42.6, 32.9, 32.8, 29.8, 29.6, 29.1, 28.9, 28.5, 26.5, 25.5, 
22.9, 21.7, 14.3. 
 
Aziridine (70) 
 
N
S
C10H21
O
O
N3
O
Chemical Formula: C28H44N4O3S
Molecular Weight: 516.7390
 
 
Following the same protocol as above for 69 led to the product 70 (yield: 239 mg, 
0.46 mmol, 83%) as a yellow oil. 
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TLC (ethyl acetate/cyclohexane = 1:5): Rf = 0.42; 1H NMR (CDCl3)  = 7.59 (m, 
2H), 7.28 (m, 2H), 5.97 (m, 1H), 5.46 (m, 1H), 4.17 (t, J = 6.64 Hz, 1H), 3.99 (m, 
2H), 3.26 (m, 5H), 2.39 (s, 3H), 2.05 (m, 2H), 1.56-1.25 (m, 22H), 0.87 (t, J = 6.64 
Hz, 3H); 13C NMR (CDCl3)  = 167.3, 142.3, 141.3, 139.5, 129.9, 125.4, 125.2, 
122.2, 66.3, 65.2, 64.3, 51.5 42.6, 32.9, 32.8, 29.8, 29.6, 29.1, 28.9, 28.5, 26.5, 25.5, 
22.9, 21.7, 14.3. 
 
Aziridine (71) 
 
N
S
O
O
O
N3
Chemical Formula: C19H26N4O3S
Molecular Weight: 390.4997
 
 
Following the same protocol as above for 69 led to the product 71 (yield: 63 mg, 
0.16 mmol, 63%) as a yellow oil. 
 
TLC (ethyl acetate/cyclohexane = 1:5): Rf = 0.44; 1H NMR (CDCl3)  = 7.57 (m, 
2H), 7.29 (m, 2H), 5.98 (m, 1H), 5.49 (m, 1H), 4.15 (m, 1H), 3.99 (m, 2H), 3.58 (m, 
1H), 3.25 (m, 5H), 2.42 (s, 3H), 1.65-1.23 (m, 8H); 13C NMR (CDCl3)  = 167.3, 
142.9,141.3, 134.0, 129.9, 125.4, 125.2, 123.6, 71.9, 68.5, 65.1, 64.3, 51.5, 42.5, 
32.8, 28.9, 26.5, 25.5, 21.7, 18.3. 
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Aziridine (72) 
 
N
S
O
O
N3
O
Chemical Formula: C19H26N4O3S
Molecular Weight: 390.4997
 
Following the same protocol as above for 69 led to the product 72 (yield: 70 mg, 
0.18 mmol, 70%) as a yellow oil. 
 
TLC (ethyl acetate/cyclohexane = 1:5): Rf = 0.44; 1H NMR (CDCl3)  = 7.57 (m, 
2H), 7.29 (m, 2H), 5.98 (m, 1H), 5.49 (m, 1H), 4.15 (m, 1H), 3.99 (m, 2H), 3.58 (m, 
1H), 3.25 (m, 5H), 2.42 (s, 3H), 1.65-1.23 (m, 8H); 13C NMR (CDCl3)  = 167.3, 
142.9,141.3, 134.0, 129.9, 125.4, 125.2, 123.6, 71.9, 68.5, 65.1, 64.3, 51.5, 42.5, 
32.8, 28.9, 26.5, 25.5, 21.7, 18.3. 
 
Aziridine (73) 
 
N
S
O
O
O
N3
Chemical Formula: C22H26N4O3S
Molecular Weight: 426.5318
 
 
Following the same protocol as above for 69 led to the product 73 (yield: 215 mg, 
0.51 mmol, 90%) as a yellow oil. 
 
TLC (ethyl acetate/cyclohexane = 1:5): Rf = 0.27; 1H NMR (CDCl3)  = 7.74 (m, 
2H), 7.45 (m, 2H), 7.33 (m, 5H), 3.85 (m, 2H), 3.72 (m, 1H), 3.49 (d, J = 7.4 Hz, 
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1H), 3.19 (t, J = 7.04 Hz, 2H), 2.42 (s, 3H), 1.61-1.17 (m, 6H), 1.01 (m, 2H); 13C 
NMR (CDCl3)  = 166.0, 142.4, 141.3, 133.0, 130.0, 128.4, 128.0, 125.5, 65.0, 
51.5, 42.3, 35.3, 28.8, 28.4, 26.4, 25.3, 21.7. 
 
Aziridine (74) 
 
N
S
O
O
N3
O
Chemical Formula: C22H26N4O3S
Molecular Weight: 426.5318
 
 
Following the same protocol as above for 69 led to the product 74 (yield: 210 mg, 
0.49 mmol, 88%) as a yellow oil. 
 
TLC (ethyl acetate/cyclohexane = 1:5): Rf = 0.27; 1H NMR (CDCl3)  = 7.74 (m, 
2H), 7.45 (m, 2H), 7.33 (m, 5H), 3.85 (m, 2H), 3.72 (m, 1H), 3.49 (d, J = 7.4 Hz, 
1H), 3.19 (t, J = 7.04 Hz, 2H), 2.42 (s, 3H), 1.61-1.17 (m, 6H), 1.01 (m, 2H); 13C 
NMR (CDCl3)  = 166.0, 142.4, 141.3, 133.0, 130.0, 128.4, 128.0, 125.5, 65.0, 
51.5, 42.3, 35.3, 28.8, 28.4, 26.4, 25.3, 21.7. 
 
Aziridine (75) 
 
N
S
C10H21
O
O
O
N3
Chemical Formula: C26H42N4O3S
Molecular Weight: 490.7017
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Following the same protocol as above for 69 led to the product 75 (yield: 84 mg, 
0.17 mmol, 85%) as a light yellow oil. 
 
TLC (ethyl acetate/cyclohexane = 1:5): Rf = 0.28; 1H NMR (CDCl3)  = 7.58 (m, 
2H), 7.32 (m, 2H), 4.18 (t, J = 6.64 Hz, 2H), 3.84 (m, 2H), 3.28 (m, 2H), 2.41 (m, 
3H), 1.63-1.26 (m, 26H), 0.88 (t, J = 6.64 Hz, 3H); 13C NMR (CDCl3)  = 167.5, 
129.9, 126.4, 125.5, 125.4, 66.3, 64.3, 51.5, 32.1, 29.8, 29.7, 29.6, 28.9, 28.5, 26.5, 
26.0, 25.6, 22.9, 14.3. 
 
Aziridine (76) 
 
N
S
C10H21
O
O
N3
O
Chemical Formula: C26H42N4O3S
Molecular Weight: 490.7017
 
 
Following the same protocol as above for 69 led to the product 75 (yield: 86 mg, 
0.18 mmol, 87%) as a light yellow oil. 
 
TLC (ethyl acetate/cyclohexane = 1:5): Rf = 0.28; 1H NMR (CDCl3)  = 7.58 (m, 
2H), 7.32 (m, 2H), 4.18 (t, J = 6.64 Hz, 2H), 3.84 (m, 2H), 3.28 (m, 2H), 2.41 (m, 
3H), 1.63-1.26 (m, 26H), 0.88 (t, J = 6.64 Hz, 3H); 13C NMR (CDCl3)  = 167.5, 
129.9, 126.4, 125.5, 125.4, 66.3, 64.3, 51.5, 32.1, 29.8, 29.7, 29.6, 28.9, 28.5, 26.5, 
26.0, 25.6, 22.9, 14.3. 
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Aziridine (77) 
 
N
S
O
O
O
N3
Chemical Formula: C22H32N4O3S
Molecular Weight: 432.5795
 
 
Following the same protocol as above for 69 led to the product 77 (yield: 169 mg, 
0.39 mmol, 70%) as a colourless oil. 
 
TLC (ethyl acetate/cyclohexane = 1:5): Rf = 0.35; 1H NMR (CDCl3)  = 7.59 (m, 
2H), 7.29 (m, 2H), 4.18 (m, 1H), 3.99 (m, 2H), 3.58 (m, 1H), 3.25 (m, 2H), 2.42 (s, 
3H), 1.62-1.24 (m, 19H); 13C NMR (CDCl3)  = 167.8, 142.9, 129.9, 129.8, 125.4, 
125.2, 66.3, 65.2, 64.3, 51.5, 46.6, 36.2, 31.3, 30.1, 29.7, 28.9, 28.5, 26.5, 25.6, 
21.7 
 
Aziridine (78) 
 
N
S
O
O
N3
O
Chemical Formula: C22H32N4O3S
Molecular Weight: 432.5795
 
 
Following the same protocol as above for 69 led to the product 78 (yield: 164 mg, 
0.38 mmol, 68%) as a colourless oil. 
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TLC (ethyl acetate/cyclohexane = 1:5): Rf = 0.35; 1H NMR (CDCl3)  = 7.59 (m, 
2H), 7.29 (m, 2H), 4.18 (m, 1H), 3.99 (m, 2H), 3.58 (m, 1H), 3.25 (m, 2H), 2.42 (s, 
3H), 1.62-1.24 (m, 19H); 13C NMR (CDCl3)  = 167.8, 142.9, 129.9, 129.8, 125.4, 
125.2, 66.3, 65.2, 64.3, 51.5, 46.6, 36.2, 31.3, 30.1, 29.7, 28.9, 28.5, 26.5, 25.6, 
21.7 
 
Aziridine (79) 
 
N
S
O
O
O
N3
Chemical Formula: C24H30N4O3S
Molecular Weight: 454.5850
 
 
Following the same protocol as above for 69 led to the product 79 (yield: 69 mg, 
0.15 mmol, 50%) as a colourless oil. 
 
TLC (ethyl acetate/cyclohexane = 1:5): Rf = 0.29; 1H NMR (CDCl3)  = 7.59 (m, 
2H), 7.18 (m, 7H), 4.10 (m, 1H), 3.75 (m, 2H), 3.44 (m, 1H), 3.14 (m, 2H), 2.65 (m, 
1H), 2.43 (m, 1H), 2.32 (s, 3H), 1.55-1.13 (m, 10H); 13C NMR (CDCl3)  = 166.4, 
142.2, 141.9, 138.9, 129.8, 128.8, 128.7, 128.6, 125.4, 66.3, 65.0, 64.4, 51.5, 43.4, 
36.1, 35.5, 34.2, 30.4, 29.0, 28.5, 26.5, 25.5, 21.7. 
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Aziridine (80) 
 
N
S
O
O
N3
O
Chemical Formula: C24H30N4O3S
Molecular Weight: 454.5850
 
 
Following the same protocol as above for 69 led to the product 80 (yield: 76 mg, 
0.17 mmol, 55%) as a colourless oil. 
 
TLC (ethyl acetate/cyclohexane = 1:5): Rf = 0.29; 1H NMR (CDCl3)  = 7.59 (m, 
2H), 7.18 (m, 7H), 4.10 (m, 1H), 3.75 (m, 2H), 3.44 (m, 1H), 3.14 (m, 2H), 2.65 (m, 
1H), 2.43 (m, 1H), 2.32 (s, 3H), 1.55-1.13 (m, 10H); 13C NMR (CDCl3)  = 166.4, 
142.2, 141.9, 138.9, 129.8, 128.8, 128.7, 128.6, 125.4, 66.3, 65.0, 64.4, 51.5, 43.4, 
36.1, 35.5, 34.2, 30.4, 29.0, 28.5, 26.5, 25.5, 21.7. 
 
Aziridine (81) 
 
N
C10H21
O
O
N3
Chemical Formula: C21H36N4O2
Molecular Weight: 376.5361
 
 
To a solution of 69 (51.6 mg, 0.1 mmol) in anhydrous THF (1 ml), LDA (130 μl, 
0.13 mmol, 1.0 M in THF) was added dropwise at -78 °C. The reaction was stirred 
at -78 °C for 15 min, at which time iodomethane (12.4 μl, 0.2 mmol) was added. 
After stirring for 20 min, the reaction was quenched with water (0.2 ml) and diluted 
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with ethyl acetate (5 ml). The organic phase was separated and aqueous phase was 
washed with ethyl acetate. The combined organic layer was washed with brine, 
dried and the crude product was purified by silica gel chromatography (ethyl 
acetate/cyclohexane = 5:1) to obtain product 81 (yield: 7 mg, 19 μmol, 20%) as a 
brown oil.  
 
TLC (ethyl acetate/cyclohexane = 1:5): Rf = 0.85. 
 
General methods for the syntheses of compounds 82 – 86 
 
Syntheses were carried out in a parallel reaction synthesizer without isolation of the 
reaction intermediates. 
Amino acids (0.2 mmol) were weighted in 12 different reaction tubes. HBTU (1.1 g, 
2.88 mmol), HOBt (440 mg, 2.88 mmol) and TEA (996 μl, 7.2 mmol) were 
dissolved in DCM (final volume 12 ml) and aliquoted to each tube. The reaction 
mixture was stirred for 5 min and a solution of AEBSF (48 mg, 0.24 mmol) in 
DCM (0.25 ml) was added and stirred at room temperature for another 3 h (TLC 
control). 
The solvent in each reaction tube was removed carefully at reduced pressure and 
50% TFA in DCM (1 ml) was added. The resulting reaction mixtures were stirred 
for 3 h. Toluene (5 ml) was added and removed at reduced pressure.  
22 (857 mg, 2.4 mmol), PyBOP (1.25 g, 2.4 mmol) and TEA (1.32 ml, 9.6 mmol) 
were dissolved in DMSO (final volume 6 ml) at room temperature. After stirring 
for 15 min, the DMSO solution (500 μl) was aliquoted to each reaction tube. The 
reactions were completed overnight. The products were isolated after removing 
DMSO by precipitation with ethyl acetate/diethyl ether 5 ml (1:1) and washed with 
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sodium bicarbonate solution and ethyl ether, dried and purified by preparative 
HPLC. 
 
Biotinyl leucinyl AEBSF (82) 
 
S
O
O F
N
H
O
NHO
N
H
O
S
HN
NH
O
H
H
Chemical Formula: C30H46FN5O6S2
Molecular Weight: 655.8445
 
 
Following the above protocol led to the product 82 (yield: 46 mg, 0.07 mmol, 35%) 
as a white solid. 
 
1H NMR (DMSO-d6)  = 8.04 (d, J = 8.2 Hz, 2H), 7.95 (t, J = 5.48 Hz, 1H), 7.79 
(d, J = 8.2 Hz, 1H), 7.68 (t, J = 5.48 Hz, 1H), 7.58 (d, J = 8.2 Hz, 2H), 6.35 (s/s, 
2H), 4.31 (m, 1H), 4.15 (m, 2H), 3.14 (t, J = 8.4 Hz, 1H), 3.08 (m, 1H), 2.96 (q, J = 
6.84 Hz, 2H), 2.84 (t, J = 6.84 Hz, 2H), 2.79 (dd, J = 12.52, 5.08 Hz, 1H), 2.55 (d, J 
= 12.52 Hz, 1H), 2.04 (m, 4H), 1.61-1.26 (m, 14H), 0.92 (t, J = 7.24 Hz, 2H), 0.78 
(d, J = 6.44 Hz, 3H), 0.74 (d, J = 6.44 Hz, 3H); 19F NMR (DMSO-d6)  = -74.0, -
199.2; MS (ESI): calcd. for C30H47FN5O6S2 [M+H]
+, 656.84, found 656.20. 
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Biotinyl valinyl AEBSF (83) 
 
S
O
O F
N
H
O
NHO
N
H
O
S
HN
NH
O
H
H
Chemical Formula: C29H44FN5O6S2
Molecular Weight: 641.8180
 
 
Following the above protocol led to the product 83 (yield: 36 mg, 0.06 mmol, 28%) 
as a white solid. 
 
1H NMR (DMSO-d6)  = 7.99 (d, J = 8.4 Hz, 3H), 7.70 (t, J = 3.32 Hz, 2H), 7.60 
(d, J = 8.4 Hz, 2H), 6.35 (s/s, 2H), 4.27 (m, 1H), 4.10 (m, 1H), 4.00 (m, 1H), 3.06 
(m, 1H), 2.96 (q, J = 6.84 Hz, 2H), 2.86 (t, J = 6.84 Hz, 2H), 2.79 (dd, J = 12.52, 
5.08 Hz, 1H), 2.55 (d, J = 12.52 HZ, 1H), 2.08 (m, 4H), 1.61-1.26 (m, 15H), 0.70 (t, 
J = 6.64 Hz, 6H); 19F NMR (DMSO-d6)  = -74.1, -199.2; MS (ESI): calcd. for 
C29H45FN5O6S2 [M+H]
+, 642.82, found 642.27. 
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Biotinyl glycinyl AEBSF (84) 
 
S
O
O F
N
H
O
NHO
N
H
O
S
HN
NH
O
H
H
Chemical Formula: C26H38FN5O6S2
Molecular Weight: 599.7382
 
 
Following the above protocol led to the product 84 (yield: 43 mg, 0.07 mmol, 36%) 
as a white solid. 
 
1H NMR (DMSO-d6)  = 8.04 (d, J = 8.2 Hz, 2H), 7.95 (t, J = 5.48 Hz, 1H), 7.79 
(d, J = 8.2 Hz, 1H), 7.68 (t, J = 5.48 Hz, 1H), 7.58 (d, J = 8.2 Hz, 2H), 6.35 (br s, 
2H), 4.28 (m, 1H), 4.12 (m, 1H), 3.59 (d, J = 5.84 Hz, 2H), 3.33 (m, 3H), 3.09 (m, 
2H), 2.99 (m, 1H), 2.86 (t, J = 6.84 Hz, 2H), 2.78 (dd, J = 12.52, 5.08 Hz, 1H), 2.55 
(d, J = 12.52 HZ, 1H), 2.06 (m, 4H), 1.61-1.26 (m, 11H); 19F NMR (DMSO-d6)  = 
-75.0, -199.2; MS (ESI): calcd. for C26H39FN5O6S2 [M+H]
+, 600.74, found 600.20. 
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Biotinyl phenylalaninyl AEBSF (85) 
 
S
O
O F
N
H
O
NHO
N
H
O
S
HN
NH
O
H
H Chemical Formula: C33H44FN5O6S2
Molecular Weight: 689.8608
 
 
Following the above protocol to get the product 85 (yield: 45 mg, 0.07 mmol, 33%) 
as a white solid. 
 
1H NMR (DMSO-d6)  = 8.04 (m, 3H), 7.56 (d, J = 8.36 Hz, 2H), 7.16 (m, 7H), 
6.35 (br s, 2H), 4.38 (m, 1H), 4.28 (m, 1H), 4.10 (m, 1H), 3.33 (m, 4H), 3.14 (t, J = 
8.4 Hz, 2H), 3.08 (m, 1H), 2.96 (q, J = 6.84 Hz, 2H), 2.84 (t, J = 6.84 Hz, 2H), 2.66 
(dd, J = 12.52, 5.08 Hz, 1H), 2.55 (d, J = 12.52 Hz, 1H), 2.04 (m, 4H), 1.61-1.26 
(m, 8H), 0.92 (t, J = 7.24 Hz, 2H); 19F NMR (DMSO-d6)  = -74.8, -199.2; MS 
(ESI): calcd. for C33H45FN5O6S2 [M+H]
+, 690.86, found 690.27. 
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Biotinyl serinyl AEBSF (86) 
 
S
O
O F
N
H
O
NHO
N
H
O
S
HN
NH
O
H
H
OH
Chemical Formula: C27H40FN5O7S2
Molecular Weight: 629.7642
 
 
Following the above protocol to get the product 86 (yield: 38 mg, 0.06 mmol, 30%) 
as a white solid. 
 
1H NMR (DMSO-d6)  = 8.04 (d, J = 8.2 Hz, 2H), 7.95 (m, 1H), 7.71 (t, J = 5.48 
Hz, 2H), 7.59 (d, J = 8.2 Hz, 2H), 6.35 (s/s, 2H), 4.30 (m, 1H), 4.26 (m, 1H), 4.12 
(m, 1H), 3.34 (m, 2H), 3.14 (m, 4H), 2.96 (q, J = 6.84 Hz, 1H), 2.84 (t, J = 6.84 Hz, 
2H), 2.79 (d/d, J = 12.52, 5.08 Hz, 1H), 2.55 (d, J = 12.52 Hz, 1H), 2.09 (m, 3H), 
1.81 (m, 4H), 1.61-1.26 (m, 10H); 19F NMR (DMSO-d6)  = -74.8, -199.1; MS 
(ESI): calcd. for C27H41FN5O7S2 [M+H]
+, 630.76, found 630.20. 
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Rhodaminyl glycinyl AEBSF (87) 
 
HNNH
O
O
N
N
O O
O
S
O
O
F
Chemical Formula: C35H33FN4O7S
Molecular Weight: 672.7225
 
 
Boc-Gly-OH (35 mg, 0.2 mmol), HOBt (27 mg, 0.2 mmol) and DIC (31 μl, 0.2 
mmol) were dissolved in DCM (2 ml). To this reaction mixture, AEBSF (48 mg, 
0.2 mmol) was added and the reaction mixture was stirred for the following 3 h. 
After that, DCM was removed and 50% TFA in DCM (1 ml) was added to cleave 
the Boc protecting group within 1 h. The solvent was removed and TEA was added 
to neutralize excess TFA. 5(6)-Carboxytetramethylrhodamine N-succinimidyl ester 
(25 mg, 47.4 μmol) in DCM (1 ml) was added, stirred overnight, evaporated and 
the product 87 was purified directly via HPLC (yield: 11 mg, 16 μmol, 8.2%) as a 
violet solid.  
 
LC-MS (ESI): tR = 7.32 min, calcd. for C35H34FN4O7S [M+H]
+, 673.72, found 
673.24. 
 
Fmoc-Ala-CMK (88) 
 
FmocHN
O
Cl Chemical Formula: C19H18ClNO3
Molecular Weight: 343.8041  
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A 0.2 M solution of N-Fmoc alanine (1.65 g, 5 mmol) in anhydrous THF was 
stirred in an ice/ acetone bath at -10 °C. To this solution, N-methylmorpholine (686 
μl, 6.25 mmol) and iso-butylchloroformate (752 μl, 5.75 mmol) were sequentially 
added. Immediately after the addition of the latter compound, a white precipitate 
formed. The reaction mixture was maintained at -10 °C for 25 min.  
Diazomethane was generated in situ using the procedure described in the Aldrich 
Technical Bulletin (AL-180). Ethereal diazomethane (20 mmol) was transferred to 
the stirred solution of the mixed anhydride at 0 °C. The reaction mixture was 
warmed to room temperature over 3 h.  
To obtain the corresponding chloromethyl ketones, a solution of concentrated 
hydrochloric acid and acetic acid 1:1 (15 mL) was added dropwise to the reaction 
mixture at 0 °C. Ethyl acetate was added and the organic layer was separated, 
washed with water, brine, saturated aqueous NaHCO3, and dried over Na2SO4, 
concentrated under reduced pressure. The product 88 was obtained (yield: 1.82 g, 5 
mmol, 100%) as a white solid without further purification. 
 
LC-MS (ESI): tR = 7.83 min, calcd. for C19H19ClNO3 [M+H]
+, 344.80, found 
344.20. 
 
Semicarbazide linker (89) 
 
H
N
H
N
O
H2N
 
 
Aminomethylpolystyrene resin (2.2 g, 1.1 mmol/g) was dried in vacuo overnight in 
a 12-mL polypropylene cartridge. The resin was presolvated with DMF for 30 min 
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and another 30 min with DCM. A 1 M solution of N, N’-Carbonyldiimidazole (1.95 
g, 12 mmol) in DCM was added to the resin and the resin was shaken at room 
temperature for 3 h. The reagent was drained and the resin was washed with DCM 
followed by DMF. A 10 M solution of hydrazine (3.76 ml, 120 mmol) in DMF was 
added to the resin, and the resin was shaken at room temperature for 1 h. The resin 
was washed with DMF followed by DCM, dried in vacuo, and stored at -4 °C. 
 
Acyoxymethyl hydrazone (90) 
 
FmocHN
N
O
NH
N
H
O
O
 
 
A 0.5 M solution of 88 (1 g, 3 mmol) in DMF was added to the resin. The cartridge 
was tightly sealed and shaken at 50 °C for 3 h. The resin was washed with DMF. A 
0.5 M solution of 2,6-dimethylbenzoic acid (750 mg, 5 mmol) and potassium 
fluoride (580 mg, 10 mmol) were added to the resin. The resin was shaken at room 
temperature overnight. After the solution was removed, the resin was washed with 
DMF followed by DCM, and dried in vacuo. The resin load was estimated by UV 
absorption of cleaved Fmoc (loading: 0.565 mmol/g). 
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General protocol for syntheses of compounds 91-100 
 
Protocol for deprotection 
1. Add 20% piperidine in DMF and shake for 15 minutes. 
2. Drain solution 
3. Wash resin with DMF (3x) 
Protocol for coupling 
1. Add Fmoc-amino acid and HOBt to the cartridge (both 3 eq.).  
2. Add DMF to the resin (so that final concentration will be 0.25 M of Fmoc-amino 
acid).  
3. Add DIC (3 eq.) to the cartridge. 
4. Shake for 2 h. 
5. Drain solution 
6. Wash with DMF (3x) 
7. Wash with DCM (2x) to get rid of residual DMF 
8. Kaiser test, if necessary. 
Protocol for elongation 
1. Wash resin with DMF. 
2. Deprotect Fmoc following deprotection protocol. 
3. Couple amino acid following coupling protocol. 
Protocol for cleavage 
1. Make a stock of 95% TFA, 2.5% H2O and 2.5% TIS. 
2. Add TFA mixture to resin. 
3. Cleave for 1h. 
4. Collect the solution into a little flask. 
5. Rinse the resin twice with 95% TFA to collect all the peptide. 
6. Evaporate the TFA, dry peptide in vacuo and purify it with preparative HPLC. 
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Ak-GDA-AOMK (91) 
 
H
N
N
H
H
N O
O
O
O
O
O
COOH
Chemical Formula: C24H29N3O8
Molecular Weight: 487.5024
 
 
Following the above protocol led to the product 91 (yield: 2.4 mg, 4.9 μmol, 9.9%) 
as a brown solid. 
 
LC-MS (ESI): tR = 7.77 min, calcd. for C24H30N3O8 [M+H]
+, 488.50, found 488.07. 
 
Az-GDA-AOMK (92) 
 
N3
H
N
N
H
H
N O
O
O
O
O
O
COOH
Chemical Formula: C21H26N6O8
Molecular Weight: 490.4665  
 
Following the above protocol led to get the product 92 (yield: 3 mg, 6 μmol, 12%) 
as a yellow solid. 
 
LC-MS (ESI): tR = 7.72 min, calcd. for C21H27N6O8 [M+H]
+, 491.47, found 491.07. 
 
Ak-GEA-AOMK (93) 
 
H
N
N
H
H
N O
O
O
O
O
O
COOH
Chemical Formula: C25H31N3O8
Molecular Weight: 501.5289
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Following the above protocol led to the product 93 (yield: 2.5 mg, 5 μmol, 10%) as 
a brown solid. 
 
LC-MS (ESI): tR = 7.75 min, calcd. for C25H32N3O8 [M+H]
+, 502.53, found 502.13. 
 
Az-GEA-AOMK (94) 
 
N3
H
N
N
H
H
N O
O
O
O
O
O
COOH
Chemical Formula: C22H28N6O8
Molecular Weight: 504.4931
 
 
Following the above protocol led to the product 94 (yield: 2 mg, 4 μmol, 8%) as a 
brown solid. 
 
LC-MS (ESI): tR = 7.69 min, calcd. for C22H29N6O8 [M+H]
+, 505.49, found 505.13. 
 
Ak-GFA-AOMK (95) 
 
H
N
N
H
H
N O
O
O
O
Ph
O
O
Chemical Formula: C29H33N3O6
Molecular Weight: 519.5888
 
 
Following the above protocol led to the product 95 (yield: 1.5 mg, 2.9 μmol, 5.8%) 
as a white solid. 
 
LC-MS (ESI): tR = 9.20 min, calcd. for C29H34N3O6 [M+H]
+, 520.59, found 520.20. 
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Az-GFA-AOMK (96) 
 
N3
H
N
N
H
H
N O
O
O
Ph
O
OO
Chemical Formula: C26H30N6O6
Molecular Weight: 522.5530
 
 
Following the above protocol led to the product 96 (yield: 2 mg, 3.8 μmol, 7.6%) 
as a yellow solid. 
 
LC-MS (ESI): tR = 9.19 min, calcd. for C26H33N6O5 [M+H]
+, 523.55, found 523.13. 
 
Ak-GSA-AOMK (97) 
 
H
N
N
H
H
N O
O
O
O
OH
O
O
Chemical Formula: C23H29N3O7
Molecular Weight: 459.4923  
 
Following the above protocol led to the product 97 (yield: 1.8 mg, 3.9 μmol, 7.8%) 
as a white solid. 
 
LC-MS (ESI): tR = 7.61 min, calcd. for C23H30N3O7 [M+H]
+, 460.49, found 460.13. 
 
Az-GSA-AOMK (98) 
 
N3
H
N
N
H
H
N O
O
O
O
OH
O
O
Chemical Formula: C20H26N6O7
Molecular Weight: 462.4564
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Following the above protocol led to the product 98 (yield: 2 mg, 4.3 μmol, 8.6%) 
as a white solid. 
 
LC-MS (ESI): tR = 7.54 min, calcd. for C20H27N6O7 [M+H]
+, 460.49, found 460.07. 
 
Ak-GRA-AOMK (99) 
 
H
N
N
H
H
N O
O
O
O
O
O
H
N NH2
NH
Chemical Formula: C26H36N6O6
Molecular Weight: 528.6006
 
 
Following the above protocol led to the product 99 (yield: 4.1 mg, 7.7 μmol, 15.4%) 
as a brown solid. 
 
LC-MS (ESI): tR = 6.53 min, calcd. for C26H37N6O6 [M+H]
+, 529.60, found 529.40. 
 
Az-GRA-AOMK (100) 
 
N3
H
N
N
H
H
N O
O
O
O
O
O
H
N NH2
NH
Chemical Formula: C23H33N9O6
Molecular Weight: 531.5648
 
 
Following the above protocol led to the product 100 (yield: 4 mg, 7.5 μmol, 15%) 
as a brown solid. 
 
LC-MS (ESI): tR = 6.51 min, calcd. for C23H34N9O6 [M+H]
+, 532.56, found 532.33. 
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Rho-GDA-AOMK (101) 
 
H
N
N
H
H
N O
O
O
O
O
O
COOH
NH
O
O
CO2 N
N
Chemical Formula: C58H64N6O12
Molecular Weight: 1037.1618
 
 
Following the above protocol led to the product 101 (yield: 6.2 mg, 6 μmol, 12%) 
as a violet solid. 
 
LC-MS (ESI): tR = 8.01 min, calcd. for C58H65N6O12 [M+H]
+, 1038.16, found 
1037.80. 
 
Fmoc-Asp(OtBu)-BMK (102) 
 
FmocHN
OBu
O
O
Br Chemical Formula: C24H26BrNO5
Molecular Weight: 488.3709
 
 
A 0.2 M solution of N-Fmoc (OtBu) aspartate (2 g, 5 mmol) in anhydrous THF was 
stirred in an ice/acetone bath at -10 °C. To this solution, N-methylmorpholine (686 
μl, 6.25 mmol) and iso-butylchloroformate (752 μl, 5.75 mmol) were sequentially 
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added. Immediately after the addition of the latter compound, a white precipitate 
formed. The reaction mixture was maintained at -10° C for 25 min.  
Diazomethane was generated in situ using the procedure described in the Aldrich 
Technical Bulletin (AL-180). Ethereal diazomethane (20 mmol) was transferred to 
the stirred solution of the mixed anhydride at 0 °C. The reaction mixture was 
warmed to room temperature over 3 h.  
To obtain the corresponding bromomethyl ketones, 30% hydrogen bromide in 
acetic acid (10 ml) was added to the reaction mixture at 0 °C. Workup was carried 
out as described for the chloromethyl ketone synthesis. The product 102 was 
obtained (yield: 2.4 g, 5 mmol, 100%) as a yellow oil without further purification. 
 
Fmoc-Asp(OtBu)-AOMK (103) 
 
FmocHN
OtBu
O
O
O
O
Chemical Formula: C33H35NO7
Molecular Weight: 557.6335
 
 
A 0.2 M solution of 102 (2.4 g, 5 mmol) in DMF was stirred at 0 °C. To this 
solution, potassium fluoride (870 mg, 15 mmol) and 2,6-dimethylbenzoic acid (900 
mg, 6 mmol) were added. The reaction mixture was warmed to room temperature 
and stirred overnight, diluted with ethyl acetate.The organic layer was separated 
and washed with water, brine, saturated aqueous NaHCO3 and dried over MgSO4. 
The solvent was removed under reduced pressure. The crude product was purified 
by silica gel chromatography (ethyl acetate/cyclohexane = 1:5) to obtain pure 
product 103 (yield: 1.65 g, 2.96 mmol, 60%) as a white solid.  
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TLC (ethyl acetate/cyclohexane = 1:5): Rf = 0.2; 1H NMR (CDCl3)  = 7.82 (d, J = 
8.2 Hz, 2H), 7.63 (m, 2H), 7.41 (m, 2H), 7.33 (m, 2H), 7.20 (t, J = 7.6 Hz, 1H), 
7.04 (d, J = 7.64 Hz, 2H), 5.89 (d, J = 8.8 Hz, 1H), 5.07 (q, J = 16.8 Hz, 3H), 4.65 
(m, 2H), 4.24 (t, J = 6.44 Hz, 1H), 2.97 (dd, J = 17.1, 4.88 Hz, 1H), 2.91 (dd, J = 
17.1, 4.88 Hz, 1H), 2.40 (s, 6H), 1.45 (s, 9H); 13C NMR (CDCl3)  = 201.1, 169.0, 
156.2, 143.7, 141.5, 141.5, 135.8, 132.7, 129.8, 127.9, 127.8, 125.2, 120.2, 120.2, 
82.4, 67.3, 66.8, 54.9, 47.4, 36.7, 28.1, 27.1, 20.0; LC-MS (ESI): tR = 11.86 min, 
calcd. for C33H36NO7 [M+H]
+, 558.63, found 558.32. 
 
Fmoc-Asp(OH)-AOMK (104) 
 
FmocHN
OH
O
O
O
O
Chemical Formula: C29H27NO7
Molecular Weight: 501.5272  
 
A 0.2 M solution of 103 (1.65 g, 2.96 mmol) was dissolved in 25% TFA in DCM 
and allowed to stand for 30 min with occasional shaking. The reaction mixture was 
diluted with DCM. The cleavage solution was removed by coevaporation with 
toluene. The product was further dried in vacuo. The crude product 104 was used 
without further purification. 
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Fmoc-Asp(O-trityl resin)-AOMK (105) 
 
FmocHN
O
O
O
O
O
Cl
 
 
2-chlorotrityl chloride resin (1.5 g, 1.95 mmol) was washed with DCM. A 0.5 M 
solution of 104 (1 g, 2 mmol) and DIPEA (1.34 ml, 8 mmol) were added to the 
resin, shaking for 2 h. The resin was washed with DCM and DMF, yielding the 
loaded resin. Resin load was determined by UV absorption of cleaved Fmoc 
(loading: 0.77 mmol/g). 
 
Bio-AHxPD-AOMK (106) 
 
N
H
N O
O
O
O
ONHO CO2HS
HN
NH
O
H
H
Chemical Formula: C35H49N5O9S
Molecular Weight: 715.8567
 
 
Following the above SPPS protocol led to the product 106 (yield: 75 mg, 0.1 mmol, 
20%) as a white solid. 
 
LC-MS (ESI): tR = 7.47 min, calcd. for C35H50N5O9S [M+H]
+, 716.86, found 
716.47. 
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Rho-AHxPD-AOMK (107) 
 
N
H
N O
O
O
O
ONHO
O
N
N
CO2H
O
O
Chemical Formula: C50H55N5O11
Molecular Weight: 901.9986
 
 
Following the above SPPS protocol led to the product 107 (yield: 5.2 mg, 6 μmol, 
12.2%) as a violet solid. 
LC-MS (ESI): tR = 7.49 min, calcd. for C50H56N5O11 [M+H]
+, 903.00, found 902.60. 
 
Diethyl (2, 2-dimethyl-4-oxo-4H-benzo[d][1,3]dioxin-5-yl)methyl phosphonate 
(112) 
 
O
O
O
PO(OEt)2
Chemical Formula: C15H21O6P
Molecular Weight: 328.2974
 
 
To a stirred solution of 128 (1.1 g, 4 mmol) in anhydrous toluene (10 ml) at room 
temperature was added triethylphosphite (10 ml, 61.2 mmol) dropwise. The 
resulting mixture was refluxed for 2 h, allowed to cool to room temperature and 
directly transferred on top of a silica gel column. Flash chromatography (ethyl 
acetate/petroleum ether = 4:1) furnished the desired diethyl benzyl phosphonate 
112 (yield: 1.3 g, 3.84 mmol, 96%) as a colourless oil.  
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TLC (ethyl acetate/petroleum ether = 4:1): Rf = 0.1; 1H NMR (CDCl3):  = 7.42 (t, 
J = 7.8 Hz, 1H), 7.06 (dd, J = 3.0, 7.6 Hz, 1H), 6.87 (ddd, J=1.1, 2.4, 8.2 Hz, 1H), 
4.08 (m, 4H), 3.99 (s, 1H); 3.93 (s, 1H); 1.71 (s, 6H); 1.24 (m, 6H); 13C NMR 
(CDCl3,):  = 160.82, 157.01, 136.53, 134.82, 126.36, 116.23, 113.04, 105.41, 
62.07, 30.92, 25.58, 16.30; IR (neat): 2987, 1730, 1016, 964 cm-1; HRMS: Calcd. 
for C15H22O6P: [M+1]
+ 329.2974, found 329.1150. 
 
(2R, 3S)-3-methyloxirane-2-carbaldehyde (114) 
 
O
O Chemical Formula: C4H6O2
Molecular Weight: 86.0892  
 
To a solution of oxalylchloride (0.447 mL, 5.2 mmol) in DCM (15 ml) was added 
dropwise DMSO (0.695 mL, 10.6 mmol) at -78 °C. After ceasing of the gas 
evolution, a solution of 129 (0.3 g, 3.4 mmol) in DCM (2 mL) was added. After 
stirring for 90 min at –78 °C, TEA (2 mL, 14.3 mmol) was added dropwise. After 
20 min the mixture was allowed to warm to room temperature. The precipitate was 
filtered off and the filtrate was concentrated in vacuo. The crude product was 
purified by column chromatography (petroleum ether/diethyl ether = 1:1) to obtain 
the product 114 (yield: 263 mg, 3 mmol, 90%) as a liquid. Because 114 has a very 
low boiling point, it can only be obtained in a diether ether solution. No NMR 
spectrum could be measured in good quality and the yield was only estimated. 
 
3-(tert-Butyldiphenylsilyloxy)-propanal (124) 
 
TBDPSO O Chemical Formula: C19H24O2Si
Molecular Weight: 312.4782  
 
To a solution of oxalylchloride (0.54 ml, 6.36 mmol) in DCM (15 ml) was added 
DMSO (0.9 g, 12.7 mmol) dropwise at -78 °C. After ceasing of the gas evolution, a 
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solution of 130 (1 g, 3.18 mmol) in DCM (10 ml) was added. After 90 min of 
stirring at -78°C, TEA (2.65 ml 18.8 mmol) was added dropwise. After additional 20 
min, the mixture was allowed to warm to room temperature. The reaction mixture 
was quenched with water, the organic layer was separated and the aqueous layer 
was extracted with DCM. The combined organic layers were successively washed 
with cold water, brine, dried over Na2SO4 and solvent was removed under reduced 
pressure. The crude product was purified by silica gel chromatography (ethyl 
acetate/cyclohexane = 1:2) to obtain pure product 124 (yield: 0.7 g, 2.2 mmol, 70%) 
as a colourless oil.  
 
TLC (ethyl acetate/cyclohexane = 1:2): Rf = 0.72; 1H NMR (CDCl3):  = 9.82 (t, J 
= 2.1 Hz, 1H), 7.66 (d, J = 1.56 Hz, 4 H), 7.41 (m, 6H), 4.02 (t, J = 5.9 Hz, 2H), 
2.61 (dt, J = 2.1, 5.9 Hz, 2H), 1.04 (s, 9H); 13C NMR (CDCl3):  = 202.0, 135.7, 
135.0, 133.4, 130.0, 127.9, 58.5, 46.5, 26.9, 19.3; LC-MS (ESI): tR = 12.45 min, 
calcd. for C19H25O2Si [M+H]
+, 313.48, found 312.86. 
 
(S)-Diethyl 2-(4-benzyl-2-oxooxazolidin-3-yl)-2-oxoethylphosphonate (125) 
 
N O
OO
P
EtO
O
OEt
Ph
Chemical Formula: C16H22NO6P
Molecular Weight: 355.3227
 
 
A stirred solution of 131 (2 g, 6.71 mmol) in triethylphosphite (10 ml) was refluxed 
for 12 h, allowed to cool to room temperature and directly transferred on top of a 
silica gel column. Flash chromatography (ethyl acetate/cyclohexane = 5:1) 
furnished the desired product 125 (yield: 1.91 g, 5.4 mmol, 80%) as a viscous 
colourless oil.  
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TLC (ethyl acetate/cyclohexane = 1:1): Rf = 0.1; 1H NMR (CDCl3):  = 7.33-7.23 
(m, 5H), 4.70 (m, 1H), 4.18 (m, 6H), 3.80 (m, 2H), 3.35 (dd, J = 3.3, 13.4 Hz, 1H), 
2.75 (dd, J = 9.8, 13.4 Hz, 1H), 1.35 (t, J = 7.0 Hz, 6H); 13C NMR (CDCl3):  = 
165.2, 164.9, 153.5, 135.3, 129.6, 129.1, 127.5, 66.2, 62.9, 55.6, 37.8, 35.1, 33.9, 
16.5; HRMS: Calcd. for C16H23NO6P: [M+1]
+ 356.3227, found 356.1255. 
 
2,2,5-trimethyl-4H-benzo[d]dioxin-4-one (127) 
 
O
O
O Chemical Formula: C11H12O3
Molecular Weight: 192.2112
 
 
126 (1.93 g, 10.7 mmol) was dissolved in 10% NaOH/EtOH solution (20 ml) and 
refluxed for 2 h. The ethanol solution was acidified and extracted with acetyl 
acetate. The solvent was removed and the intermediate was used for the next step.  
To a solution of 6-methylsalicylic acid (1.62 g, 10.7 mmol), DMAP (67 mg, 0.55 
mmol) and acetone (0.96 ml, 13 mmol) in dimethoxyethane (3.6 ml) was added 
dropwise a solution of thionylchloride (1.1 ml, 15 mmol) in dimethoxyethane (0.5 
ml). The temperature was maintained below 30 °C. The reaction mixture was 
stirred for 3 h, after which it was concentrated. The crude product was purified by 
silica gel chromatography (ethyl acetate/cyclohexane = 1:2) to obtain 127 (yield: 
1.82 g, 9.5 mmol, 89%) as a colourless solid.  
 
TLC (ethyl acetate/cyclohexane = 1:2): Rf = 0.55; 1H NMR (CDCl3):  = 7.37 (t, J 
= 7.8 Hz, 1H), 6.91 (d, J = 7.6 Hz, 1H), 6.79 (dq, J = 0.5, 8.2 Hz, 1H), 2.67 (s, 3H), 
1.70 (s, 6H); 13C NMR (CDCl3):  160.60, 156.98, 143.53, 135.01, 125.70, 115.02, 
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112.46, 105.13, 25.67, 21.94; LC-MS (ESI): tR = 11.04 min, calcd. for C11H13O3 
[M+H]+, 193.21, found 193.00. 
 
5-(bromomethyl)-2,2-dimethyl-4H-benzo[d]dioxin-4-one (128) 
 
O
O
O
Br
Chemical Formula: C11H11BrO3
Molecular Weight: 271.1072
 
 
A solution of 127 (1.55 g, 8 mmol), N-bromosuccinimide (1.56 g, 8.8 mmol) and 
AIBN (197 mg, 0.8 mmol) in carbon tetrachloride (20 ml) was refluxed for 15 h. 
The reaction mixture was filtered, and the filtrate was concentrated in vacuo. The 
crude product was dissolved in ethyl acetate, and the organic phase was washed 
with water, brine and dried over Na2SO4. The crude product was purified by silica 
gel chromatography (ethyl acetate/cyclohexane = 1:2) to obtain 128 (yield: 2.15 g, 
7.9 mmol, 99%) as a white solid.  
 
TLC (ethyl acetate/cyclohexane = 1:2): Rf = 0.61; 1H NMR (CDCl3):  = 7.47 (dd, 
J = 7.6, 8.2 Hz, 1H), 7.16 (d, J = 7.6 Hz, 1H), 6.94 (dd, J = 1.1, 8.2 Hz, 1H), 5.05 
(s, 2H), 1.72 (s, 6H); 13C NMR (CDCl3):  = 159.70, 157.26, 141.76, 135.57, 
125.75, 117.99, 111.45, 105.70, 30.85, 25.58; LC-MS (ESI): tR = 10.05 min, calcd. 
for C11H12BrO3 [M+H]
+, 271.99, found 271.07. 
 
[(2S, 3S)-3-methyloxiran-2-yl] methanol (129) 
 
OH
O Chemical Formula: C4H8O2
Molecular Weight: 88.1051  
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Molecular sieves (4 g, 4 Å) in a Schlenk flask were carefully dried under reduced 
pressure (ca. 0.1 mbar). In an argon atmosphere, DCM (150 ml) was cooled to – 20 
°C.  L-(+) isopropyl tartrate (1 g, 4.3 mmol), (E)-2-buten-1-ol (5 g, 69.4 mmol) and 
titanium (IV)-isopropoxide (1 g, 10 mmol) were added. After stirring for 15 min at 
-20 °C, tert-butyl hydroperoxide solution (23.6 ml, 5.5 M) was added dropwise. 
The mixture was stirred for 2 h at -20 °C. Then, tributylphosphine (17.1 ml) was 
added to the reaction mixture until no peroxides were detected. The solvent was 
removed under reduced pressure; the residue was distilled using a Vigreux column 
(13 mbar, 64 °C) to give pure product 129 (yield: 3.3 g, 37.5 mmol, 54%) as 
colorless liquid.  
 
B.p. = 64 °C at 13 mbar; 1H NMR (CDCl3):  = 3.89 (dd, J = 12.6, 2.16 Hz, 1H), 
3.61 (dd, J = 12.6, 3.92 Hz, 1H), 3.03 (q, J = 2.32 Hz, 1H), 2.88 (t, J = 2.16 Hz, 
1H), 1.86 (br s, 1H), 1.33 (d, J = 5.28 Hz, 3H); 13C NMR (CDCl3):  = 61.73, 
59.52, 52.06, 17.29. 
 
3-(tert-Butyldiphenylsilyloxy)-propanol (130) 
 
TBDPSO OH Chemical Formula: C19H26O2Si
Molecular Weight: 314.4940  
 
To a stirred solution of propanediol (5.8 g, 76.4 mmol) in DCM (50 ml) was added 
DIPEA (5.2 ml, 38.2 mmol) at 0 oC under an inert atmosphere. After 10 min, 
TBDPSCl (7.0 g, 25.5 mmol) in DCM was added at 0 
oC and stirred for 12 h at 
room temperature. Water was added and the organic layer was separated. The 
aqueous layer was re-extracted with DCM.  The combined organic layers were 
washed with brine, dried, evaporated and the residue was purified by silica gel 
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chromatography (ethyl acetate/cyclohexane = 1:2) to obtain 130 (yield: 7.2 g, 23 
mmol, 90%) as a viscous liquid. 
 
TLC (ethyl acetate/cyclohexane = 1:2): Rf = 0.4; 1H NMR (CDCl3):  = 7.68 (m, 4 
H), 7.42 (m, 6H), 3.84 (m, 4H), 1.81 (m, 2H), 1.06 (s, 9H); 13C NMR (CDCl3):  = 
135.7, 133.4, 129.9, 127.9, 63.4, 62.1, 34.4, 27.0, 19.2; LC-MS (ESI): tR = 12.04 
min, calcd. for C19H27O2Si [M+H]
+, 315.49, found 315.07. 
 
(S)-4-Benzyl-3-(2-bromoacetyl)oxazolidin-2-one (131) 
 
N O
OO
Br
Ph
Chemical Formula: C12H12BrNO3
Molecular Weight: 298.1326
 
 
To a solution of (2R)-4-(phenyl methyl)-2-oxazolidinone (4 g, 22.5 mmol) in 
anhydrous THF (50 ml) at – 78 oC was added n-butyl lithium (15.5 ml, 31.5 mmol, 
1.6 M in hexane), followed by bromoacetyl bromide (2.76 ml, 24.8 mmol). The 
solution was stirred at -78 oC for 10 min and then the cooling bath was removed. 
After 20 min, the reaction was quenched by addition of sat. aqueous NH4Cl (50 ml) 
and the residue was extracted with DCM. The organic phases were dried over 
Na2SO4 and concentrated. The crude product was purified by silica gel 
chromatography (ethyl acetate/cyclohexane = 1:2) to obtain 131 (yield: 6.3 g, 21 
mmol, 94%) as a yellow oil.  
 
TLC (ethyl acetate/cyclohexane = 1:2): Rf = 0.28; 1H NMR (CDCl3, 400 MHz):  = 
7.34 (m, 3H), 7.21 (m, 2H), 4.70 (m, 1H), 4.55 (d, J = 12.7 Hz, 1H), 4.52 (d, J = 
12.7 Hz, 1H), 4.25 (m, 2H), 3.33 (dd, J = 3.3, 13.4 Hz, 1H), 2.81 (dd, J = 9.5, 13.4 
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Hz, 1H); 13C NMR (CDCl3):  = 166.1, 153.1, 134.9, 129.6, 129.2, 127.7, 66.8, 
55.6, 37.7, 28.3; LC-MS (ESI): tR = 9.46 min, calcd. for C12H13BrNO3 [M+H]
+, 
298.56, found 298.27. 
 
(S,E)-4-Benzyl-3-(5-(tert-butyldiphenylsilyloxy)pent-2-enoyl)oxazolidin-2-one 
(132) 
 
N
O
OO
Ph
TBDPSO
Chemical Formula: C31H35NO4Si
Molecular Weight: 513.6994
 
 
To a solution of 125 (1 g, 3.2 mmol) in anhydrous THF (20 ml) at 0 oC was added 
NaHMDS (0.586 g, 3.2 mmol), leading to a hazy orange solution, to which was 
added a solution of 124 (1.13 g, 3.2 mmol) in anhydrous THF (14 ml). The reaction 
mixture was allowed to warm to room temperature and stirred for 1 h before it was 
poured into ethyl acetate and sat. aqueous NH4Cl. The layers were separated and 
the aqueous layer was extracted with ethyl acetate. The combined organic extracts 
were dried with Na2SO4, and concentrated in vacuo. The crude product was 
purified by silica gel chromatography (ethyl acetate/cyclohexane = 1:2) to obtain 
132 (yield: 1.4 g, 2.7 mmol, 85%) as a colourless oil.  
 
TLC (ethyl acetate/cyclohexane = 1:2): Rf = 0.65; 1H NMR (CDCl3):  = 7.68 (m, 
4H), 7.46-7.19 (m, 13H), 4.77-4.69 (m, 1H), 4.23-4.14 (m, 2H), 3.81 (t, J = 6.3 Hz, 
2H), 3.33 (dd, J = 3.2, 13.3 Hz, 1H), 2.80 (dd, J = 9.5, 13.3 Hz, 1H), 2.54 (q, J = 
6.3 Hz, 2H), 1.06 (s, 9H); 13C NMR (CDCl):  = 164.8, 153.3, 148.4, 135.6, 135.4, 
133.6, 133.6, 129.7, 129.4, 128.9, 127.7, 127.3, 122.0, 66.1, 62.4, 55.3, 37.9, 36.0, 
26.8, 19.2; HRMS: Calcd. for C31H36NO4Si [M+H]
+ 514.6994, found 514.2404.  
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(S)-4-Benzyl-3-((S)-5-(tert-butyldiphenylsilyloxy)-2-((R)-1-hydroxyethyl)pent-
3-enoyl) oxazolidin-2-one (133) 
 
TBDPSO
OH
O
N
O
O
Ph Chemical Formula: C33H39NO5Si
Molecular Weight: 557.7520  
 
To a solution of 132 (1.2 g, 2.34 mmol) in anhydrous DCM (20 ml), TEA (0.445 
ml, 3.26 mmol) and Bu2BOTf (2.8 mL, 2.8 mmol, 1.0 M in DCM) were added at -
78oC. The mixture was stirred for 1 h at -78 oC and 1 h at 0 oC. Acetaldehyde 
(0.262 ml, 4.6 mmol) in DCM (1 mL) was added dropwise at -78 
oC. The mixture 
was stirred for 2 h at -78 oC and 2 h at 0 oC. The reaction was quenched with a 
mixture of phosphate buffer pH 7, MeOH and H2O2 (1:1:1, 15 ml) and the mixture 
was kept under vigorous stirring overnight. The product was then extracted with 
ethyl acetate and the combined extracts were washed with water and brine, dried 
over Na2SO4, and concentrated under reduced pressure. The crude product was 
purified by silica gel chromatography (ethyl acetate/cyclohexane = 1:2) to obtain 
133 (yield: 1.2 g, 2.1 mmol, 91%) as a light yellow oil.  
 
[]20D = +18.97 (c = 0.78, CDCl3); TLC (ethyl acetate/cyclohexane = 1:2): Rf = 
0.16; 1H NMR (CDCl3):  = 7.72 (m, 4H), 7.46 (m, 6H), 7.29 (m, 3H), 7.18 (m, 
2H), 5.94 (d, J = 6.08 Hz, 1H), 4.72 (m, 1H), 4.52 (m, 1H), 4.28-4.14 (m, 5H), 3.22 
(dd, J = 9.36, 13.36 Hz, 1H), 2.70 (dd, J = 9.36, 13.36 Hz, 1H), 1.20 (d, J = 6.24 Hz, 
3H), 1.07 (s, 9H); 13C NMR (CDCl3):  = 174.3, 153.1, 136.3, 135.7, 135.1, 133.7, 
129.8, 129.60, 127.8, 123.9, 123.0, 66.1, 64.2, 60.5, 55.2, 52.2, 48.7, 37.7, 27.0, 
20.0, 19.3; HRMS: Calcd. for C33H40NO5Si [M+H]
+ 558.7520, found 558.2667. 
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(S)-4-Benzyl-3-((S)-5-(tert-butyldiphenylsilyloxy)-2-((S)-1-para-
nitrobenzoicylethyl)pent-3- enoyl)oxazolidin-2-one (134) 
 
TBDPSO
O
O
N
O
O
Ph
O
NO2
Chemical Formula: C40H42N2O8Si
Molecular Weight: 706.8556
 
 
To an ice-cooled solution of 133 (0.84 g, 1.5 mmol) in THF (50 ml) were added 
para-nitrobenzoic acid (0.5 g, 3 mmol), triphenylphosphine (0.79 g, 3 mmol) and 
dropwise di-iso-propyl azodicarboxylate (627 μl, 3 mmol). The reaction mixture 
was stirred for 30 min at 0 oC and 30 min at room temperature. After concentration 
in vacuo, the residue was purified by silica gel chromatography (ethyl 
acetate/cyclohexane = 1:2) to obtain 134 (yield: 0.96 g, 1.36 mmol, 91%) as a 
yellow oil. 
 
TLC (ethyl acetate/cyclohexane = 1:2): Rf = 0.5; 1H NMR (CDCl3):  = 7.65 (m, 
5H), 7.46-7.32 (m, 14H), 6.69 (m, 1H), 5.85 (m, 1H), 4.69 (m, 1H), 4.29 (m, 2H), 
4.14 (m, 4H), 3.42 (dd, J = 9.36, 13.36 Hz, 1H), 2.72 (dd, J = 9.36, 13.36 Hz, 1H), 
1.86 (d, J = 6.24 Hz, 3H), 1.07 (s, 9H); 13C NMR (CDCl3):  = 181.4, 169.5, 135.3, 
134.9, 134.2, 133.2, 130.5, 129.4, 129.1, 128.7, 127.4, 121.8, 121.4, 65.8, 63.8, 
55.0, 37.6, 26.6, 21.3, 18.9, 13.3; LC-MS (ESI): tR = 13.10 min, calcd. for 
C40H43N2O8Si [M+H]
+, 707.86, found 707.32. 
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(S)-4-benzyl-3-((S)-5-(tert-butyldiphenylsilyloxy)-2-((S)-1-hydroxyethyl)pent-3-
enoyl) oxazolidin-2-one (135) 
 
TBDPSO
OH
O
N
O
O
Ph Chemical Formula: C33H39NO5Si
Molecular Weight: 557.7520
 
 
To a solution of 134 (0.96 g, 1.36 mmol) in MeOH (50 mL) was added K2CO3 
(0.414 g, 3 mmol). After stirring for 2 h at room temperature, the reaction mixture 
was filtered and then evaporated. The residue was purified by silica gel 
chromatography (ethyl acetate/cyclohexane = 1:2) to obtain 135 (yield: 0.6 g, 1.07 
mmol, 79%) as a colourless oil. 
 
[]20D = -5.19 (c = 0.67, CDCl3); TLC (ethyl acetate/cyclohexane = 1:2): Rf = 0.2; 
1H NMR (CDCl3):  = 7.72 (m, 4H), 7.46 (m, 6H), 7.29 (m, 3H), 7.18 (m, 2H), 
6.52 (m, 2H), 5.68 (m, 2H), 4.24 (m, 3H), 4.14 (m, 1H), 3.66 (m, 2H), 2.86 (m, 2H), 
2.45 (br s, 1H), 1.76 (d, J = 6.24 Hz, 3H), 1.08 (s, 9H); 13C NMR (CDCl3):  = 
169.4, 137.7, 135.7, 135.6, 134.8, 133.6, 132.3, 129.9, 129.3, 128.8, 126.9, 122.7, 
121.4, 69.8, 65.2, 64.0, 53.5, 37.0, 27.0, 19.4, 14.0; LC-MS (ESI): tR = 12.43 min, 
calcd. for C33H40NO5Si [M+H]
+, 558.75, found 558.42. 
 
tert-Butyl-((4R,5R)-5-methoxy-4-((tetrahydro-2H-pyran-2-yloxy)methyl)hex-2-
enyloxy)diphenylsilane (137) 
 
TBDPSO
O
OTHP
Chemical Formula: C29H42O4Si
Molecular Weight: 482.7269  
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To a solution of 136 (0.8 g, 1.4 mmol) and methanol (115 μl, 2.8 mmol) in diethyl 
ether (25 ml) was added LiBH4 (62 mg, 2.8 mmol) at 0 °C. After stirring for 2 h, 
the resulting mixture was warmed to room temperature and stirred for 1 h. The 
reaction mixture was quenched with sat. NH4Cl and extracted with ethyl acetate. 
The combined organic extracts were washed with brine, dried over Na2SO4 and 
concentrated in vacuo. The residue was purified by silica gel chromatography 
(ethyl acetate/cyclohexane = 1:2) to obtain the intermediate (yield: 0.52 g, 1.3 
mmol, 93%) as a colourless oil. 
 
TLC (ethyl acetate/cyclohexane = 1:2): Rf = 0.5;  
 
To a solution of the above intermediate (0.46 g, 1.14 mmol) in DCM (20 ml) were 
added DHP (0.32 mL, 3.5 mmol) and PPTS (28 mg, 0.11 mmol) at room 
temperature. After 5 h, the mixture was quenched by addtion of  NaHCO3, the 
organic layer was separated and the aqueous layer was re-extracted. The combined 
organic layers were dried over Na2SO4, concentrated and the crude product was 
purified by silica gel chromatography (ethyl acetate/cyclohexane = 1:9) to obtain 
product 137 (yield: 0.43 g, 0.9 mmol, 80%) as a colourless oil. 
 
TLC (ethyl acetate/cyclohexane = 1:9): Rf = 0.67; 1H NMR (CDCl3):  = 7.68 (m, 
4H), 7.38 (m, 6H), 5.82 (m, 1H), 5.68 (m, 1H), 4.55 (m, 1H), 4.27 (m, 1H), 4.18 (m, 
1H), 3.73 (m, 2H), 3.54-3.33 (m, 3H), 3.31 (s, 3 H), 2.48 (m, 1H), 1.87-1.43 (m, 
6H), 1.10 (d, J = 6.3 Hz, 3H), 1.04 (s, 9H); 13C NMR (CDCl3):  = 134.6, 133.9, 
132.0, 129.5, 128.3, 127.6, 99.0, 98.8, 76.5, 67.9, 67.8, 64.7, 62.2, 56.7, 48.2, 47.9, 
30.7, 26.9, 26.8, 25.5, 19.5, 19.2, 16.6. 
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(4R, 5R)-5-Methoxy-4-((tetrahydro-2H-pyran-2-yloxy)methyl)hex-2-en-1-ol 
(138) 
 
HO
O
OTHP
Chemical Formula: C13H24O4
Molecular Weight: 244.3273  
 
To a solution of 137 (0.36 g, 0.74 mmol) in THF (30 ml), TBAF (0.26 g, 0.82 
mmol) was added at room temperature. After 3 h, the reaction mixture was 
quenched by addition of sat. aqueous NH4Cl and extracted with ethyl acetate. The 
organic layer was washed with water and brine, dried over Na2SO4, and 
concentrated in vacuo. The crude product was purified by silica gel 
chromatography (ethyl acetate/cyclohexane = 1:2) to obtain product 138 (yield: 
0.15 g, 0.63 mmol, 85%) as a yellow oil. 
 
TLC (ethyl acetate/cyclohexane = 1:2): Rf = 0.23; 1H NMR (Acetone-d6):  = 5.68 
(m, 1H), 5.58 (m, 1H), 4.56 (t, J = 8.4 Hz, 1H), 4.03 (m, 2H), 3.80 (m, 1H), 3.55 (m, 
2H), 3.45 (m, 1H), 3.28 (s, 3H), 3.25 (m, 1H), 2.76 (t, J = 1.0 Hz, 1H); 2.35 (m, 
1H), 1.85-1.40 (m, 6H), 1.07 (d, J = 8.2 Hz, 3H); 13C NMR (Acetone-D6):  = 
135.3, 129.6, 100.5, 77.7, 69.7, 64.3, 63.3, 57.7, 50.3, 32.5, 27.4, 21.2, 17.9; LC-
MS (ESI): tR = 7.32 min, calcd. for C13H25O4 [M+H]
+, 245.33, found 245.01. 
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5-((1E,3E,5R,6R)-6-Methoxy-5-((tetrahydro-2H-pyran-2-yloxy)methyl)hepta-
1,3-dienyl)-2,2-dimethyl-4H-benzo[d][1,3]dioxin-4-one (139) 
 
O
OTHP
O O
O
Chemical Formula: C24H32O6
Molecular Weight: 416.5073
 
 
To a solution of 138 (120 mg, 0.48 mmol) in DCM (15 mL) was added NaHCO3 
(81 mg, 1 mmol) and DMP (312 mg, 0.73 mmol). The mixture was stirred at 0 °C 
for 45 min and quenched by addition of aqueous Na2S2O3 and aqueous NaHCO3. 
The layers were separated and the organic phase was extracted with diethyl ether. 
The combined organic layers were washed with brine, dried over Na2SO4 and 
concentrated in vacuo to give the crude aldehyde intermediate (105 mg) which was 
used immediately.  
 
To a solution of 112 (141 mg, 0.43 mmol) and the above aldehyde intermediate 
(105 mg, 0.43 mmol) in anhydrous THF (10 ml) was added KOtBu (50 mg, 0.45 
mmol) at 0 oC and stirred for 1 h. The reaction mixture was quenched by addition 
of NH4Cl and extracted with ethyl acetate. The organic layer was separated, dried, 
concentrated and the crude product was purified by silica gel chromatography 
(ethyl acetate/cyclohexane = 1:1) to obtain product 139 (yield: 100 mg, 0.24 mmol, 
57%) as a colourless oil. 
 
TLC (ethyl acetate/cyclohexane = 1:1): Rf = 0.62; 1H NMR (CDCl3):  = 7.63 (d, J 
= 14.7 Hz, 1H), 7.42 (t, J = 7.9 Hz, 1H), 7.29 (d, J = 8 Hz, 1H), 6.80 (q, J = 8.2 Hz, 
2H), 6.42 (m, 1H), 5.85 (m, 1H), 4.59 (t, J = 3.4 Hz, 1H), 3.89 (m, 2H), 3.75 (m, 
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3H), 3.34 (s, 3H), 2.48 (m, 1H), 1.88-1.74 (m, 2H), 1.70 (s, 6H), 1.64-1.46 (m, 4H), 
1.14 (d, J = 6.8 Hz, 3H); 13C NMR (CDCl3):  = 157.1, 135.1, 134.4, 134.3, 133.9, 
128.6, 120.8, 115.9, 105.2, 99.3, 98.9, 68.1, 62.4, 56.9, 49.1, 30.8, 27.0, 25.8, 19.7, 
17.0. 
 
5-((1E,3E,5R,6R)-5-(Hydroxymethyl)-6-methoxyhepta-1,3-dienyl)-2,2-
dimethyl-4H-benzo[d][1,3]dioxin-4-one (140) 
 
O
OH
O O
O
Chemical Formula: C19H24O5
Molecular Weight: 332.3909
 
 
To a stirred solution of 139 (90 mg, 0.22 mmol) in methanol (15 ml) were added 
catalytic amounts of PPTS (12 mg) at 0 oC under an inert atmosphere. The reaction 
mixture was stirred for 2 days at room temperature. The solvent was removed 
under reduced pressure and the residue was purified by silica gel chromatography 
(ethyl acetate/cyclohexane = 1:1) to obtain product 140 (yield: 46 mg, 0.14 mmol, 
66%) as a colourless oil. 
 
TLC (ethyl acetate/cyclohexane = 1:1): Rf = 0.21; 1H NMR (CDCl3):  = 7.65 (d, J 
= 15.6 Hz, 1H), 7.43 (t, J = 7.9 Hz, 1H), 7.29 (d, J = 7.9 Hz, 1H), 6.80 (m, 2H), 
6.42 (m, 1H), 5.83 (dd, J = 9.1, 15.2 Hz, 1H), 3.82-3.61 (m, 3H), 3.36 (s, 3H), 2.52 
(m, 1H), 1.70 (s, 6H), 1.16 (d, J = 6.24 Hz, 3H); 13C NMR (CDCl3):  = 160.6, 
157.1, 141.9, 135.2, 134.3, 133.2, 132.5, 129.4, 128.1, 120.8, 116.1, 105.3, 79.2, 
64.6, 56.7, 50.1, 25.8, 16.2; IR (neat): 3435, 2928, 1725, 1042 cm-1; LC-MS (ESI): 
tR = 8.24 min, calcd. for C19H25O5 [M+H]
+, 333.39, found 333.22. 
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5-((1E,3E,5R,6R)-5-Formyl-6-methoxyhepta-1,3-dienyl)-2,2-dimethyl-4H-
benzo[d][1,3]dioxin-4-one (141) 
 
O
O
O O
O
Chemical Formula: C19H22O5
Molecular Weight: 330.3750
 
 
To a solution of 140 (40 mg, 0.12 mmol) in DCM (5 ml) was added NaHCO3 (21 
mg, 0.25 mmol) and DMP (0.08 g, 0.18 mmol). The resulting mixture was stirred at 
0 °C for 30 min and directly transferred on top of a silica gel column. Flash 
chromatography (ethyl acetate/cyclohexane = 1:1) furnished the desired 141 (yield: 
33 mg, 0.1 mmol, 86%) as a colourless oil, which was used immediately.  
 
TLC (ethyl acetate/cyclohexane = 1:1): Rf = 0.56. 
 
5-((1E,3E,5R,6R)-5-(1-Hydroxyl-2-diethylphosphonyl-propyl)-6-
methoxyhepta-1,3-dienyl)-2,2-dimethyl-4H-benzo[d][1,3]dioxin-4-one (142) 
 
O
O O
O OH
P OEt
OEt
O
Chemical Formula: C25H37O8P
Molecular Weight: 496.5302
 
 
To a solution of diethylethylphosphonate (50 mg, 0.3 mmol) in THF (1 ml) at -78 
°C was added n-BuLi (125 μl, 0.2 mmol, 1.6 M in hexanes) dropwise. The reaction 
mixture was stirred for 15 min and then a solution of 141 (33 mg, 0.1 mmol) in 
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THF (1 ml) was added dropwise. The dark yellow solution was stirred at - 78 °C 
for 1h, and a sat. NH4Cl solution (2 ml) was added. The mixture was diluted with 
water (2 ml) and the organic layer was separated, dried over Na2SO4, and 
concentrated in vacuo. The residue was purified by silica gel chromatography 
(ethyl acetate/cyclohexane = 1:1) to obtain product 142 (yield: 11 mg, 23 μmol, 
23%) as a yellow oil, which was inpure due to remaining impurity. 
 
TLC (ethyl acetate/cyclohexane = 1:1): Rf = 0.47; LC-MS (ESI): tR = 7.67 min, 
calcd. for C25H38O8P [M+H]
+, 497.53, found 497.26. 
 
5-((1E,3E,6R)-6-Methoxyhepta-1,3-dienyl)-2,2-dimethyl-4H-
benzo[d][1,3]dioxin-4-one (144) 
 
O
O O
O
Chemical Formula: C18H22O4
Molecular Weight: 302.3649
 
 
To a solution of 112 (435 mg, 1.33 mmol) in anhydrous THF (5 ml) was added 
KOtBu (145 mg, 1.3 mmol) at 0 °C. After the reaction mixture turns red, 146 (170 
mg, 1.33 mmol) in anhydrous THF (4 ml) was added. The reaction mixture was 
stirred at 0 °C for 1 h and at room temperature for 1 h, quenched by addition of sat. 
NH4Cl and extracted with ethyl acetate. The organic layer was separated, dried over 
Na2SO4, and concentrated in vacuo. The residue was purified by silica gel 
chromatography (ethyl acetate/cyclohexane = 1:5) to obtain pure product 144 (yield: 
321 mg, 1.06 mmol, 80%) as a yellow oil.  
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TLC (ethyl acetate/cyclohexane = 1:5): Rf = 0.27; 1H NMR (CDCl3):  = 7.59 (d, J 
= 15.6 Hz, 1H), 7.38 (t, J = 8 Hz, 1H), 7.29 (q, J = 7.8 Hz, 1H), 6.76 (m, 2H), 6.35 
(m, 1H), 5.86 (m, 1H), 3.38 (q, J = 6.08 Hz, 1H), 3.32 (s, 3H), 2.31 (m, 2H), 1.68 (s, 
6H), 1.14 (d, J = 6.04 Hz, 3H); 13C NMR (CDCl3):  = 160.5, 157.0, 142.1, 135.1, 
133.5, 133.2, 133.1, 128.4, 120.7, 115.8, 110.7, 105.2, 76.6, 56.2, 39.5, 25.7, 19.1; 
LC-MS (ESI): tR = 11.20 min, calcd. for C18H23O4 [M+H]
+, 303.36, found 303.07. 
 
5-Methoxy-(2E)-hexenal (146) 
 
O
O Chemical Formula: C7H12O2
Molecular Weight: 128.1690  
 
To a solution of 5-(S)-Hydroxy-(2E)-hexenal (500 mg, 4.38 mmol) and 2,6-di-tert-
butyl-4-methylpyridine (1.17 g, 5.7 mmol) in anhydrous DCM (8 ml) was added 
methyltriflate (645 μl, 5.7 mmol) at room temperature. After stirring overnight, the 
mixture was directly transferred on top of a silica gel column. Flash 
chromatography (ethyl acetate/petroleum ether = 1:2) furnished the desired 146 
(yield: 504 mg, 3.9 mmol, 90%). However it could not be obtained as pure 
compound due to its low boiling point, and used directly for the next reaction. 
 
B.p. = 33 °C at 16 mbar; TLC (ethyl acetate/petroleum ether = 1:2): Rf = 0.52. 
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1-Methyl-(3S,4S)-oxirane-(2E)-hexenoic acid (147) 
 
O
O
HO
Chemical Formula: C7H10O3
Molecular Weight: 142.1525  
 
To a 0.1 M NaOH solution (THF/H2O 1:1, 10 ml) was added 150 (167 mg, 1.1 
mmol) at room temperature for 3 h. The unreacted 150 was removed by addition of 
ethyl acetate and extraction. The aqueous phase was acidfied by addition of 0.1 M 
HCl to pH 4 and the product was extracted by addition of ethyl acetate. The organic 
layer was dried over Na2SO4 and concentrated in vacuo. The residue was purified 
by silica gel chromatography (methanol/DCM = 1:9) to obtain pure product 147 
(yield: 79 mg, 0.56 mmol, 51%) as a viscous colourless oil.  
 
TLC (methanol/DCM = 1:9): Rf = 0.48; 1H NMR (MeOD):  = 6.65 (d, J = 9.1 Hz, 
1H), 4.20 (dd, J = 6.24, 9.16 Hz, 1H), 3.68 (m, 1H), 1.88 (s, 3H), 1.12 (d, J = 6.44 
Hz, 3H); 13C NMR (MeOD):  = 171.3, 141.7, 131.4, 73.6, 71.5, 18.7, 13.4. 
 
5-Hydroxy-(2E)-hexenal (148) 
 
OH
O Chemical Formula: C6H10O2
Molecular Weight: 114.1424  
 
A mixture of THF/acetaldehyde (4:1, 500 ml) and L-proline (1.2 g) was stirred for 
14 h at 4 °C. The crude reaction mixture was filtered through silica gel and 
concentrated in vacuo. The residue was then purified by silica gel chromatography 
(ethyl acetate/petroleum ether = 1:1) to obtain pure product 148 (yield: 3.2 g, 28 
mmol) as a colourless oil.  
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TLC (ethyl acetate/petroleum ether = 1:1): Rf = 0.38. The obtained NMR 
spectrums were in accordance to the literature values. 
 
Methyl (triphenylphosphoranylidene)propionate (149) 
 
OMe
O
PPh3
Chemical Formula: C22H21O2P
Molecular Weight: 348.3747  
 
A mixture of triphenylphosphine (2.11 g, 8.06 mmol) and methyl bromopropionate 
(1.00 ml, 8.96 mmol) in H2O (10 mL) was stirred for 24 h at 70 °C. The mixture 
was cooled to room temperature, then a solution of NaOH (716 mg, 17.9 mmol) in 
H2O (21 mL) was added. The resulting mixture was stirred for 5 min at room 
temperature, then DCM was added to redissolve the suspension formed overnight. 
The organic layer was separated, and the aqueous layer was extracted with DCM. 
The combined organic layers were dried over Na2SO4 and concentrated. The 
residue was triturated with hexane and filtered. The resulting residue was dried in 
vacuo to give 149 (2.66 g, 7.64 mmol, 95%) as a light yellow solid.  
 
The obtained NMR spectrums were in accordance to the literature values. 
 
1-methyl-(3S,4S)-oxirane-(2E)-hexenoic methyl ester (150) 
 
O
O
O
Chemical Formula: C8H12O3
Molecular Weight: 156.1791  
 
To a solution of 129 (317 mg, 3.6 mmol) and 149 (1.5 g, 4.33 mmol) in DCM (90 
ml) was added MnO2 (2.5 g, 29 mmol) at room temperature. The resulting mixture 
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was stirred for 2 days and then filtrated through Celite and washed with DCM. The 
filtrate was concentrated. The residue was purified by silica gel chromatography 
(ethyl acetate/petroleum ether = 1:5) to obtain pure product 150 (yield: 546 mg, 3.5 
mmol, 97%) as a colourless oil.  
 
TLC (ethyl acetate/petroleum ether = 1:5): Rf = 0.47; 1H NMR (CDCl3):  = 6.28 
(d, J = 8.8 Hz, 1H), 3.74 (s, 3H), 3.31 (dd, J = 1.76, 8.8 Hz, 1H), 3.03 (m, 1H), 2.00 
(s, 3H), 1.39 (d, J = 5.28 Hz, 3H); 13C NMR (CDCl3):  = 167.8, 138.4, 132.4, 56.4, 
55.6, 52.2, 17.7, 13.1; LC-MS (ESI): tR = 7.99 min, calcd. for C8H12O3 [M]
+, 156.18, 
found 156.93. 
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6.2 Biological part 
6.2.1 Material of bioassays 
Chemicals, antibiotics and inhibitors 
 
All chemicals and antibiotics were purchased from Sigma, Roth, Merck and 
Duchefa. DCG-04 was provided by Dr. H. Overkleeft (Leiden University, 
Netherlands) and Dr. M. Bogyo (Stanford Medical School, US). “Click Chemistry” 
trifunctional tag was provided by Dr. B. F. Cravatt (Skaggs Institute for Chemical 
Biology, US). Inhibitors for competition assays were purchased from Sigma, 
Bachem, Fluka, Calbiochem and from labs of Dr. Dr. H. Overkleeft, Dr. M. Bogyo, 
Dr. B. F. Cravatt and Dr. S. Q. Yao (National University of Singapore). 
 
Enzymes 
 
Restriction enzymes were purchased from Fermentas and New England Biolabs. 
Taq polymerase for standard PCR was purchased from Promega and BioBudget. 
High-fidelity polymerase was purchased from Roche. Ligase was purchased from 
Promega and Fermentas. Wheat germ lipase Type I and Pseudomonas fluorescence 
lipase were purchased from Sigma-aldrich.  
  
Vectors 
 
Plasmid pFK26 was supplied by Dr. F. Kaschani at MPIZ (Colonge, Germany). 
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Kits and primers 
 
Oligonucleotide primers were purchased from Invitrogen. Kits for isolating DNA 
were purchased from Qiagen (Hilden, Germany). Kits for isolating Plasmid were 
purchased from Peqlab (Erlangen, Germany) or Macherey-Nagel (Duren, 
Germany). 
 
Pathogens 
 
Pseudomonas syringea pv. tomato strain DC3000 (Pst) was obtained from Dr. 
Silke Robatzek and Dr. Jane Parker at the MPIZ (Cologne, Germany). 
Pseudomonas syringea pv. tomato DC3000 carrying AvrPphB was obtained from 
lab of Dr. R. A. van der Hoorn at MPIZ (Cologne, Germany). 
 
Bacterial strains 
 
Cloning was applied with Escherichia coli strain DH10B. Agrobacterium-
infiltration and plant transformation was utilized with Agrobacterium tumefaciens 
strain GV3101. 
  
Plant material 
 
The Arabidopsis thaliana was carried out using ecotype Columbia (Col-0). -VPE 
overexpressor and knockout lines described in (Rojo et al., 2003 and Rojo et al., 
2004) and quadrupole mutant of VPE described in (Gruis et al., 2004) were used 
for labelling assays. Arabidopsis thaliana ecotype Landsberg cell suspension 
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culture was obtained from Sainsbury lab (John Innes centre, Norwich, UK). N. 
benthamiana (310A) were grown at the MPIZ (Cologne, Germany). 
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6.2.2 Methods of bioassays 
Plant growth conditions 
 
Arabidopsis used for labelling assays were grown in two different ways: long day 
(16:8 day/night regime) or short day condition (12:12 day/night regime). Four to 
five weeks old plants were applied for labelling assays. N. benthamiana were 
grown in a climate chamber at a 14 h light regime at 18°C (night) and 22°C (day). 
Four to six weeks old plants were applied for agroinfiltration.  
All the plants were planted by labmates from plant chemetics lab and workers in 
MPIZ. 
 
Preparation of leaf extracts 
 
The leaves of Arabidopsis were usually 1 cm long and 0.5 cm broad. The well 
growing leaves, without speckles on the surface, were used for assays.  
 
a. Extraction with 10% triton TX-100 
 
Leaves in an Eppendorf tube (1.5 ml) with water (100 μl) were grinded with a blue 
stick (sigma C7353). After that, water (890 μl) was added with 10% triton TX-100 
(10 μl). The mixture was centrifugated at 13.2 krpm for 1 min after a short time of 
vibration by a vortex. Clear green aqueous extract (900 μl) was removed out and 
used for labelling assays.  
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b. Extraction without 10% triton TX-100 
 
The process is same as above without using triton. 
 
General principle of ABPP  
 
Basic Material: 
TBS: 150 mM NaCl and 50 mM pH 7.5 Tris-HCl Buffer 
TBST: TBS + 0.1% Tween-20 
TBS + 3% BSA: 50 ml TBS + 1.5 g BSA 
Loading buffer (2 x SDS buffer): 5 ml total, 0.5 ml 1M pH 6.8 Tris, 3.5 ml 
50% glycerol, 1.6 ml 10% SDS, 0.4 ml BME + BFB 
 
Master solution: per each assay 
25 μl buffer (final 50 mM); 
0.5 μl 1M CaCl2 (end 1 mM); if needed 
0.5 mg L-Cys (final 1 mg/ml) or DTT (final 1 mM); if needed 
375 μl H2O  
 
Labelling 
 
To one Eppendorf tube (1.5 ml) with master solution (400 μl) was added fresh leaf 
extract (100 μl) and ABP (n μM). The mixture was rotated with a rotary shaker for 
n h and the labelling reaction was quenched with a -20°C acetone (1 ml). The 
proteins were centrifugated at 13 krpm for 2 min and supernatant was removed. 70 
% acetone (500 μl) of -20°C was added again. The proteins in acetone solution 
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were vortexed and centrifugated (1 min, 13 krpm) and the supernatant was removed. 
The protein pellets were dried at room temperature, resuspended in 50 μl SDS 
loading buffer, heated at 90°C for 10 min and stored at -20°C.  
 
Western blot for detecting biotinylated proteins: 
 
Samples were loaded onto polyacrylamide gel (12%) and proteins were transferred 
to a PVDF membrane (Millipore IVPH00010). The membrane was incubated with 
ultrasensitive streptavidin-HRP (Sigma S2438, dilution of 1:3000) and signals were 
detected using enhanced chemiluminescence (pierce femto ECL 34095)/(pico ECL 
34080) (Thermo Fisher Scientific, Bonn, Germny) on X-ray films (Kodak, 
Germany). 
 
Fluorescence scan for detecting fluorescent probe labelled proteins 
 
Samples were loaded onto polyacrylamide gel (12%). After a short time of washing 
the gel, proteins on the gel were directly scanned with a Typhoon 8600 variable 
mode imager.  
 
No probe control 
 
The protocol is same as above, only using same volume of DMSO instead of ABP 
solution. 
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Cloning for AvrPphB 
 
AvrPphB was amplified from Pseudomonas syringea pv. tomato DC3000 carrying 
AvrPphB with the primers we designed. Cloning vector pFK26 was digested with 
restriction enzymes XhoI and Pst1. PCR products were digested and ligated into 
pFK26 and the plasmids were transformed into E. coli. Successful clones, validated 
by nucleotide sequencing, were digested using the same restriction enzymes for 
shuttling into the PTP05 binary vector. Inserts in the generated pZM05 plasmid 
were confirmed by PCR using vector specific primers. 
 
Agrobacterium infiltration of AvrPphB construct 
 
pZM05 plasmids were transformed into Agrobacterium tumefaciens strain GV3101. 
Spin down the bacteria from the medium, add 0.5 to 1 ml MES Buffer (10 mM 
MgCl2, 10 mM 2-(N-Morpholino)ethanesulfonic acid) and measure OD. Tune the 
concentration and dilute OD into 2, add acetosyringon (final 10 mM). Let the 
mixture stay in darkness for 2 hours and in the meanwhile put water on the plant 
soil under light to activate the plant. When plant is treated water under light, the 
stomas back side of leaves will be open. The bacteria were infiltrated into the 
leaves of N. benthamiana with a syringe. 
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6.2.3 Procedures of ABPP 
All the procedures follow the general principle of ABPP, and the detail information 
of each assay is described according to the figure of the assay. 
 
Figure 3 
 
Wheat germ lipase Type I (WGL) and Pseudomonas fluorescence lipase (PL) were 
prepared as 0.5 mg/ml aqueous solutions, which were incubated with probes 23 and 
24 at a final concentration (4 μM) for 3 h at room temperature. Preparation of 
protein samples was followed the general method and the proteins on the protein 
blots were detected by streptavidin-HRP. 
 
Figure 4 
 
Arabidopsis leaf extracts (LE) and cell cultures (CC) were prepared as 5 mg/ml (LE) 
and 50 mg/ml (CC) pH 6 NaOAc buffer solutions respectively, which were 
incubated with probes 23 and 24 at a final concentration (4 μM) for 3 h at room 
temperature. Preparation of protein samples was followed the general method and 
the proteins on the protein blots were detected by streptavidin-HRP. 
 
Figure 5a/b 
 
Arabidopsis leaf extracts were prepared as 5 mg/ml pH 6 NaOAc buffer solutions, 
which were incubated with probe 23 at a final concentration (4 μM) and co-
incubated with inhibitors at a final concentration (40 μM) for competition labelling, 
for 3 h at room temperature. Preparation of protein samples was followed the 
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general method and the proteins on the protein blots were detected by streptavidin-
HRP. 
 
Figure 6 
 
a 
Arabidopsis leaf extracts were prepared as 5 mg/ml pH (4 or 6) NaOAc and (8 or 
10) Tris buffer solutions respectively, which were incubated with probe 23 at a 
final concentration (4 μM) for 3 h at room temperature.  
b 
Arabidopsis leaf extracts were prepared as 5 mg/ml pH 6 NaOAc buffer solutions 
with additional cofactors (Cysteine or CaCl2) respectively, which were incubated 
with probe 23 at a final concentration (4 μM) for 3 h at room temperature. 
c 
Arabidopsis leaf extracts were prepared as 5 mg/ml pH 6 NaOAc buffer solutions, 
which were incubated with probe 23 at a final concentration (4 μM) for (1/4, 1/2, 1, 
2, 3, 4, 5, 10) h at room temperature. 
d 
Arabidopsis leaf extract was separated as membrane proteome (M) and soluble 
proteome (S) with an ultra-centrifugation. Another equal leaf extract as total 
proteome (T) with M and S were prepared as 20 mg/ml (T) pH 6, NaOAc buffer 
solutions respectively, which were incubated with probe 23 at a final concentration 
(4 μM) for 3 h at room temperature. 
All preparation of protein samples was followed the general method and the 
proteins on the protein blots were detected by streptavidin-HRP. 
 
Zhe Ming Wang Experimental section Doctoral Dissertation 2009 
 - 236 - Chemical Genomics Centre (CGC) 
Figure 9a/b 
 
Arabidopsis leaf extracts were prepared as 5 mg/ml (a) and 0.15 mg/ml (b) pH 8 
Tris buffer solutions with DTT (1 mM), which were incubated with probes 38 - 45 
at a final concentration (2 μM) for 3 h at room temperature. Preparation of protein 
samples was followed the general method and the proteins on the protein blots were 
detected by streptavidin-HRP. 
 
Figure 10 
 
Arabidopsis leaf extracts were prepared as 50 μg/ml pH 7.4 TBS and pH 7.5 
caspase buffer solutions with DTT (1 mM) respectively, which were incubated with 
probes 41 and DCG-04 at a final concentration (2 μM) and co-incubated with 
inhibitors at a final concentration (60 μM) for competition labelling, for 3 h at room 
temperature. Preparation of protein samples was followed the general method and 
the proteins on the protein blots were detected by streptavidin-HRP. 
 
Figure 12 
 
a 
Arabidopsis leaf extracts were prepared as 50 μg/ml pH (4 – 6.5) NaOAC and pH 
(7 – 10) Tris buffer solutions with DTT (1 mM) respectively, which were incubated 
with probes 41 at a final concentration (2 μM) for 3 h at room temperature.  
b 
Arabidopsis leaf extracts were prepared as 50 μg/ml pH 8 Tris buffer solutions with 
or without DTT (1 mM) respectively, which were incubated with probes 41 at a 
final concentration (2 μM) for 3 h at room temperature. 
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c 
Arabidopsis leaf extracts were prepared as 50 μg/ml pH 8 Tris buffer solutions with 
DTT (1 mM), which were incubated with probes 41 at a final concentration (2 μM) 
for (1/30, 1/4, 1/2, 1, 2, 3, 4, 5, 6, 7, 8) h at room temperature. 
d 
Arabidopsis leaf extracts were prepared as (12.5, 25, 50, 100, 200) μg/ml pH 8 Tris 
buffer solutions with DTT (1 mM) respectively, which were incubated with probes 
41 at a final concentration (2 μM) for 3 h at room temperature. 
Preparation of protein samples was followed the general method and the proteins 
on the protein blots were detected by streptavidin-HRP. 
 
Figure 13a/b 
 
Arabidopsis leaf extracts were prepared as 50 μg/ml pH 8 Tris buffer solutions with 
DTT (1 mM), which were incubated with probes 41 and DCG-04 at a final 
concentration (2 μM) and co-incubated with inhibitors at a final concentration (30 
μM) for competition labelling, for 3 h at room temperature. Preparation of protein 
samples was followed the general method and the proteins on the protein blots were 
detected by streptavidin-HRP. 
 
Figure 18 
 
Arabidopsis leaf extracts were prepared as 50 μg/ml pH 8 Tris buffer solutions, 
which were incubated with probes 69 - 80 at a final concentration (5 μM) for 2 h at 
room temperature. The next step was followed “click chemistry” protocol 
(Kaschani et al., 2009). Preparation of protein samples was followed the general 
method and the proteins on the protein blots were detected by streptavidin-HRP. 
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Figure 19 
 
Arabidopsis leaf extracts were prepared as 200 μg/ml pH 6 NaOAc and pH 8 Tris 
buffer solutions, which were incubated with probes 82 - 86 and biotinylated 
AEBSF at a final concentration (20 μM) for 2 h at room temperature. Preparation 
of protein samples was followed the general method and the proteins on the protein 
blots were detected by streptavidin-HRP. 
 
Figure 20 
 
Arabidopsis leaf extracts were prepared as 30 μg/ml pH 8 Tris buffer solutions, 
which were incubated with a mixed probe of 84 and 87 at a final concentration (2 
μM) for 2 h at room temperature. Preparation of protein samples was followed the 
general method and the proteins labelled by fluorescent probe 87 on protein gel 
were detected by fluorescence photometer and proteins labelled by affinity probe 
84 on the protein blots from the same protein gel were detected by streptavidin-
HRP. 
 
Figure 21 
 
a 
Arabidopsis leaf extracts were prepared as 20 μg/ml pH 8 Tris buffer solutions, 
which were incubated with probe 87 at a final concentration (4 nM - 4 μM) for 2 h 
at room temperature.  
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b 
Arabidopsis leaf extracts were prepared as 20 μg/ml pH (4 – 6.5) NaOAc and pH (7 
– 9) Tris buffer solutions, which were incubated with probe 87 at a final 
concentration (2 μM) for 2 h at room temperature. 
Preparation of protein samples was followed the general method and the proteins 
on protein gel were detected by fluorescence photometer. 
 
Figure 25 
 
Arabidopsis leaf extracts were prepared as 20 μg/ml pH 8 Tris buffer solutions, 
which were pre-incubated with AEBSF at a final concentration (600 μM) for 1/2 h 
at room temperature and then incubated with probe 87 at a final concentration (2 
μM) for 2 h at room temperature. Preparation of protein samples was followed the 
general method and the proteins on protein gel were detected by fluorescence 
photometer. 
 
Figure 26 
 
Arabidopsis leaf extracts and mouse liver extracts were prepared as 20 μg/ml pH 8 
Tris buffer solutions, which were pre-incubated with AEBSF or Ac-AEBS at a final 
concentration (600 μM) for 1/2 h at room temperature and then incubated with 
probe 87 and BCR at a final concentration (2 μM) for 2 h at room temperature. 
Preparation of protein samples was followed the general method and the proteins 
on protein gel were detected by fluorescence photometer. 
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Figure 30 
 
Non-transformed Pseudomonas (-), Pseudomonas expressing HA-tagged (pFK141) 
or His-tagged (pFK142) AvrPphB were grown in rich medium (NYG) containing 
gentamicin (10 μg/ml) and rifampicin (30 μg/ml) at 28°C overnight. The bacteria 
were measured OD at 600 nm and calculated as 1.25 (-), 0.97 (pFK141) and 1.03 
(pFK142). The bacterial medium was centrifuged at 5000 rpm for 10 min and the 
liquid and pellets were separated. Secreted proteins in medium and proteins in 
bacterial pellet were Samples were loaded onto polyacrylamide gel (12%) and 
proteins were transferred to a PVDF membrane (Millipore IVPH00010). The 
membrane was incubated with anti-HA antibody (plant chemetics lab, dilution of 
1:3000) and followed with ultrasensitive streptavidin-HRP (Sigma S2438, dilution 
of 1:3000) and signals were detected using enhanced chemiluminescence (pierce 
femto ECL 34095)/(pico ECL 34080) (Thermo Fisher Scientific, Bonn, Germny) 
on X-ray films (Kodak, Germany). 
 
Figure 31 
 
a 
Non-transformed Pseudomonas (-), Pseudomonas expressing HA-tagged (pFK141) 
or His-tagged (pFK142) AvrPphB were grown in rich medium (NYG) and min-A 
medium containing gentamicin (10 μg/ml) and rifampicin (30 μg/ml) at 28°C 
overnight. The bacteria were measured OD at 600 nm and calculated as 0.78 (-), 
1.02 (pFK141) and 0.86 (pFK142) in NYG medium and 0.88 (-), 1.04 (pFK141) 
and 1.06 (pFK142) in min-A medium. The western blot was performed as same as 
above. 
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b 
Pseudomonas pellets were frozen with liquid nitrogen and crashed by metal balls 
with a shaker. After one minute shaking, the solid baterial powder were prepared as  
pH 8 Tris buffer solutions, which were incubated with probe 101 at a final 
concentration (5 μM) for 2 h at room temperature. Preparation of protein samples 
was followed the general method and the proteins on protein gel were detected by 
fluorescence photometer and the proteins were transferred to a PVDF membrane 
(Millipore IVPH00010) to perform the western blot as above and the protein blot 
was finally stained by coomassie. 
 
Figure 32 
 
Non-transformed Pseudomonas (-) and Pseudomonas expressing His-tagged 
(pFK142) AvrPphB were grown in min-A medium containing gentamicin (10 
μg/ml) and rifampicin (30 μg/ml) at 28°C overnight. The bacteria were measured 
OD at 600 nm and calculated as 0.47 (-) and 0.5 (pFK142). The bacterial proteome 
solutions were prepared following above procedure, which were incubated with 
probe 101 at a final concentration (5 μM) for 2 h at room temperature. After that, 
the 101 labelled AvrPphB were incubated with Nickel beads (50 μl, Qiagen Ni-
NTA Agarose) in 8 ml pH 7.4 PBS buffer for 1 h. The supernatant and beads were 
separated by centriguation at 3000 rpm for 5 min, and preparation of protein 
samples in both components was followed the general method. The proteins on 
protein gel were detected by fluorescence photometer and then stained by 
coomassie. 
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Figure 33 
 
Pseudomonas expressing HA-tagged (pFK141) was grown in min-A medium 
containing gentamicin (10 μg/ml) and rifampicin (30 μg/ml) at 28°C overnight. The 
bacteria were measured OD at 600 nm and calculated as 0.5 (pFK141). The 
bacterial proteome solutions were prepared following above procedure but with 
variant pH (6 – 9), which were incubated with probe 101 at a final concentration (5 
μM) for 2 h at room temperature. Preparation of protein samples was followed the 
general method. The proteins on protein gel were detected by fluorescence 
photometer. 
 
Figure 34 
 
Pseudomonas expressing HA-tagged (pFK141) was grown in min-A medium 
containing gentamicin (10 μg/ml) and rifampicin (30 μg/ml) at 28°C overnight. The 
bacteria were measured OD at 600 nm and calculated as 0.47 (pFK141). The 
bacterial proteome solutions were prepared following above procedure at pH 7, 
which were pre-incubated with inhibitors (92, 94, 96, 98, 100) at a final 
concentration (100 μM) for 1/2 h at room temperature and then incubated with 
probe 101 at a final concentration (5 μM) for 1.5 h at room temperature. 
Preparation of protein samples was followed the general method. The proteins on 
protein gel were detected by fluorescence photometer. 
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Figure 36 
 
a 
Arabidopsis leaf extracts of different lines: Columbia wildtype (Col), -VPE over 
expressed (O), -VPE knockout (K), , , , -VPEs quadruple knockout (K) 
were prepared as 100 μg/ml pH 5.5 NaOAc buffer solutions, which were incubated 
with probe 107 at a final concentration (5 μM) for 2 h at room temperature. 
Preparation of protein samples was followed the general method and the proteins 
on protein gel were detected by fluorescence photometer and stained by coomassie. 
b 
Arabidopsis leaf extracts of -VPE over expressed (O), were prepared as 100 
μg/ml pH 5.5 NaOAc buffer solutions, which were pre-incubated with 106 at a 
final concentration (100 μM) for 1/2 h at room temperature and then incubated with 
probe 107 at a final concentration (5 μM) for 2 h at room temperature. Preparation 
of protein samples was followed the general method and the proteins on protein gel 
were detected by fluorescence photometer. 
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